CURRICULUM VITAE

MARILIE DENISE GAMMON

May 2016 EDUCATION 1989 Yale University Ph.D., Chronic Disease Epidemiology 1982 University of Washington, Seattle M.S.P.H., Epidemiology & International Health 1974 University of California, Berkeley B.S., Conservation of Natural Resources ACADEMIC APPOINTMENTS 2006-present University of North Carolina at Chapel Hill Program Leader, Environmental and Occupational Epidemiology Department of Epidemiology, School of Public Health 2003-present University of North Carolina at Chapel Hill Professor with permanent tenure, Department of Epidemiology, School of Public Health 2002-2014 University of North Carolina at Chapel Hill Deputy Director, Center for Environmental Health and Susceptibility, School of Public Health 1999-2003 University of North Carolina at Chapel Hill Associate Professor with permanent tenure, Department of Epidemiology, School of Public Health 1996-1999 Columbia University in the City of New York, NY Associate Professor of Clinical Public Health (Epidemiology), Joseph L. Mailman School of Public Health 1989-1996 Columbia University in the City of New York, NY Assistant Professor of Public Health (Epidemiology), School of Public Health 1986-1989 Yale University, New Haven, CT Research Associate, Department of Epidemiology and Public Health, School of Medicine 1982-1985 Harvard University, Boston, MA Associate, Department of Dental Care Administration, School of Dental Medicine

PROFESSIONAL ORGANIZATIONS 2011-present Member, AACR, American Association for Cancer Research 2005-present Member, TOS, The Obesity Society 2004-2009 Program Leader, Obesity and Chronic Diseases, Inter-Disciplinary Obesity Center, University of North Carolina 2001-2014 Member, University of North Carolina Center for Environmental Health and Susceptibility, University of North Carolina 2000-present Fellow, ACE, American College of Epidemiology

MD GAMMON

2

1999-present Member, The Lineberger Comprehensive Cancer Center, University of North Carolina 1994-present Member, ASPO, American Society of Preventive Oncology 1994-1999 Member, NY Cooperative Cancer Epidemiology and Prevention Group 1993-1999 Member, Herbert Irving Columbia-Presbyterian Comprehensive Cancer Center 1985-present Member, SER, Society for Epidemiologic Research HONORS 2014 Faculty Award for Excellence in Doctoral Mentoring, The Graduate School, University of North Carolina at Chapel Hill 2012 Nominated for the Faculty Award for Excellence in Doctoral Mentoring, The Graduate School, University of North Carolina at Chapel Hill 2006 Nominated for the Carolina Women's Leadership Council Mentoring Award, University of North Carolina at Chapel Hill 2005 Top NIH Grantee: Above the 95th percentile of the distribution of National Institutes of Health extramural grants over the last 25 years 2002 Certificate of Appreciation, Long Island Breast Cancer Network 2001 Nominated as Candidate for President, Society for Epidemiologic Research 1995 Voted Most Valuable Course (Principles of Epidemiology, Instructor: MD Gammon), Executive MPH Program Alumni Survey, Columbia University

1991-1993 Calderone Junior Faculty Award, Columbia University 1985-1988 National Cancer Institute Training Grant, Yale University 1986 NCI Program on the Histopathobiology of Cancer, Keystone, CO 1977-1980 Public Health Service Training Grant, University of Washington 1974 Honors at Graduation, UC Berkeley 1973-1974 Irene Purrington Award, UC Berkeley 1973-1974 Phoebe A. Hearst Award, UC Berkeley 1970-1972 California State Scholarship Award, UC Berkeley 1970-1972 California Alumni Scholarship Award, UC Berkeley 1970 Honors at Entrance, UC Berkeley 1970 California Scholastic Federation, Seal Bearer, State of California 1969 Americans Abroad Program, AFS Student, Ceylon (Sri Lanka) RESEARCH AWARDS Past Support: 1989-1992 NCI RFP-CP95604-32; Breast Cancer in Women Under Age of 45. PI: JB

Schoenberg (New Jersey State Department of Health), Subcontract PI: JL Kelsey, Co-Investigator: MD Gammon, 20 percent effort, 10/1/89-9/30/92, $23,248 (direct costs).

1991-1992 Calderone Research Award, Columbia University Pilot Study: Feasibility of Assessing Residential Exposure to Electromagnetic Fields (EMF) Among Young Women in New Jersey. PI: MD Gammon, as needed, 7/1/91-6/30/92, $3,500 (direct costs).

1992-1993 NCI RFP-CP95604-32: Breast Cancer in Women Under Age of 45 (Extension). PI: JB Schoenberg (New Jersey State Department of Health). Subcontract PI: MD Gammon, 15 percent effort, 10/1/92-4/30/93, $7,381 (direct costs).

MD GAMMON

3

1992-1993 Calderone Award, Columbia University (Extension): Differences in breast cancer among black and white women. PI: MD Gammon, as needed, 7/1/92-6/30/93, $3,500 (direct costs).

1991-1994 NCI R01 CA50658: Case/Control Study of Benign Ovarian Neoplasms. PI: CL Westhoff, Co-Investigator: MD Gammon, 20 percent effort, 8/1/91-7/31/94, $820,930 (direct costs).

1994-1995 NCI 2P30CA13696-22: Columbia-Presbyterian Cancer Center. PI: I.B. Weinstein, Ph.D., Seed Funds: Pre- versus Post-treatment Blood Levels of Organochlorine Pesticides Among Newly Diagnosed Breast Cancer Patients. PI: MD Gammon, as needed basis, $11,000 (direct costs).

1994-1995 NCI 1R21CA/ESA66224-01: Columbia Cancer Center Breast Cancer Research Programs. PI: KH Antman. Ancillary Funds for a Pilot Project: Breast Cancer and the Environment on Long Island. PI: MD Gammon, 40 percent effort, $165,329 (direct costs).

1992-1996 NCI 1U01 CA57983: Adenocarcinomas of the Esophagus and Gastric Cardia. PI: MD Gammon, 30 percent effort, $1,110,381 (direct costs).

1995-1996 NCI 1R21CA/ES66224-01: Columbia Cancer Center Breast Cancer Research Programs. PI: KH Antman. Seed Funds: Preliminary Studies for Columbia-HIP Minority Cohort Study. PI: A Neugut, Co-Investigator: MD Gammon, as needed basis, $20,000 (direct costs).

1995-1996 NCI 1R21CA/ES66224-01: Columbia Cancer Center Breast Cancer Research Programs. PI: KH Antman. Seed Funds: Cyclin D, p53, and Breast Cancer in New Jersey. PI: MD Gammon, as needed basis, $20,000 (direct costs).

1994-1997 U.S. Army DAMD-94-j-4250 AIBS 2445: Oral Contraceptive Use and HER-2/neu-Positive Breast Cancer among White and Black Women. PI: MD Gammon, 10 percent effort, $149,973.

1996-1997 NCI 1R21CA/ES66224-02: Columbia Cancer Center Breast Cancer Research Programs. PI: KH Antman, Seed Funds: Comparative Genotype of Inherited and Sporadic Breast Cancer. PI: J Krolewski, Co-Investigator: MD Gammon, as needed basis, $20,000 (direct costs).

1996-1997 NCI 1R21CA/ES66224-02: Columbia Cancer Center Breast Cancer Research Programs. PI: KH Antman. Seed Funds: Alternative Medical Therapies and Breast Cancer Outcomes. PI: J Jacobsen, Co-Investigator: MD Gammon, as needed basis, $15,000 (direct costs).

1996-1997 NCI 1R21CA/ES66224-02: Columbia Cancer Center Breast Cancer Research Programs. PI: KH Antman. Seed Funds: Polymorphic enzymes and breast cancer. PI: H Ahsan, Co-PI: MD Gammon, as needed basis, $15,000 (direct costs).

1997-1998 NCI/NIEHS UO1CA/ES66572 (Supplement): Breast Cancer and the Environment on Long Island: Supplement to the Long Island Breast Cancer Study Project to Expand Subject Recruitment Efforts. PI: MD Gammon, as needed, $135,000

1996-1999 NCI RO1 CA69361: The Prevalence of BRCA1: A Population-Based Study. PI: J Bernstein (Mt. Sinai), Subcontract PI: MD Gammon, 2.5 percent effort, $1,317,452 (direct costs)

1997-1999 NCI 1R21CA/ES66224-01: Columbia Cancer Center Breast Cancer

MD GAMMON

4

Research Programs. PI: KH Antman. Seed Funds: 4-Amino-biphenyl DNA-adducts in breast cancer. PI: R Santella, Co-PI: MD Gammon, as needed basis, $15,000 (direct costs).

1997-1999 NCI RO3 CA77185 NAT2: Genetic Polymorphisms and Risk of Breast Cancer. PI: H Ahsan, Co-PI: MD Gammon, as needed, $49,995 (direct).

1997-1999 NCI RO1 CA64245: The Molecular Epidemiology of Breast Cancer. PI: J Bernstein (Mt. Sinai), Subcontract PI: MD Gammon, 4.5 percent effort, $1,286,222 (direct costs).

1998-1999 CRFA, Cancer Research Foundation of America: CYP19 Polymorphism and Risk of Breast Cancer. PI: H Ahsan, Co-PI: MD Gammon, as needed, $35,000 (direct).

1998-1999 NIEHS P30ES09089: Center for Environmental Health in Northern Manhattan. PI: J Graziano, Co-Investigator: MD Gammon, as needed, $499,987.

1998-1999 AMDEC: Feasibility Study for a Multi-ethnic Cohort Study in New York City. PI: AI Neugut, Co-Investigator: MD Gammon, 10 percent effort.

1996-2001 NCI/NIEHS UO1CA/ES66572 (Supplement): Breast Cancer and the Environment on Long Island: Supplement to the Long Island Breast Cancer Study Project to Enlarge the Environmental Sampling and Laboratory Analyses Component among African Americans. PI: MD Gammon, as needed, $419,859.

1997-2001 NCI/NIEHS UO1CA/ES66572 (Supplement): Breast Cancer and the Environment on Long Island: Supplement to the Long Island Breast Cancer Study Project for a Feasibility Study of Geographic Modeling. PI: MD Gammon, as needed, $169,000.

1998-2001 U.S. Army BC972005: Cytochrome P450C17 Polymorphi Cancer. PI: H Ahsan, Co-PI: MD Gammon, as needed, $232,732.

1999-2001 NCI R03CA81619: Cancer-Related Behaviors among Latinos. PI: A Abraido-Lanza, Co-Investigator: MD Gammon, as needed, $161,514

2001-2002 UNC, Population-based Research Advisory Committee and Lineberger Cancer Center: Pilot Studies for the Carolina’s Health Among the African AMerican Population (CHAAMP) Study. PI: MD Gammon, as needed, $37,500 (annual direct).

1998-2003 U.S. Army BC972772: p53, Environmental Risk Factors and Breast Cancer: A Population-Based Study. PI: MD Gammon, as needed, $456,638.

2000-2004 U.S. Army BC990191: Folate, Genetic Susceptibility and Breast Cancer Risk. PI: J Chen, Co-Investigator: MD Gammon, as needed, $399,759.

2002-2005 U.S. Army DAMD17-02-1-0522: Estrogen Receptor Alterations in Benign Breast Lesions and the Risk of Subsequent Breast Cancer. PI: K Conway-Dorsey, Co-investigator: MD Gammon, 3% effort, $435,716.

2002-2005 Lance Armstrong Foundation: Complimentary and Alternative Medicine (CAM) Use among Breast Cancer Survivors on Long Island. PI: J Jacobson, Co-investigator: MD Gammon, as needed, $150,000.

2003-2004 Breast Cancer Research Foundation: Environmental Exposures and Genetic Susceptibility. PI: RM Santella, Co-investigator: MD Gammon, as needed, $200,000 per year.

2003-2005 Avon Breast Cancer Foundation: Gene-environment interactions in breast cancer risk and survival. PI: R Santella, Co-investigator: MD Gammon, as needed, $200,000.

MD GAMMON

5

2001-2006 NCI P50 CA58233: Specialized Program of Research Excellence in Breast Cancer (SPORE). PI: HS Earp, Research Program Leader Project #3: MD Gammon, Oxidative Stress and Breast Cancer Risk: The Long Island Breast Cancer Study Project, 20%, $1,749,208 (annual direct)

2004-2006 American Institute for Cancer Research AICR-03B091: Cooked Meat, DNA Repair Genes, and Breast Cancer. PI: MD Gammon, 5% effort, $90,378.

2005-2006 Lance Armstrong Foundation: Flavonoid intake and breast cancer incidence and survival. PI: MD Gammon, 10% effort, $144,000.

1995-2007 NCI/NIEHS UO1CA/ES66572: Breast Cancer and the Environment on Long Island (Long Island Breast Cancer Study Project). PI: MD Gammon, 30 percent effort, $6,455,798 (years 1-6); $1,527,373 (years 7-12).

2004-2007 U.S. Army BC031746: One-Carbon Metabolism and Breast Cancer Survival. PI: J Chen, Subcontract PI: MD Gammon, 5% effort, $205,763.

2006-2007 Lance Armstrong Foundation, Survivorship Center of Excellence, Planning Grant. PI: M Campbell, Steering Committee Member: MD Gammon, as needed. 2004-2009 NIH Roadmap: Inter-Disciplinary Obesity center (IDOC). PI: B Popkin, Program

Leader (Chronic Disease Epidemiology): MD Gammon, 10% effort, $1,752, 000.

2006-2009 NCI R03CA125768 Telomere Dysfunction, Oxidative Damage, and Breast Cancer Risk. PI: J Shen, Subcontract PI: MD Gammon, 5% effort, $100,000, no cost extension.

2006-2011 NCI R01 CA109753. Dietary methyl content, epigenetics and etiology of breast cancer: a population-based study. PI: J Chen, Subcontract PI: MD Gammon, 10% effort (including supplement), $2,464,426 (total).

2008-2012 Lance Armstrong Foundation Survivorship Center of Excellence. PI: M Campbell, Steering Committee Member: MD Gammon, 3% effort.

2010-2012 NCI R03CA139261: Dietary supplement use, physical activity, body mass index, and pancreatic cancer risk. PI: K He, Co-Investigator: MD Gammon, 5% effort, $100,000. 2008-2013 NCI U01CA122171 Genome Wide Association Study for Early Onset Breast Cancer. PI: H Ahsan, Center PI: MD Gammon, as needed. 2002-2014 NIEHS P30ES10126: University of North Carolina-CH Center for Environmental

Health and Susceptibility. PI: J Swenberg. Deputy Director: MD Gammon, 20% effort, $3,756,803.

2009-2014 NCI R01CA136725 Genome Wide Association Study for the Esophageal Adenocarcinoma Disease Spectrum. PI: T Vaughan, Co-Investigator: MD Gammon, 5% effort 2012-2014 NCI R03: CA159409 Flavonoid intake, esophageal adenocarcinoma and Barrett’s esophagus. PI: MD Gammon, 3% effort. 2010-2015 NCI U54: Racial disparities in cancer outcomes. Co-PIs HS Earp, Richards. Co- Investigator: MD Gammon, 10% effort. 2010-2015 NIEHS 5U01ES019459: Breast cancer genomics in windows of susceptibility to endocrine disruptors. Co-PIs: S Teitelbuam, J Chen, Sub-contract PI: MD Gammon, 5% effort 2014-2015 BETRnet Pilot Project: Sugar/carbohydrate intake and the Barrett’s esophagus-

esophageal adenocarcinoma continuum PI: MD Gammon, donated effort, $35,000

MD GAMMON

6

Active Support: 2013-2018 NCI RO1 CA8630725: MicroRNA and breast cancer risk. PI: J Chen, Subcontract PI: MD Gammon, 5% effort MENTORED/TRAINING RESEARCH AWARDS Past Awards: 1990-1999 NCI 5-T32 CA09529-10: Training Program in Cancer Epidemiology, Biostatistics,

and Environmental Science. PI: AI Neugut, Preceptor: MD Gammon, as needed.

2001-2003 ACS Clinical Research Training Grant for Junior Faculty CRTG-01-019-01-CCE: Alcohol intake, metabolism, and breast and esophageal cancer risk. PI: MB Terry, Mentor: Primary MD Gammon, as needed, $272,000.

2001-2003 NIOSH/CDC: Occupational Safety and Health Education and Research Center, Occupational Epidemiology Program (Bonnie Rogers, Center Director, Dana Loomis, Program Director). Preceptor: MD Gammon, as needed.

2001-2004 U.S Army Pre-doctoral Award BC000556: Insulin-like Growth Factor I Gene Polymorphisms in Breast Cancer. PI: R Cleveland, MPH, Primary Mentor: MD Gammon, as needed, $66,000.

2003-2005 U.S. Army Pre-doctoral Award BC021366: Interactions of Lifestyle Factors, Manganese Superoxide Dismutase, Catechol-O-Methyltransferase, and the Risk of Breast Cancer. PI: M Gaudet, Primary Mentor: MD Gammon, as needed, $60,000.

2004-2006 Susan G. Komen Breast Cancer Foundation DISS0402898 Predoctoral Fellowship. Reproduction, Oral Contraceptives and Breast Cancer Survival among Young Women. PI: Katrina Trivers, MPH. Primary Mentor: MD Gammon, as needed, $30,000

2001-2006 NCI U56 CA91419: NCCU/UNC Lineberger Partnership in Cancer Research. PI: HS Earp, Mentor: MD Gammon, as needed, $125,000 per year.

2003-2007 NCI 1K07CA102640: Gene-Nutrient Interactions and Breast Cancer. PI: SS Scott, Primary Mentor: MD Gammon, as needed, $620,000.

2004-2009 NCI KO1 CA104517: Insulin-like Growth Factors and Esophageal Cancer. PI: C Hoyo, Primary Mentor: MD Gammon, as needed, $650,348. (no cost extension)

2004-2009 ACS Mentored Award: IGF polymorphisms and Esophageal Cancer. PI; C Hoyo, Primary Mentor: MD Gammon, as needed (no cost extension) 2004-2007 NCI T32CA72319: NCI Nutritional Biochemistry and Cancer Epidemiology

Training Grant. PI: S Zeisel, Preceptor: MD Gammon, as needed 2005-2010 NIH Roadmap: Inter-Disciplinary Postdoctoral Training in Obesity. PI: B Popkin, Preceptor: MD Gammon, as needed. 2008-2010 NCI 1R03CA136077-01: Cancer Survivors’ Information Seeking and Lifestyle

Behaviors. PI: D Mayer, Ph.D., RN. Mentor: MD Gammon, as needed, $108, 377.

2006-2010 NIH L30 CA124219-01, Loan Repayment for Clinical Research: GST poylmorphisms, PAH and organochlorine exposures, and breast cancer risk

and survival. PI: K McCarty, Ph.D. Primary Mentor: MD Gammon, as needed, $24,497.

2008-2011 Susan B. Komen Breast Cancer Foundation, Career Catalyst Research Award:

MD GAMMON

7

Effects of biologically related genetic variants and biomarkers of obesity and type II diabetes on breast cancer survival and incidence. PI: R Cleveland. Primary Mentor: MD Gammon, as needed, $341,156.

2001-2012 NCI 2-T32-CA09330: Training Grant in Cancer Epidemiology. PI: A Olshan, Preceptor: MD Gammon, as needed, $1,647,733.

2010-2013 Susan B. Komen Breast Cancer Foundation KG101573: Identifying modifiable determinants of cardiovascular disease outcomes among breast cancer survivors. Postdoctoral Trainee: Patrick Bradshaw, Ph.D.; PI: MD Gammon, as needed, $180,000. (Declined final year of grant to accept another award.)

2010-2013 Department of Defense, U.S. Army: BC093608 Modifying Effects of DNA repair variants on physical activity and breast cancer risk. PI: L McCullough, MSPH. Primary Mentor: MD Gammon, as needed, $127,157.

2011-2013 American Lung Association, Healthy Lungs Dissertation Award: Air pollution and TB. PI: Genee Smith, MSPH. Primary Mentor: MD Gammon, as needed, $42,000.

2011-2014 Department of Defense, U.S. Army: Vehicular traffic, genetic susceptibility, and breast cancer risk. PI: I Mordukhovich, MSPH. Primary Mentor: MD Gammon, as needed, $150,000.

2008-2014 NIEHS ES007127: Pre- and Postdoctoral Training in Toxicology. PI: J Swenberg, Program Faculty: MD Gammon, as needed. Active Awards: 2001-present NIH T32 DK07634: Digestive Epidemiology Training Program. PI: R Sandler,

Preceptor: MD Gammon, as needed. 2002-present NIH R25 CA057726: Cancer Control Education Program. PI: JAL Earp,

Preceptor: MD Gammon, as needed. 2007-present NIEHS ES07018: Biostatistics for Research in Environmental Health. PI: A

Herring, Program Leader in Epidemiology: MD Gammon, as needed, $777,156.

2015-2017 NCI CA171524: Cancer Research Network Scholars Program. “Trends in surgical menopause and implications for breast cancer disparities: a pilot study of data from Kaiser Permanente Northern California” PI: L Kushi; Scholar: W Robinston; Primary Host Institution Mentor: MD Gammon, as needed.

MENTORING Junior Faculty Mentoring (n = 16): 2016-present Laura Loehr, M.D., Ph.D., University of North Carolina, Chapel Hill, Research

Assistant Professor, Department of Epidemiology Career Development Committee, Role: MD Gammon, Co-mentor with Gerardo Heiss, M.D., Ph.D.

2014-present Whitney Robinson, Ph.D., University of North Carolina, Chapel Hill, Assistant Professor, Department of Epidemiology Career Development Committee, Role: MD Gammon, Co-mentor with Steve Cole, Ph.D. and now Til Sturmer, Ph.D.; and Cancer Research Network (CRN) Scholars Program, National Cancer Institute, applicant. Role: MD Gammon, Primary Mentor.

2012-2013 Karin Yeatts, Ph.D., University of North Carolina, Chapel Hill, Research Assistant Professor without tenure, Department of Epidemiology Career Development Committee. Role: MD Gammon, Co-mentor with Til Sturmer, M.D., Ph.D.

MD GAMMON

8

Currently, Clinical Assistant Professor, Department of Epidemiology, University of North Carolina at Chapel Hill.

2010-2013 Stephanie Engel, Ph.D., University of North Carolina, Chapel Hill, Associate Professor without tenure, Department of Epidemiology Career Development Committee. Role: MD Gammon, Co-mentor with Gerardo Heiss, M.D., Ph.D. Currently Associate Professor with tenure, University of North Carolina at Chapel Hill.

2009-present Kathy Conway Dorsey, Ph.D., University of North Carolina, Chapel Hill, Department of Epidemiology, Research Assistant Professor without tenure, Department of Epidemiology Career Development Committee. Role: MD Gammon, Co-mentor with Ralph Baric, Ph.D., and now with Steve Meshnick, M.D., Ph.D.

2008-2012 Rebecca Cleveland, Ph.D., University of North Carolina, Chapel Hill, Research Assistant Professor, Department of Nutrition, Susan B. Komen Breast Cancer Foundation: Career Catalyst Award, “Effects of biologically related genetic polymorphisms and biomarkers of obesity and type II diabetes on breast cancer risk and survival” Role: MD Gammon, Primary Mentor. Currently, Department of Medicine, University of North Carolina at Chapel Hill

2007-2009 Katherine Crew, MD, MPH, Columbia University in the City of New York, Assistant Professor, Department of Biostatistics, Jean Sindab Award, “Vitamin D and breast cancer risk and survival,” Role: MD Gammon, Co-mentor; primary mentor, Regina Santella, Ph.D., Currently, Assistant Professor, Department of Medicine, Columbia University, NY NY.

2006-2012 Kathleen McCarty, Ph.D., Yale University, New Haven CT, Division of Environmental Health, Department of Epidemiology and Public Health, Assistant Professor, NIH L30 CA124219-01, Environmental exposures, genetic polymorphisms, and breast cancer risk and survival." Role: MD Gammon, Primary Mentor.

2006-2011 Jing Shen, Ph.D., Columbia University in the City of New York, Research Assistant Professor, Department of Environmental Health Sciences, RO3 CA125768, “Telomere dysfunction and breast cancer risk,” Role: MD Gammon, Co-mentor; primary mentor, Regina Santella, Ph.D.

2004-2009 Cathrine Hoyo, Ph.D., Duke University, Assistant Professor, Department of Community and Preventive Medicine, NCI KO1 CA104517-01 and ACS Mentored Award "Insulin-like growth factors, obesity and esophageal adenocarcinoma." Role: MD Gammon, Primary Mentor. Currently, Associate Professor, Department of Obstetrics and Gynecology, Duke University & Department of Toxicology, North Carolina State University.

2004-2009 Susan Teitelbaum, Ph.D., Mt. Sinai School of Medicine, Assistant Professor, Department of Community and Preventive Medicine, U.S. Army BC030558 and NIEHS K01 ES012645-01 “Xenoestrogens and breast cancer risk.” Role: Marilie Gammon, Co-Mentor; primary mentor, Mary Wolff, Ph.D. Currently, Associate Professor, Mt. Sinai School of Medicine. Currently, Associate Professor, Department of Preventive Medicine, Ican School of Medicine at Mt. Sinai, New York, NY.

2003-2009 Susan Steck, Ph.D., University of North Carolina, Chapel Hill, Marilyn Gentry Fellow and Assistant Professor, Department of Nutrition, NCI

MD GAMMON

9

K07CA102640, "Gene-nutrient interactions and breast cancer." Role: MD Gammon, Primary Mentor. Currently Associate Professor, Department of Biostatistics and Epidemiology, University of South Carolina, Columbia SC

2001-2005 Judith Jacobson, Dr.P.H., Columbia University in the City of New York, Assistant Professor of Clinical Public Health, Lance Armstrong Award, “CAM use among breast cancer survivors on Long Island, NY.” Role: MD Gammon, Co-Mentor; primary mentor Alfred Neugut, M.D., Ph.D. Currently, Associate Professor of Clinical Public Health, Columbia University, New York, NY.

2001-2003 Mary Beth Terry, Ph.D., Columbia University in the City of New York, Assistant Professor, Department of Epidemiology, ACS Clinical Research Training Grant for Junior Faculty CRTG-01-019-01-CCE, "Alcohol intake, metabolism, and breast and esophageal cancer risk," Role: Primary Mentor. NCI K-Award “Prenatal exposures and breast cancer risk.” Role: MD Gammon, Co-Mentor; Primary mentor, Alfred Neugut, M.D., Ph.D. Currently Professor, Department of Epidemiology, Columbia University, New York, NY

1999-2004 Jia Chen, Ph.D., Mt. Sinai School of Medicine, Assistant Professor, Department of Community Medicine, U.S. Army BC990191, “Folate intake, genetic susceptibility, and risk of breast cancer.” Role: MD Gammon, Co-Mentor with Regina Santella, Ph.D., Columbia University. Currently, Professor, Mt. Sinai School of Medicine, New York, NY.

1999-2004 Ana F. Abraído-Lanza, Ph.D., Columbia University, Assistant Professor, Department of Sociomedical Sciences, NCI 1R03CA81619, “Breast and Cervical Cancer Screening Among Latinas and Non-Latina Whites.” Role: MD Gammon, Primary Mentor. Currently Associate Professor, Columbia University, New York, NY

1999-2001 Julie Britton, Ph.D., Mt Sinai School of Medicine, Research Assistant Professor, CI RFP-CP95604-32 and NCI R01 CA50658 “Modifiable risk factors and

reproductive tumors.” Role: MD Gammon, Co-Mentor; Primary mentor, Mary Wolff, Ph.D. Currently Research Assistant Professor, Department of Community and Preventive Medicine, Mt. Sinai School of Medicine, New York, NY (on leave)

Postdoctoral Fellow Mentoring (n=9): 2013-2015 Lauren McCullough, Ph.D., University of North Carolina, Chapel Hill, Department

of Epidemiology, Postdoctoral Fellow, The UNC Lineberger Cancer Control Education Fellow (NIH R25 CA057726), “Epigenetics and the associations of obesity, physical activity, and breast cancer.” Role: MD Gammon, Primary Mentor. Currently, Rollins Endowed Assistant Professor, Department of Epidemiology, Emory University, Atlanta GA.

2011- 2014 Monica Nye, Ph.D. University of North Carolina, Chapel Hill, Department of Epidemiology, Postdoctoral Fellow, The UNC Lineberger Cancer Control Education Fellow (NIH R25 CA057726). “Early life environmental exposures and reproductive outcomes: implications for carcinogensis.” Role: MD Gammon, Primary Mentor. Currently, Instructor, Department of Biology, University of North Carolina at Charlotte.

2010-2011 Patrick Bradshaw, Ph.D., University of North Carolina, Chapel Hill, Department of

MD GAMMON

10

Epidemiology, Postdoctoral Fellow, Susan B. Komen Breast Cancer Foundation: Postdoctoral Fellowship – Translational Research (KG101573), “Identifying Modifiable Determinants of Cardiovascular Disease Outcomes among Breast Cancer Survivors” Role: MD Gammon, Primary Mentor. Currently, Assistant Professor and Martin Sisters Endowed Chair in Medical Research and Public Health, Division of Epidemiology, University of California, Berkeley.

2008-2010 Yoon Hee Cho, Ph.D., Columbia University in the City of New York, Department of Environmental Health Sciences, Postdoctoral Fellow, Breast Cancer Research Foundation, “Gene-specific promoter hypermethylation and breast cancer prognosis.” Role: MD Gammon, Co-mentor; Primary mentor: Regina Santella, Ph.D. Currently, Assistant Professor, University of Idaho.

2005-2009 Pavel Rossner, Jr., Ph.D. Columbia University in the City of New York, Department of Environmental Health Sciences, Postdoctoral Fellow, Breast Cancer Research Foundation, “DNA repair and breast cancer risk and survival.” Role: MD Gammon, Co-mentor; Primary mentor: Regina Santella, Ph.D. Currently, Laboratory of Genetic Ecotoxicology, Institute of Experimental Medicine AS CR, Prague, Czech Republic

2005-2007 Rebecca Cleveland, Ph.D., University of North Carolina, Chapel Hill, Postdoctoral Fellow, Department of Epidemiology, NCI T32CA72319: Nutrition and Cancer Training Grant, "Energetic-related exposures, genetic polymorphisms, and breast cancer risk and survival." Role: MD Gammon, Primary Mentor. Currently, Department of Medicine, University of North Carolina, Chapel Hill

2005-2006 Kathleen McCarty, Ph.D., University of North Carolina, Chapel Hill, Postdoctoral Fellow, Department of Epidemiology, NIEHS ES07018: Environmental Health Training Grant” “Environmental exposures, genetic polymorphisms,

and breast cancer risk and survival.” Role: MD Gammon, Primary Mentor. Currently, Associate Director (on medical leave), Epidemiology, Biogen, Cambridge MA, and Adjunct Research Assistant Professor, Department of Preventive Medicine, Mt. Sinai School of Medicine, New York, NY.

2004-2006 Jing Shen, Ph.D., Columbia University in the City of New York, Postdoctoral Fellow, Department of Environmental Health Sciences, Breast Cancer Research Fund, “Gene-environmental interactions and breast cancer risk.” Role: MD Gammon, Co-mentor; Primary mentor, Regina Santella, Ph.D. Currently, Assistant Professor, Department of Environmental Health Sciences, Columbia University, New York, NY

1995-1997 Habibul Ahsan, MBBS, MPH, Columbia University in the City of New York Postdoctoral Fellow, Department of Epidemiology, NCI 1U01 CA57983 "Epidemiology of esophageal adenocarcinoma." Role: MD Gammon, Co-

mentor; Primary mentor: Alfred Neugut, M.D., Ph.D. Currently Professor, University of Chicago, IL

Predoctoral Student Dissertation/Thesis Committee Chair (n=25): 2015-present Shahar Shmuel, MPH, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. student, Department of Epidemiology, “Modifiable risk factors for breast cancer.” Role: MD Gammon, Primary Mentor 2015-present TengTeng Wang, MPH, University of North Carolina at Chapel Hill, School of

MD GAMMON

11

Public Health, Ph.D. student, Department of Epidemiology, “Inflammation-related risk factors and cancer.” Role: MD Gammon, Primary Mentor

2014-present Humberto Parada, MPH, University of North Carolina at Chapel Hill, School of Public Health, Currently Ph.D. candidate, Department of Epidemiology, “Changes in long-term PAH exposures and survival following breast cancer.” Role: MD Gammon, Primary Mentor

2013-present Kathleen McClain, MPH, University of North Carolina at Chapel Hill, School of Public Health, Currently Ph.D. student, Department of Epidemiology.

“Polyunsaturated fatty acid intake and the Barrett’s esophagus-adenocarcinoma: a pooled analysis.” Role: MD Gammon, Primary Mentor

2012-present Nan Li, MSPH, University of North Carolina at Chapel Hill, School of Public Health, Currently Ph.D. candidate, Department of Epidemiology. “Intake of sugar, carbohydrates and the Barrett’s esophagus-adenocarcinoma cancer continuum: a pooled analysis.” Role: MD Gammon, Primary Mentor

2012-2015 Alexandra White, MSPH, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Epidemiology, NIEHS Environmental Epidemiology Predoctoral Traineee (ES07018); and The UNC Lineberger Cancer Control Education Fellow (NIH R25 CA057726), “Long-term sources of polycyclic aromatic hydrocarbons, methylation, and breast cancer risk.” Role: MD Gammon, Primary Mentor. Currently, Postdoctoral Fellow, National Institute of Environmental Health Sciences, Research Triangle Park, NC.

2010-present Peter Samai, MPH, University of North Carolina at Chapel Hill, School of Public Health, Currently Ph.D. student, Department of Epidemiology: Role: Doctoral Dissertation Committee Chair, “Changes in obesity, physical activity and pancreatic cancer risk: the Vital cohort study.” Role: MD Gammon, Primary Mentor.

2010-2014 Nikhil Khankari, Ph.D, University of North Carolina at Chapel Hill, School of Public Health. Ph.D. candidate, Department of Epidemiology, NCI CA109753: “Dietary methyl intake, epigenetics and breast cancer risk;” and NCI 2-T32-CA09330: Cancer Epidemiology Training Grant, “Poly-unsaturated fatty acids, genetic susceptibility and breast cancer risk.” Role: MD Gammon, Primary Mentor. Currently, Molecular Cancer Epidemiology Postdoctoral Fellow, Vanderbilt University, Nashville TN.

2009-2014 Jessica Jensen Petrick, Ph.D, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Epidemiology, NIEHS ES07018 Environmental Health Training Grant; NCI T32-CA09330; and NIH RO3 Award: Cancer Epidemiology Training Grant: “Flavonoid intake and risk of Barrett’s esophagus and esophageal-gastric cardia adenocarcinomas.” Role: MD Gammon, Primary Mentor. Currently, Epidemiology & Genetics Postdoctoral Fellow, National Cancer Institute, Bethesda MD.

2009- 2013 Irina Mordukovich, MSPH, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Epidemiology

NIEHS ES07018 Environmental Health Training Grant and NCI 2-T32-CA09330: Cancer Epidemiology Training Grant, and DOD Predoctoral Dissertation Award: “Vehicular traffic, genetic susceptibility, and breast

MD GAMMON

12

cancer risk.” Role: MD Gammon, Primary Mentor. Currently, Environmental Health Postdoctoral Fellow, Harvard School of Public Health, Boston MA.

2009-2013 Genee Smith, Ph.D. University of North Carolina at Chapel Hill, School of Public Health. Ph.D. candidate, Department of Epidemiology, NIEHS ES07018 Environmental Health Training Grant, the Joan Cornoni Huntley Doctoral Award, and the American Lung Association Healthy Lung Doctoral Dissertation Award: “Air pollution and TB.” Role: MD Gammon, Primary Mentor. Currently, ORISE Postdoctoral Fellow, Environmental Protection Agency, Chapel Hill NC.

2007-2013 Lauren McCullough, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Epidemiology NCI 2-T32-CA09330: Cancer Epidemiology Training Grant, and Department of Defense, U.S. Army: BC093608. “Physical activity, genetic susceptibility,

and risk of breast cancer,” Role: MD Gammon, Primary Mentor. Currently, Rollins Endowed Assistant Professor, Department of Epidemiology, Emory University, Atlanta GA.

2006-2010 Sarah Schweitzer Cohen, Ph.D. University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Epidemiology NCI 2-T32-CA09330: Cancer Epidemiology Training Grant “Select environmental and genetic determinants of obesity among African American women.” Role: MD Gammon, Primary Mentor. Currently Epidemiologist, Epid Stat Institute, Ann Arbor MI, and Adjunct Assistant Research Professor of Medicine, Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville TN.

2005-2009 Patrick Bradshaw, Ph.D. University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Epidemiology, NCI T32CA72319: Nutrition and Cancer Training Grant, and NCI 2-T32-CA09330: Cancer Epidemiology Training Grant, "Obesity, physical activity, and breast cancer survival: a longitudinal study with missing data.” Role: MD Gammon, Primary Mentor. Currently, Assistant Professor and Martin Sisters Endowed Chair in Medical Research and Public Health, Division of Epidemiology, University of California, Berkeley

2004-2008 Amanda Golembesky, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, Department of Epidemiology, Ph.D. candidate, NCI T32CA72319: Nutrition and Cancer Training Grant, “PPAR polymorphisms, obesity and breast cancer risk and survival." Role: MD Gammon, Primary Mentor. Currently, Director, Epidemiology, UCB Pharma, Raleigh, NC

2003-2006 Katrina Trivers, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, Department of Epidemiology, Ph.D. candidate, NCI R25 CA057726: Cancer Control and Education Training Grant, “Reproductive factors, oral contraceptives and breast cancer survival among young women.” Role: MD Gammon, Primary Mentor. Currently Epidemiologist, Centers for Disease Control and Prevention, Atlanta, GA

2003-2006 Brian Fink, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, Department of Epidemiology, Ph.D. candidate, NCI 2-T32-CA09330: Cancer Epidemiology Training Grant, “Intake of flavonoids in relation to

MD GAMMON

13

breast cancer risk and survival.” Role: MD Gammon, Primary Mentor. Currently Associate Professor, University of Toledo, OH

2000-2006 Sumitra Shantakumar, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, Department of Epidemiology, Ph.D. candidate, NCI 2-T32-CA09330: Cancer Epidemiology Training Grant, “Use of hormone replacement therapy and oral contraceptives and risk of breast cancer among women by age and menopausal status.” Role: MD Gammon, Primary Mentor. Currently Regional Epidemiology Director, Asia Pacific and North Asia, GlaxoSmithKline, Singapore and Adjunct Assistant Professor, University of North Carolina at Chapel Hill

2001-2005 Mia Gaudet, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Epidemiology, U.S. Army Predoctoral Award in Breast Cancer Research, “MnSOD, COMT polymorphisms, hormonal factors and breast cancer incidence.” Role: MD Gammon, Primary Mentor. Currently, Strategic Director, Breast and Gynecologic Cancer Research, American Cancer Society, Atlanta GA.

2000-2005 Page Abrahamson, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Epidemiology,

NCI R25 CA057726: Cancer Control and Education Training Grant “Physical activity, body size, and breast cancer survival among young women.” Role: MD Gammon, Primary Mentor. Currently, Epidemiologist,

Salmon Bay Consulting, Seattle, WA 2000-2003 Rebecca Cleveland, Ph.D., University of North Carolina at Chapel Hill, School of

Public Health, Ph.D. candidate, Department of Epidemiology U.S. Army Predoctoral Award in Breast Cancer Research, “Insulin-like

growth factor-1 polymorphisms and breast cancer.” Role: MD Gammon, Primary Mentor. Currently, Research Associate, Department of Medicine, University of North Carolina, Chapel Hill

1998-2002 Sybil Eng, Ph.D., Columbia University Graduate School of Arts and Sciences, Ph.D. candidate, Division of Epidemiology, "Body size changes, physical

activity and risk of breast cancer." Role: MD Gammon, Primary Mentor. Currently, Research Scientist, Columbia University, New York, NY

1994-2000 Susan L. Teitelbaum, Ph.D. (Awarded with Distinction), Columbia University Graduate School of Arts and Sciences, Ph.D. candidate, Division of Epidemiology, Anna M. Gelman Award, Columbia School of Public Health

“Reported pesticide exposure and breast cancer in Long Island, New York." Role: MD Gammon, Primary Mentor. Currently Associate Professor, Mt. Sinai School of Medicine, New York, NY

1993-1997 Peter A. Kanetsky, Ph.D. (Awarded with Distinction), Columbia University Graduate School of Arts and Sciences, Ph.D. candidate, Division of Epidemiology, Anna M. Gelman Award, Columbia School of Public Health

"Smoking and diet and risk for cervical cancer among non-Hispanic black women." Role: MD Gammon, Primary Mentor. Currently Professor and Chair of Cancer Epidemiology, Moffitt Cancer Center, University of South Florida, Tampa FL.

Masters’ Student-Primary Mentor (n=13): 2014-present Nicole Niehoff, BS, University of North Carolina at Chapel Hill, School of Public

MD GAMMON

14

Health, MSPH/PhD student, Department of Epidemiology (as of Fall 2014). “Does body size modify the association between polycyclic aromatic hydrocarbons and breast cancer incidence?” Role: MD Gammon, Primary Mentor.

2011-2013 Ja Yeon Kim, MD, University of North Carolina at Chapel Hill, School of Public Health, MPH student, Department of Epidemiology: “Polycystic ovary syndrome and breast cancer risk.” Role: MD Gammon, Primary Mentor. Currently, Seoul University Hospital, Seoul, Korea.

2012 Sasha McGee, M.D., University of North Carolina at Chapel Hill, School of Public Health, MPH student, Department of Epidemiology, Role: MD Gammon, Masters Thesis Reader, Robert Millikan, DVM, Ph.D., Masters Thesis Chair, “Insurance coverage, socioeconomic status, and emotional well-being and their influence on time from diagnosis until first treatment for white and African American breast cancer patients.” Currently, Epidemic Intelligence Service (EIS) Officer at Centers for Disease Control and Prevention, Atlanta GA

2010-2012 Alexandra White, BS, University of North Carolina at Chapel Hill, School of Public Health, MSPH/Ph.D. student, Department of Epidemiology, NIEHS ES07018: Environmental Epidemiology Training Grant: “Self-reported exposure to fogger trucks and breast cancer risk.” Role: MD Gammon, Primary Mentor. Currently, Postdoctoral Fellow, National Institute of Environmental Health Sciences, Research Triangle Park NC

2007-2009 Irina Mordukovich, BS, University of North Carolina at Chapel Hill, School of Public Health, MSPH student, Department of Epidemiology NCI 2-T32-

CA09330: Cancer Epidemiology Training Grant “PAH-related risk factors, p53 mutations, and breast cancer.” Role: MD Gammon, Primary Mentor. Currently, Postdoctoral Fellow, Department of Environmental Health, Harvard University, Boston MA

2004-2005 Sarah Nyante, BS, University of North Carolina at Chapel Hill, School of Public Health, Department of Epidemiology, MSPH student, NIEHS ES07018: Environmental Epidemiology Training Grant, “Oral contraceptive use in relation to risk of lobular breast cancer among young women.” Role: MD Gammon, Primary Mentor. Currently, Assistant Professor of Radiology, University of North Carolina School of Medicine, Chapel Hill, NC.

1998-1999 Alison Sugarman, M.P.H., Columbia University, Mailman School of Public Health MPH student, Division of Epidemiology, "Tea drinking and risk of

esophageal and gastric cancer" Role: MD Gammon, Primary Mentor 1998 Ashita Solanki, M.P.H., Columbia University, Mailman School of Public Health MPH student, Division of Epidemiology, "DES exposure and breast cancer

risk." Role: MD Gammon, Primary Mentor. Currently, Council of Science Editors, New York, NY

1995-1997 Susan P. Larson, M.D., M.P.H., Anna M. Gelman Award, Columbia School of Public Health, MPH student, Division of Epidemiology, "Environmental chemicals and their role in breast carcinogenesis: suitability for inclusion in an epidemiological study." Role: MD Gammon, Primary Mentor. Currently, Private Practice, Preventive Medicine, San Mateo CA

1994-1996 Ellen Morrison, M.D., M.P.H., Columbia University School of Public Health

MD GAMMON

15

MPH student, Division of Epidemiology, "Pregnancy and cervical infection with human papillomaviruses." Role: MD Gammon, Primary Mentor. Currently, Assistant Professor of Clinical Epidemiology, Mailman School of Public Health, Columbia University, New York, NY

1992-1993 Ann V. Schwartz, M.P.H., Ph.D., Columbia University School of Public Health, MPH student, Division of Epidemiology, "Age-specific risk factors for breast cancer among black women." Role: MD Gammon, Primary Mentor. Currently Associate Adjunct Professor of Preventive Medicine and Public Health, University of California at San Francisco

1989-1991 Peter A. Kanetsky, M.P.H., Columbia University School of Public Health, MPH student, Division of Epidemiology, "Risk factors for cervical neoplasms in a black, elderly population." Role: MD Gammon, Primary Mentor. Currently, Professor and Chair of Cancer Epidemiology, Moffitt Cancer Center, University of South Florida, Tampa FL

Other Predoctoral Mentoring (n=46): 2015-present Laura McGuinn, MS, University of North Carolina at Chapel Hill, School of Public

Health, Ph.D. Student, Department of Epidemiology: “Air pollution, social stressors and air pollution.” Role: Dissertation Committee Member. Julie Daniels, Ph.D., Research Mentor.

2015 Nathaniel (MacHardy) MacNell, MSPH, University of North Carolina at Chapel Hill, School Public Health, Ph.D. student, Department of Epidemiology, Role: IDR Committee Member, Steve Wing, Ph.D., Research Mentor.

2015-present Jean Strelitz, MSPH, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. Student, Department of Epidemiology: “Exposure to PM, PAH and BTEX during oil spill cleanup work and incident cardiovascular disease.” Role: Dissertation Committee Member. Larry Engel, Ph.D., Research Mentor.

2015-present Veeral Saraiya, DVM, MPH, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. Student, Department of Epidemiology: “Dietary indices and head and neck cancer.” Role: Dissertation Committee Member. Andrew Olshan, Ph.D., Research Mentor.

2014 Laura McGuinn, MS, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. Student, Department of Epidemiology. Role: IDR Committee

Member. Julie Daniels, Ph.D., Research Mentor. 2014 Veeral Saraiya, DVM, MPH, University of North Carolina at Chapel Hill, School of

Public Health, Ph.D. Student, Department of Epidemiology, Role: IDR Committee Member. Andrew Olshan, Ph.D., Research Mentor.

2014-2015 Humberto Parada, MPH, University of North Carolina at Chapel Hill, School of Public Health, PhD student, Department of Epidemiology. Role: Mentor, “Biomarkers of organochlorine compounds, PCBs and survival following a breast cancer diagnosis.”

2013-present Kirstin Huiber, MPH, University of North Carolina at Chapel Hill, School of Public Health, PhD student, Department of Epidemiology. Role: Doctoral Dissertation Committee Member, Larry Engel, Ph.D., Research Mentor. “Organochlorine pesticide metabolism and the risk of developing melanoma.”

2013-2015 John Beard, MPH, University of North Carolina at Chapel Hill, School of Public

MD GAMMON

16

Health, Ph.D. student, Department of Epidemiology, “Amyotrophic Lateral Sclerosis and Military Exposures: Etiology and Survival,” Role: Dissertation Committee member, Larry Engel, Ph.D., Research Mentor. Currently, CDC Intelligence Officer Program, Atlanta GA.

2013 Nathanial MacHardy, MSPH, University of North Carolina at Chapel Hill, School of Public Health, MSPH/PhD student, Department of Epidemiology. Role: IDR Committee Member, Steve Wing, Ph.D., Research Mentor.

2012-2013 Brionna Hair, MSPH, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. student, Department of Epidemiology, Role: Dissertation Committee member, Melissa Troester, Ph.D., Research Mentor.

2013 Kyla Taylor, MPH, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. student, Department of Epidemiology, Role: IDR Committee member, Melissa Troester, Ph.D., Committee Chair.

2013 John Beard, MPH, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. student, Department of Epidemiology, Role: IDR Committee member, Larry Engel, Ph.D., Committee Chair.

2012-2014 Laura McGuinn, MS, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. student, Department of Epidemiology, Role: Academic Advisor.

2012 Leila Family, MSPH, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. student, Department of Epidemiology, Role: IDR Committee Member, Robert Millikan, DVM, Ph.D., Research Mentor.

2012 Evan Busch, MSPH, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. student, Department of Epidemiology, Role: IDR Committee Member, Robert Sandler, MD, MPH, Research Mentor

2012 Danielle Durham, MPH, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. student, Department of Epidemiology, Role: IDR Committee Member, Whitney Robinson, Ph.D., Research Mentor.

2012 Laurel Harduar-Morano, MPH, University of North Carolina at Chapel Hill, School Public Health, Ph.D. student, Department of Epidemiology, Role: IDR

Committee Member, Steve Wing, Ph.D., Research Mentor. 2011-2013 Nicholas Taylor, MPH, University of North Carolina at Chapel Hill, School of

Public Health, Ph.D. candidate, Department of Epidemiology, Role: Dissertation Committee Member, Robert Millikan, DVM, Ph.D., and Andrew Olshan, Ph.D., Doctoral Dissertation Committee Chairs, “AURKA, BRCA1-interacting genes and their association with breast cancer subtype.” Current Position: Postdoctoral Fellow, Moffitt Cancer Center, Tampa FL

2007-2009 Sarah Nyante, MSPH, University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Epidemiology, Role: Dissertation Committee Member, Robert Millikan, DVM, Ph.D., Doctoral Dissertation Committee Chair, “Single nucleotide polymorphisms and the etiology of basal-like and luminal A breast cancer: a pathway-based approach.” Currently, Assistant Professor of Radiology, University of North Carolina School of Medicine, Chapel Hill, NC.

2006-2010 Xinran Xu, Mt. Sinai School of Medicine, Ph.D. candidate, Department of Oncology; Role: Co-mentor , DOD Predoctoral Award W81XWH-06-1-0298: “One-carbon metabolism and breast cancer.” Currently, Tongji

MD GAMMON

17

University School of Medicine, Shanghai, China. 2006-2008 Heather Greenlee, Ph.D., Columbia University, Mailman School of Public Health,

Ph.D. candidate, Department of Epidemiology, Role: Dissertation Committee Member, Judith Jacobsen, Ph.D., Doctoral Dissertation Committee Chair, “Supplement use, estrogen metabolism, and breast cancer.” Currently, Assistant Professor, Columbia University, New York, NY

2006-2008 Yu Chen, Ph.D., Columbia University, Mailman School of Public Health, Ph.D. candidate, Department of Epidemiology, Habib Ahsan, MBBS, MPH, Doctoral Dissertation Committee Chair, Role: Co-mentor, “CYP17, risk factors for breast cancer, and breast cancer risk: LIBCSP.” Currently, Associate Professor, New York University, New York, NY

2006-2008 Kathryn (Talbott) Singh, MPH, Columbia University, Mailman School of Public Health, MPH student, Department of Epidemiology, Habib Ahsan, MBBS, MPH, Masters’ Essay Primary Mentor, Role: Co-mentor, “CYP19, risk factors for breast cancer, and breast cancer risk: LIBCSP.” Currently, Health Sciences Assistant Clinical Professor, Pediatrics, School of Medicine, University of California, Irvine

2005-2007 Thao T. Vo, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Epidemiology, Role: Dissertation Committee Member, David Richardson, Ph.D., Doctoral Dissertation Committee Chair, "Predictors of menopause: the role of organochlorine compounds."Currently, Pharmacoepidemiologist, Merck, North Wales, PA.

2004-2008 Sharon Sagiv, Ph.D. University of North Carolina, Chapel Hill, Ph.D. student, Department of Epidemiology, Role: Co-mentor, UO1CA/ES66572, "Environmental exposures and breast cancer risk and survival." Currently Adjunct Assistant Professor, Division of Epidemiology, University of California, Berkeley CA

2004-2006 Kyna McCullough Gooden, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Epidemiology, Role: Dissertation Committee Member, Jane Schroeder, D.V.M., Ph.D., Doctoral Dissertation Committee Chair, “Estrogen-related genetic polymorphisms and uterine leiomyomas." Currently, Associate Director, Epidemiology, Bristol-Myers Squibb, Princeton NJ

2004-2006 Jiyoung Ahn, Ph.D., Cornell University, Ithaca, NY, Ph.D. student, Department of Nutrition, C. Garza, Ph.D., Doctoral Dissertation Committee Chair, Role: Co-mentor, “Oxidative-stress polymorphisms, fruit and vegetable intake, and breast cancer risk.” Currently, Associate Professor, New York University, New York NY

2004-2005 Yueh-Yun Chi, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Biostatistics, Role: Dissertation Committee Member, Joseph Ibrahim, Ph.D., Doctoral Dissertation Committee Chair, "Joint modeling of longitudinal and time-to-event data in the International Breast Cancer Study Group (IBCSG): prognostic impact of patients' quality of life on disease progression." Currently, Research Assistant Professor, University of Florida, Gainesville

2004-2005 Qingxia Chen, Ph.D., University of North Carolina at Chapel Hill, School of Public

MD GAMMON

18

Health, Ph.D. candidate, Department of Biostatistics, Role: Dissertation Committee Member, Joseph Ibrahim, Ph.D. and Donglin Zeng, Ph.D, Co-Doctoral Dissertation Committee Chairs, "Impact of missing data on melanoma cancer and breast cancer data." Currently, Associate Professor of Biostatistics, Vanderbilt University, Nashville, TN

2004 Jada Brooks, RN, MSPH, University of North Carolina at Chapel Hill, School of Public Health, MSPH student, Department of Epidemiology, Role: Masters

Paper Reader, Bonnie Yankaskas, Ph.D., Masters Paper Chair, "Knowledge, attitudes, and beliefs toward breast cancer and mammography utilization among American Indian women in NC." Currently, Duke University School of Nursing, Durham, NC

2003 Katrina Trivers, MSPH, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, MSPH student, Department of Epidemiology, Role: Masters Paper Reader, Andrew Olshan, Ph.D., Masters Paper Chair, “Demographic and lifestyle predictors of survival in patients with esophageal and gastric cancers.” Currently, Epidemiologist, Centers for Disease Control and Prevention, Atlanta, GA

2003 Whitney Robinson, MSPH, Ph.D., University of North Carolina at Chapel Hill, School of Public Health MPH student, Department of Epidemiology, Role:

Masters Paper Reader, June Stevens, Ph.D., Masters Paper Chair, “Adolescent body size and prostate cancer risk.” Currently, Assistant

Professor, Department of Epidemiology, University of North Carolina at Chapel Hill

2002 Mia Gaudet, MSPH, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, MSPH student, Department of Epidemiology, Role: Masters

Paper Reader, Andrew Olshan, Ph.D., Masters Paper Chair, “Gene-environment interactions in head and neck cancer.” Currently, Strategic Director, Breast and Gynecologic Cancer Research, American Cancer Society, Atlanta GA

2000-2001 Lesley Butler, Ph.D., University of North Carolina at Chapel Hill, School of Public Health Ph.D. candidate, Department of Epidemiology, Role: Dissertation Committee Member, Robert Millikan, D.V.M., Ph.D., Doctoral Dissertation Committee Chair, “Exposure to heterocyclic amines and polyaromatic hydrocarbons, genetic susceptibility at the N-acetyltransferase 1 (NAT1) and 2 (NAT2) loci, and risk of colon cancer.” Currently, Associate Professor, Department of Epidemiology, University of Pittsburgh, PA

2000 Sherry Farr, MSPH, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, MSPH student, Department of Epidemiology, Role: Masters Paper Reader, June Stevens, Ph.D., Masters Paper Chair, "The effect of the menopause transition and hormone replacement therapy on body mass index and abdominal obesity in African Americans and whites." Currently, Postdoctoral Fellow, National Institute of Environmental Health Sciences, Research Triangle Park, NC

1999-2001 Helena Furberg, Ph.D., University of North Carolina at Chapel Hill, School of Public Health, Ph.D. candidate, Department of Epidemiology, Role: Dissertation Committee Member, Robert Millikan, D.V.M., Ph.D., Doctoral Dissertation Committee Chair, “P53 overexpression and risk factors for breast cancer.”

MD GAMMON

19

Currently, Epidemiologist, Memorial Sloan-Kettering Cancer Center, New York, NY.

1998-2002 Regina Zimmerman, Ph.D., Columbia University Graduate School of Arts and Sciences, Ph.D. student, Department of Epidemiology, Habibul Ahsan, MBBS, MPH, Doctoral Dissertation Committee Chair, Role: Co-mentor, "Family history of breast cancer and risk of breast cancer." Currently, Director, Vital Data Use and Disclosure Unit at New York City Department of Health and Mental Hygiene NY

1998-2000 Tamar Ngoc Do, Ph.D., Columbia University, Mailman School of Public Health Ph.D. student, Division of Environmental Health Sciences, Role: Dissertation Committee Member, Paul Brandt-Rauf, M.D., Ph.D., Doctoral Dissertation Committee Chair, "Serum anti-bodies to p53 in relation to breast cancer." Currently, Research Assistant Professor, Columbia University, NY

1996-1999 Mary Beth Terry, Ph.D., Columbia University Graduate School of Arts and Sciences Ph.D. candidate, Division of Epidemiology, Anna M. Gelman Award,

Mailman School of Public Health, Role: Dissertation Committee Member Alfred I. Neugut, M.D. Ph.D., Doctoral Dissertation Committee Chair “Risk factors for neoplastic progression of tumors of the colon.” Currently,

Associate Professor, Columbia University, New York, NY 1995-1998 Julie A. Britton, Ph.D., Columbia University Graduate School of Arts and Sciences Ph.D. candidate, Division of Epidemiology, Role: Dissertation Committee

Member, Carolyn Westhoff, M.D., MPH, Doctoral Dissertation Committee Chair, “Benign ovarian tumors and diet.” Currently, Research Assistant Professor, Mt. Sinai School of Medicine, New York, NY (on leave)

1997 Lisa Samuelson, Ph.D., Columbia University Graduate School of Arts and Sciences Ph.D. candidate, Division of Epidemiology, Role: Dissertation Committee

Member, Jennifer Kelsey, Ph.D., Doctoral Dissertation Committee Chair "Reproductive and related risk factors for hip fractures." Currently, Associate

Scientist, Institute for Aging Research, Hebrew SeniorLife, Boston, MA 1995 Judith Jacobsen, Dr.P.H., Columbia School of Public Health, Dr.P.H. Candidate,

Division of Epidemiology, Role: Dissertation Committee Member, Alfred I. Neugut, M.D., Ph.D., Doctoral Dissertation Committee Chair, "Reproductive and menstrual history and the risk of colorectal neoplasia." Currently, Research Associate Professor, Columbia University, NY NY

1995 Sung Suh, MPH, Columbia School of Public Health, MPH student, Division of Epidemiology, Role: Masters Paper Reader, Alfred I. Neugut, M.D., Ph.D., Masters Essay Chair, "Proposal for a case-control study on potential risk factors of small intestinal cancer"

1994 Ghada Sherif, MD, MPH, Columbia School of Public Health, MPH student, Division of Epidemiology, Role: Masters Paper Reader, Alfred I. Neugut,

M.D., Ph.D., Masters Essay Chair, "History of coronary heart disease and the risk of benign colorectal polyps"

1993 Jerri Nieves, Ph.D., Columbia University Graduate School of Arts and Sciences Ph.D. candidate, Division of Epidemiology, Role: Dissertation Committee

Member, Jennifer Kelsey, Ph.D., Doctoral Dissertation Committee Chair

MD GAMMON

20

"Relationship of dietary constituents to bone mineral density in young women and hip fracture in older women." Currently, Associate Professor of Clinical Epidemiology, Columbia University, NY NY

1993 Jason Santos, MPH, Columbia School of Public Health, MPH student, Division of Epidemiology, Role: Masters Paper Reader, Alfred I. Neugut, M.D., Ph.D.,

Masters Essay Chair, "The association between cancers of the small and large bowel." Currently, Research Assistant, Columbia University, NY, NY

1993 Clark C Chen, DDS, MPH, Columbia School of Public Health, MPH student, Division of Epidemiology, Role: Masters Paper Reader, Alfred I. Neugut, M.D., Ph.D., Masters Essay Chair, "Risk factors for cancer of the small intestine: a pilot study." Currently, private practice, CA.

1992 Sara Olson, Ph.D., Columbia University Graduate School of Arts and Sciences Ph.D. candidate, Division of Epidemiology, Role: Dissertation Committee

Member, Jennifer Kelsey, Ph.D., Doctoral Dissertation Committee Chair "Selection of control groups in case-control studies: evaluation of control

groups selected by random digit dialing and from hospitals." Currently, Senior Epidemiologist, Memorial-Sloan Kettering Cancer Center, NY

1992 Xiao-Ou Shu, M.D., Ph.D., Columbia University Graduate School of Arts and Sciences Ph.D. candidate, Division of Epidemiology, Role: Dissertation Committee Member, Maureen Hatch, Ph.D., Doctoral Dissertation Committee Chair, "Obesity, diet, physical activity and the risk of endometrial cancer." Currently, Professor, Department of Medicine (Epidemiology), Vanderbilt University, Nashville, TN

1991 Erica Gollub, MPH, Dr.P.H., Columbia School of Public Health, Dr.P.H. candidate, Division of Epidemiology, Role: Dissertation Committee Member,

Carolyn Westhoff, MD, MPH, Dissertation Committee Chair, "Limitations of ovarian cancer screening." Currently, Assistant Professor, Department of Epidemiology, Florida International University, Miami FL

1989-1990 Susie Hoffman, M.P.H., DrPH. Columbia University School of Public Health, predoctoral student, Division of Epidemiology, "Parity, lactation, and hip fracture among white women." Role: Dissertation Committee Member. Currently, Associate Professor of Clinical Epidemiology, Department of Psychiatry, Columbia University, New York, NY

Undergraduate Training (n=1): 2007 Elizabeth Blackman, Howard University, Summer Pre-Graduate Research

Experience (SPGRE) Intern, “Environmental exposures and breast cancer risk.” Undergraduate student, Howard University, Washington DC. Currently, Research Specialist, Fox Chase Cancer Center, Philadelphia PA.

TEACHING Course Responsibilities -- University of North Carolina at Chapel Hill: 2015-present Instructor, Research Planning (EPID 725), School of Public Health, 30 students, Fall 2006-2014 Instructor/Course Coordinator, Epidemiologic Research Methods (EPID 726), School of Public Health, 25-36 Students, Spring 2005-2014 Instructor/Course Coordinator, Research Planning (EPID 725), School of Public Health, 25-36 students, Fall

MD GAMMON

21

2005 Instructor, Epidemiologic Research Methods (EPID 201), School of Public Health, 21 Students, Spring 2004 Instructor, Research Planning (EPID 200), School of Public Health, 21 students, Fall 2002-2004 Instructor, Advanced Cancer Epidemiology (EPID 335), School of Public Health, 12 Students, Spring 2000-2001 Co-instructor, Fundamentals of Epidemiology (EPID 168), School of Public Health, 60 students, Fall Course Responsibilities -- Columbia University School of Public Health: 1991-1999 Instructor/Course Coordinator, Introduction to the Principles of Epidemiology

(PH6400), Columbia School of Public Health, Executive MPH Program, 30 students, Spring

1991 Instructor/Course Coordinator, Research Seminar in Epidemiology, 50 Students, Fall 1990 Instructor/Course Coordinator, Design and Conduct of Observational Epidemiologic Studies, 60 Students, Spring

1989-1990 Instructor/Course Coordinator, Introduction to the Principles of Epidemiology (PH6400), Columbia School of Public Health, MPH Program, 150 students, Spring Other Teaching -- University of North Carolina-Chapel Hill 2015 Lecturer, Epidemiologic Research Methods (EPID 726), “Data Analysis in a Grant Application,” Department of Epidemiology, School of Public Health, 25-36 Students, Spring 2014-present Lecturer, Fundamentals of Epidemiology (EPID 710), “Case-Control Study

Methods: The Long Island Breast Cancer Study Project,” Department of Epidemiology, School of Public Health, 60 students, Fall

2010-2012 Faculty Leader, Nutrition and Cancer Journal Club, Department of Epidemiology, Fall/Spring 2010 Panel Member, CVD Workshop, “Collaborative research,” Department of Epidemiology, Fall 2009-2012 Lecturer, Intro to Obesity: From Cell to Society (NUTR), “Obesity and cancer,” Spring 2008 Lecturer, Diet and Cancer (NUTR 815), “Physical activity and cancer,” Fall 2007 Lecturer, Obesity Epidemiology (EPID814), “Obesity, physical activity, and cancer,” Spring 2006-present Faculty Leader, Environmental/Occupational Epidemiology Seminar Series, Department of Epidemiology, Fall/Spring 2006 Lecturer, Diet and Cancer (NUTR 815), “Obesity and cancer,” Fall 2006 Lecturer, Resources for International Students (EPID 689), “Developing a research topic,” Fall 2005 Lecturer, Obesity Epidemiology (EPID 261), “Obesity, physical activity and cancer,” Spring 2005 Lecturer, Cancer Prevention and Control (EPID 290), “Polycylic aromatic hydrocarbons and breast cancer,” Fall 2005-2008 Lecturer, Resources for International Students, “Developing a research topic,” Fall 2004 Lecturer, Cancer Prevention and Control (EPID 290), “Environmental risk factors for breast cancer,” Fall 2004 Lecturer, Obesity Epidemiology (EPID 261), “Obesity, physical activity and cancer,” Spring

MD GAMMON

22

2003 Lecturer, Cancer Prevention and Control (EPID 290), “Environmental risk factors for breast cancer,” Fall 2003 Lecturer, Masters Seminar (EPID 150), “Epidemiologic research,” Fall 2003 Lecturer, Obesity Epidemiology (EPID 261), “Obesity, physical activity and cancer,” Spring

2003 Lecturer, Occupational Epidemiology (EPID 276), “Occupational history and risk of esophageal and gastric cancer,” Spring

2003 Lecturer, Cancer Prevention and Control (EPID 290), “Environmental risk factors for breast cancer,” Fall 2003 Lecturer, Masters in Science in Public Health Seminar (EPID 105), “The role of epidemiology in public health,” Fall

2002 Lecturer, Diet and Cancer (NUTR 362), “Physical activity and cancer,” Spring 2002 Lecturer, Cancer Prevention and Control (EPID 290), “Environmental risk factors

for breast cancer,” Fall 2001 Lecturer, Cancer Prevention and Control (EPID 290), “Environmental risk factors for breast cancer,” Fall

2001 Lecturer, Obesity Epidemiology (EPID 261), “Obesity and cancer,” Spring 2000 Lecturer, Diet and Cancer (NUTR 362), “Polycyclic aromatic hydrocarbons and breast cancer,” Spring 2000 Lecturer, Theory and Quantitative Methods in Epidemiology (EPID 268), “Subject identification and recruitment in epidemiologic studies,” Spring

2000 Lecturer, Cancer Prevention and Control (EPID 290), “Environmental risk factors for breast cancer,” Fall Other Teaching -- Columbia University School of Public Health:

1998 Lecturer, Science and Journalism, Columbia School of Journalism, “Long Island Breast Cancer Study Project," 25 students, Spring

1998 Lecturer, Environmental Epidemiology (P8432), “Pesticides and breast cancer,” 15 students, Spring 1998 Lecturer, Cellular and Molecular Biology of Cancer (G4500), “Epidemiology of adenocarcinomas of the esophagus and gastric cardia,” 25 students, Spring

1997 Lecturer, Seminar in Epidemiology, "Do pesticides increase the risk of breast cancer?" 50 students, Fall

1997 Lecturer, Seminar at the Sergievsky Center, "Long Island Breast Cancer Study Project," 30 students, Fall 1997 Lecturer, Seminar in Environmental Health Sciences, "Long Island Breast Cancer Study Project," 20 students, Spring

1996 Lecturer, Environmental Epidemiology (P8432), “Breast cancer and the environment,” 16 students, Spring

1996 Examiner, Ph.D. Specialty Qualifying Exam in Cancer Epidemiology: "Childhood leukemia," J Britton, B Ji, S Kizelnick, I Prokup, Spring

1995 Lecturer, Columbia Cancer Epidemiology and Environmental Sciences Training Grant Seminar, “Physical activity and breast cancer: an analysis in progress,” 10 students, Fall

1994 Lecturer, Student Orientation: Epidemiology in Public Health, 150 students, Fall 1994 Chair, Ph.D. Specialty Qualifying Exam in Cancer Epidemiology: "Testicular cancer," P Kanetsky and J Mandelblatt, MD, Fall 1994 Lecturer, Introduction to the Principles of Epidemiology, “Breast cancer

MD GAMMON

23

epidemiology among black women,” 180 students, Fall 1994 Member, Ph.D. Dissertation Proposal Committee: "Parity, lactation, and menopause and the risk of hip fracture in black and white women," E Samuelson, Fall 1994 Member, Dr.P.H. Dissertation Proposal Committee: "Reproductive and menstrual history and the risk of colorectal neoplasia," J Jacobsen, Fall

1993 Examiner, Ph.D. Specialty Qualifying Exam in Cancer Epidemiology: "Ovarian cancer," J Jacobsen and E Taoli, MD, Spring

1993 Instructor, Tutorial: "Determinants of mammographic screening among black immigrant women," AV Schwartz, Spring

1993 Lecturer, Student Orientation: Epidemiology in Public Health, Fall 1993 Lecturer, Tutorial: Readings in General Epidemiology, M-Y Lai, Fall 1993 Chair, Ph.D. Qualifying Exam in General Epidemiology, 5 students, Fall

1992 Preceptor, Epidemiology III: Women's Health Initiative, 10 Students, Spring Chair: Ph.D. Qualifying Exam in Epidemiologic Methods, 5 Students, Spring

1992 Examiner, Ph.D. Specialty Qualifying Exam in Cancer Epidemiology: "Hormones and cancers of the breast, endometrium, and ovary," X-O Shu, MD, Spring

1992 Examiner, Ph.D. General Qualifying Exam in Epidemiology: "Hormone replacement therapy and breast cancer," 4 Students, Spring 1992 Examiner, Ph.D. Specialty Qualifying Exam in Cancer Epidemiology: "Male breast cancer," J Jacobsen and E Taoli, MD, Fall 1992 Preceptor, Introduction to Epidemiology, Columbia College of Physicians and Surgeons, First Year Medical Students, 30 Students, Fall

1991 Instructor, Tutorial: "The epidemiology of cervical cancer among black women," P Kanetsky, Spring

1991 Reader, Masters Essay: "Determinants of willingness to accept cervical cancer screening among elderly black women," Spring 1991 Preceptor, Epidemiology III: "Breast cancer and oral contraceptives, 15 Students, Spring 1991 Chair, Ph.D. Qualifying Exam in Epidemiologic Methods, 9 Students, Summer 1991 Examiner, Ph.D. General Qualifying Exam in Epidemiology, "Screening for breast cancer," 5 Students, Fall

1990 Lecturer, Research Seminars in Epidemiology: New Epidemiologic Studies of Breast Cancer, 40 Students, Fall

1990 Reader, Masters Essay: Cross-Cultural Comparison of Mortality Rates in Alaska, Fall 1990 Examiner, Ph.D. Specialty Qualifying Exam in Epidemiology: "The Epidemiology of osteosarcoma," D Glasser, Fall

1989 Lecturer, Introduction to the Principles of Epidemiology: Study Design, 60 Students, Fall

1989 Examiner, Ph.D. General Qualifying Exam in Epidemiology: Screening for Breast Cancer, 6 Students, Fall 1989 Examiner, Dr.P.H. Specialty Qualifying Exam in Cancer Epidemiology: Screening for Ovarian Cancer, E Gollub, Fall

Other Teaching -- Harvard University School of Dental Medicine: 1983-1985 Lecturer, Program in Dental Care Administration and Oral Epidemiology:

Introduction to Dental Epidemiology; Parametric and Nonparametric Methods in the Analysis of Dental Data; Clinical Trials in Dentistry, 20

MD GAMMON

24

Students, Summer SERVICE TO THE UNIVERSITY Intramural Committees/Programs -- University of North Carolina -Chapel Hill: 2015 Member, 2016 Hooding Ceremony Speaker Selection Committee, The Graduate

School, University of North Carolina at Chapel Hill 2015 Reviewer, Graduate Scholarship Review Committee, Department of Epidemiology, University of North Carolina at Chapel Hill 2012-2014 Member, Admissions Practices, Gillings School of Public Health, University of

North Carolina at Chapel Hill 2012-2013 Chair, Search Committee for Cancer Epidemiology Faculty (three positions at all

levels), University of North Carolina at Chapel Hill 2012-2013 Member, Core Methods Curriculum Review Committee, Committee Chair: S Cole,

University of North Carolina at Chapel Hill 2011 Member, Scholarship Review Committee, Department of Epidemiology, University

of North Carolina at Chapel Hill 2010 Member, Population Pilot Projects Review Committee, Lineberger Cancer Center, University of North Carolina at Chapel Hill 2008-2011 Member, Public Health-Nursing Institutional Review Board, University of North

Carolina at Chapel Hill 2007-present Member, Steering Committee, UNC Survivorship Cohort, University Cancer

Research Fund, Lineberger Cancer Center, University of North Carolina, E. Shelton Earp, M.D., Director

2007-2010 Member, Internal Advisory Committee, LIVESTRONG Survivorship Center of Excellence, Lineberger Cancer Center, University of North Carolina, Marci Campbell, Ph.D., Director

2007-2008 Member, Search Committee, Nutrition and Cancer team leader for the Nutrition Research Institute at Kannapolis, School of Public Health 2007-2014 Member, Curriculum on Toxicology, School of Medicine, University of North Carolina, Jim Swenberg, DVM. Ph.D., Director 2006-present Program Leader, Environmental/Occupational Epidemiology, Department of

Epidemiology, School of Public Health 2006-2007 Member, Internal Advisory Committee, Planning Year, Lance Armstrong

Foundation Center for Excellence, Lineberger Cancer Center, University of North Carolina, Marci Campbell, Ph.D./Paul Godley, M.D., Co-Directors

2006 Chair, Post-tenure Ad Hoc Evaluation Committee for Dana Loomis, Ph.D., Professor and Acting Chair of Epidemiology, University of North Carolina, Spring

2005-2014 Member, Advisory Committee, UNC Superfund Basic Research Program, Environmental Protection Agency, James Swenberg, Ph.D., Director

2005-2007 Abstract Reviewer, Annual Women's Health Research Day, School of Medicine 2005-2014 Chair, Graduate Student Admissions Committee, Department of Epidemiology, School of Public Health 2005-2008 Member, Appointments and Promotions Committee, School of Public Health 2005-present Member, Population Sciences Pilot Project Review Committee, Lineberger Comprehensive Cancer Center 2005-2006 Chair, Search Committee for Chair of the Department of Environmental Sciences & Engineering, School of Public Health

MD GAMMON

25

2005-2006 Member, Search Committee for Nutritional Epidemiologist, Departments of Nutrition and Epidemiology 2004-2012 Program Leader, Chronic Disease Epidemiology, Inter-Disciplinary Obesity Center, School of Public Health 2004-2005 Member, Search Committee for Nutritional Epidemiologist, Departments of

Epidemiology and Nutrition 2003-2005 Member, Research Council, School of Public Health 2002-2004 Member, Search Committee for Environmental Epidemiologist, Department of Epidemiology 2002- present Examiner, Doctoral Qualifying Exam in Environmental Health Sciences Program, Department of Epidemiology 2002-2006 Examiner, Doctoral Qualifying Exam in Cancer Epidemiology, Department of Epidemiology 2001 Examiner, Doctoral Qualifying Exam, Department of Epidemiology 2001-present Member, Program in Environmental Epidemiology, Department of Epidemiology 2000-2005 Member, Admissions Committee, Department of Epidemiology 2000-2002 Member, Health Sciences Library Committee, School of Public Health 1999-2002 Member, Search Committee for Cancer Epidemiologists, Department of Epidemiology and Lineberger Comprehensive Cancer Center 1999-2000 Member, Graduate Studies Committee, Department of Epidemiology 1999-present Member, Program in Cancer Epidemiology, Department of Epidemiology 1999-present Member, Program in Cancer Epidemiology, Lineberger Comprehensive Cancer Center Intramural Committees -- Columbia University School of Public Health: 1996-1999 Member, Doctoral Admissions Committee, Division of Epidemiology 1996-1999 Member, Curriculum Committee, Division of Epidemiology 1996-1999 Member, Space Committee, Division of Epidemiology 1994-1997 Co-Chair, Epidemiology Committee, Breast Cancer Research Programs, Columbia- Presbyterian Cancer Center 1994-1997 Member, Executive Committee, Breast Cancer Research Programs, Columbia- Presbyterian Cancer Center 1994-1996 Member, Missions, Goals, and Budget Committee, Special Advisory Committee to the Dean, School of Public Health 1994-1996 Member, Dr.P.H. Admissions Committee, Division of Epidemiology 1993-1996 Member, Ph.D. Admissions Committee, Division of Epidemiology 1993-1994 Member, Committee on Instructional Programs and Objectives 1993 Chair, General Exam in Epidemiology Committee, Division of Epidemiology 1992 Member, Academic Standards, School of Public Health 1990-1992 Member, Steering Committee, School of Public Health 1990-1991 Acting Chair, Dr.P.H. Committee, School of Public Health 1990-1991 Chair, Epidemiologic Methods Committee, Division of Epidemiology 1989-1999 Member, Ph.D. Subcommittee, Division of Epidemiology 1989-1999 Member, Dr.P.H. Committee, School of Public Health SERVICE TO THE PROFESSION Advisory Boards: 2014-15 Member, Joint Biomedical Laboratory and Clinical Science Scientific Merit Review

MD GAMMON

26

Board, Veterans Administration, Washington DC 2012-present Co- Chair, Food Frequency Questionnaire Pooling Working Group, Barrett's

Esophagus and Adenocarcinoma Consortium (BEACON), National Cancer Institute, Bethesda MD

2010 Member, Science Advisory Board Panel, Environmental Protection Agency, Review of the Technical Document on Polycyclic Aromatic Hydrocarbon (PAH)

Mixtures, Washington DC, June - December 2005-2010 Chair and Co-Chair, Questionnaire Pooling Working Group, Barrett's Esophagus and Adenocarcinoma Consortium (BEACON), National Cancer Institute, Bethesda MD

2002 Member, Scientific Advisory Panel, National Conference on Research Needs in Environmental Exposures and Breast Cancer Risk, Centers for Disease

Control and Prevention and University of California, Berkeley, School of Public Health Disease Prevention and Research Center, Santa Cruz, CA,

2000-present Associate Editor, American Journal of Epidemiology, Society for Epidemiologic Research, Baltimore, MD 1999-2005 Member, Scientific Advisory Board, Maurer Foundation for Breast Health Education, Manhasset, NY 1997-2001 Editorial Advisory Board, Journal of the American Medical Association, Women's Health Information Center on the World Wide Web, Chicago, IL 1995-1996 External Advisory Council, Environmental Health Sciences Center of the Mount

Sinai School of Medicine (NIEHS Grant P30 ES 00928, PI: Philip J. Landrigan, M.D.), New York, NY

1991 Advisory Committee, Epidemiology and Quantitative Methods Track, Graduate Program in Public Health, University of Medicine and Dentistry of New

Jersey, Robert Wood Johnson Medical School, Piscataway, NJ Other Extramural Committees: 2011 Invited Member, Breast Cancer Survivorship, Centers for Disease Control and the

National Institute of Environmental Health Sciences, Chapel Hill NC, March 2008 Member, Abstract Placement Committee, Era of Hope Annual Breast Cancer

Meeting, US Army Medical Research and Materiel Command (USAMRMC) Breast Cancer Research Program (BCRP), Herndon, VA, March

2008 Abstract Reviewer, Era of Hope Annual Breast Cancer Meeting, US Army Medical Research and Materiel Command (USAMRMC) Breast Cancer Research

Program (BCRP), February 2007 Member, Review Committee, Cancer Prevention Research Training Program, M.D. Anderson Cancer Center, Houston, TX, December 2006 Ad hoc Member, External Review Committee, Breast Cancer and Environmental Factors, Cornell University, Ithaca, NY, December 2005 Member, External Review Committee, Environmental Risk Factors for Breast Cancer, Susan B. Komen Foundation, Dallas, TX, November 2005 Chair, Esophageal Cancer Working Group, National Cancer Institute Annual Meeting on Rare Cancers, Boston, MA, September 2005 Member, External Advisor, National Institute of Environmental Health Sciences (NIEHS) Strategic Planning Committee, Research Triangle Park, NC 2005 Symposium Co-Chair, Non-Hereditary Factors Contributing to Breast Cancer Risk

and Outcomes, 2005 ERA of Hope Meeting, Department of Defense,

MD GAMMON

27

Philadelphia, PA, June 2003 Spotlight Session Moderator, Cancer in Women, Society for Epidemiologic Research, Atlanta, GA, June

2003 Member, Scientific Advisory Panel, National Academy of Sciences and Environmental Protection Agency, 2003 Cancer Risk Assessment Guidelines,

Washington DC, January 2002 Stomach/Esophageal Cancers Progress Review Group, National Cancer Institute, Chantilly, VA, May 2001 Epidemiology Congress 2001, Panelist, Career Development Workshop, NIH Grant Review, Toronto, Canada, June 2001 Epidemiology Congress 2001, Abstract Review for First North American Congress, Toronto, Canada, June 2000 Society for Epidemiologic Research, Abstract Review for Annual Meeting, Female Cancer, Seattle, WA, June

2000 Search Committee for Director, Central Cancer Registry, North Carolina State Center for Health Statistics, Raleigh, NC

2000 “Physical Activity and Cancer Prevention,” (Invited Expert Panel Member), Cancer Care Ontario, Action Cancer Ontario, Toronto, Ontario, March

1999 “Pesticides,” (Rapporteur), Epidemiology in the Twenty-First Century, National Institute of Environmental Health Sciences, Raleigh, NC, November

1999-2000 Academic Research Advisor, Central Cancer Registry, North Carolina, State Center for Health Statistics, Raleigh, NC 1997 Member, National Action Plan on Physical Activity and Breast Cancer, National Cancer Institute and Susan B. Komen Foundation, Albuquerque, NM, November

Extramural Faculty Evaluations: 1998-present Columbia University in the City of New York, NY; Duke University, Durham, NC;

Fred Hutchinson Cancer Research Center, Seattle, WA; Johns Hopkins University, Baltimore, MD; Mt. Sinai School of Medicine, New York, NY; New York University, New York, NY; The Ohio State University, Columbus, OH; University of Arizona, Tuscon, AZ; University of California at Los Angeles, CA; University of Chicago, IL; University of New York, Buffalo, NY; University of Southern California, CA; University of South Carolina, Columbia SC; University of Texas, Houston, TX; University of Toronto, Ontario, Canada; University of Washington, Seattle, WA; University of Wisconsin, Madison, WI, Wayne State University, Detroit MI

Manuscript Reviews: 1989-present American Journal of Epidemiology; American Journal of Industrial Medicine;

American Journal of Public Health; Annals of Epidemiology; Annals of Internal Medicine; BMC Cancer; Breast Cancer Research; Breast Cancer Research and Treatment; British Journal of Cancer; Cancer Causes and Control; Cancer Epidemiology, Biomarkers, and Prevention; Cancer Research; Carcinogenesis; Clinical Gastroenterology and Hepatology; Environmental Health Perspectives; Epidemiologic Reviews; Epidemiology; European Journal of Cancer; Gastroenterology; Genes and Nutrition; International Journal of Cancer; International Journal of Environmental Research and Public Heath; Journal of the American Medical Association;

MD GAMMON

28

Journal of Cancer; Journal of Cellular and Molecular Medicine; Journal of Clinical Oncology; Journal of the National Cancer Institute; Journal of Occupational and Environmental Medicine; Lancet Oncology; Medicine and Science in Sports and Exercise; New England Journal of Medicine; Nutrition and Cancer; PLOS ONE; Women and Health

Extramural Grant Reviews: 2013-2015 Chair, VA Merit Review Committee, Gulf War-related Research, Department of Veteran Affairs, Washington DC, May/June & December 2012 Ad hoc Member, 2013/01 ZRG1 F16-L (20) L Fellowships: Risk, Prevention and Health Behavior, NCI/NIH, Washington DC, November 2012 Member, Special Emphasis Panel/Scientific Review Group 2013/01 ZRG1 F16-E (02) S (Program Projects), NCI/NIH, Bethesda MD, October 2012 Member, Ad Hoc Review Committee, VA RFAs for Gulf War-related Research, Department of Veteran Affairs, Washington DC, October 2012 Member, Ad Hoc Review Committee, VA RFAs for Gulf War-related Research, Department of Veteran Affairs, Washington DC, March 2011 Member, Special Panel Review Committee: (U54) for NCI FOA: Barrett’s Esophagus Translational Research Network, National Institutes of Health, Bethesda MD, May 2011 Member, Grant Review Panel: Racial Disparities in Breast Cancer Research, Susan B. Komen Foundation, Dallas TX, January 2010 Ad hoc Member, Population Sciences and Epidemiology Integrated Review Group (PSE-D (03), Special Emphasis Panel, National Institutes of Health, Bethesda, MD, March

2009 Ad hoc Member, ZCA1 RPRB-0 (01), PO1 Program, Cancer Prevention, Control and Population Sciences, National Cancer Institute, Bethesda, MD, June 2009 Ad hoc Reviewer, Pilot Project Program, Center of Environment Health, University

of Southern California, Los Angeles CA January 2008 Ad hoc Member, Integration Panel, US Army Medical Research and Materiel

Command (USAMRMC) Breast Cancer Research Program (BCRP), Rockville, MD, September

2007 Ad hoc Member, Integration Panel, US Army Medical Research and Materiel Command (USAMRMC) Breast Cancer Research Program (BCRP),

Rockville, MD, November 2007 Member, Community Based Research Review Committee, California Breast Cancer Research Program, University of California, San Francisco, CA, April 2007 Member, Etiology and Prevention Review Committee, California Breast Cancer Research Program, University of California, San Francisco, CA, March

2006 Ad hoc Member, Community Based Research Review Committee, California Breast Cancer Research Program, University of California, San Francisco, CA,

December 2006 Ad hoc Member, Social Psychology, Personality and Interpersonal Processes Study

Section (SPIP), Risk, Prevention and Health Behavior Integrated Review Group, Center for Scientific Review. National Institutes of Health, Bethesda, MD, October

2006 Ad hoc Member, Community Based Research Review Committee, California Breast Cancer Research Program, University of California, San Francisco, CA, April

MD GAMMON

29

2005 Ad hoc Member, Community Based Research Review Committee, California Breast Cancer Research Program, University of California, San Francisco, CA,

December 2005 Member, Community Based Research Review Committee, California Breast Cancer Research Program, University of California, San Francisco, CA, April

2004 Member, Community Based Research Review Committee, California Breast Cancer Research Program, University of California, San Francisco, CA, December

2004 Ad hoc Member, Special Review Panel, National Cancer Institute, Biostatistics Branch, Bethesda, MD, October

2004 Member, Review Panel, U.S. Army, Department of Defense, ERA of Hope Investigator Awards, Bethesda, MD, September

2004 Member, Etiology and Prevention Review Committee, California Breast Cancer Research Program, University of California, San Francisco, CA, April

2004 Ad hoc Member, Community Based Research Review Committee, California Breast Cancer Research Program, University of California, San Francisco, CA, April

2003 Special Review Panel, National Cancer Institute, Cancer Prevention Studies Branch and Basic Research Laboratory, Bethesda, MD, November

2003 Member, Special Emphasis Panel, Breast Cancer and the Environment Center, National Institute of Environmental Health Sciences, Research Triangle Park,

NC, July 2003 Faculty Mentor, Student Workshop, Faculty Member, Society for Epidemiologic Research, Atlanta, GA, June

2003 Member, Canadian Breast Cancer Research Initiative, Breast Cancer Etiology Competition, Toronto, Ontario, May 2003 Member, Etiology and Prevention Review Committee, California Breast Cancer Research Program, University of California, San Francisco, CA, April

2003 Outside Reader, Ph.D. Dissertation Committee, “Environmental Exposures in Early Life and Risk of Breast Cancer,” Matthew Bonner, State University of New

York at Buffalo, NY, March 2002 Member, Grant Review Committee, Canadian Breast Cancer Research Initiative, Breast Cancer Etiology Competition, Toronto, Ontario, May

2002 Member, Grant Review Committee, Workers Compensation Board of British Columbia, Occupation and Breast Cancer, Richmond, British Columbia,

April 2002 Member, Special Review Committee, Specialized Program in Research Excellence (SPORE) in Breast Cancer, National Cancer Institute, Bethesda, MD, June 2001 Member, Grant Review Committee, Canadian Breast Cancer Research Initiative, Breast Cancer Etiology Competition, Toronto, Ontario, November

2001 Ad hoc Member, CRC/Socio-cultural, Behavioral and Pyschological Committee, California Breast Cancer Research Program, University of California, San

Francisco, CA, April 2001 Member, Etiology and Prevention Review Committee, California Breast Cancer Research Program, University of California, San Francisco, CA, April 2000 Member, Special Review Panel, Epidemiology and Disease Control Study Section 2 (EDC2), National Institutes of Health, Bethesda, MD, August

1999 Chair, Special Review Committee, Epidemiology and Disease Control Study Section 2 (EDC-2), National Institutes of Health, Bethesda, MD, April

MD GAMMON

30

1999 Member, New Jersey Commission on Cancer Research, State of New Jersey, Trenton, NJ, March 1999 Faculty Reviewer, New Investigator Workshop, American Society for Preventive Oncology, University of Texas, Houston, TX, March

1998 Ad hoc Member, NCI Scientific Review Group/Subcommittee E (Program Project Grant Applications), Silver Springs MD, December

1998 Member, Special Review Panel, Site Visit for Program Project Application, NCI Scientific Review Group/Subcommittee E, Nurses Health Study II, Harvard

University, Boston MA, September 1998 Chair, Special Review Committee, Four-Corners Study of Breast Cancer, Epidemiology and Disease Control Study Section 2 (EDC-2), National

Institutes of Health, Bethesda, MD, June 1997-1998 Member, Epidemiology and Disease Control Study Section 2 (EDC-2), National Institutes of Health, Bethesda, MD

1997 Ad hoc Member, Review Committee, Small Grants Program for Cancer Epidemiology, Cancer Prevention and Control Research Small Grant

Program, National Cancer Institute, National Institutes of Health, Bethesda MD, March

1996-1998 Member, Community-Initiated Research Collaborative Award Review Committee, Breast Cancer Research Program, University of California for the State of California, San Francisco, CA, December and April

1996 Member, Special Review Committee, Epidemiology and Disease Control Study Section 2 (EDC-2), National Cancer Institute, National Institutes of Health, Bethesda, MD, August

1996 Member, Special Review Committee, Small Grants Program for Cancer Epidemiology, Cancer Prevention and Control Research Small Grant

Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, August

1996 Outside Reader, Ph.D. Dissertation Committee, "Environmental Organochlorine Exposure and Postmenopausal Breast Cancer Risk," Kirsten B. Moysich,

State University of New York at Buffalo, NY, November 1995-1996 Member, Etiology and Prevention Review Committee, California Breast Cancer Research Program, University of California, San Francisco, CA, April 1993 Member, Breast Cancer Surveillance Research Committee for Geographic Variation

in Breast Cancer, National Cancer Institute, National Institutes of Health, Rockville, MD, November

1992 Member, Special Scientific Review Committee for Predoctoral Fellowships, Agency for Health Care Policy and Research, Department of Health and Human

Services, Rockville, MD, April 1991 Member, Grant Application Review, Basic Research Foundation, The Israel Academy of Sciences and Humanities, Jerusalem, April

1990 Outside Reader, Ph.D. Dissertation Committee, "Hypertension, oral contraceptive use, and smoking among young and middle aged American women,"

Department of Epidemiology and Public Health, Yale University, New Haven, CT, April

ORAL PRESENTATIONS

MD GAMMON

31

Targeted to Scientific Audiences: 2009 Invited Speaker, “Long Island Breast Cancer Study Project: 5-year Update,” Grand

Rounds, Karmanos Cancer Institute, Wayne State University, Detroit MI, October

2008 Invited Speaker/Panel Member, “Environmental toxins and breast cancer risk: Update from the Long Island Breast Cancer Study Project,” President’s Cancer Panel on Environmental Factors in Cancer, National Cancer Institute, Charleston SC, December

2008 Invited Speaker/Symposium Co-Chair, “Correlating Lifecourse Approaches and Risk,” Department of Defense Breast Cancer Research Program, Era of Hope Meeting, Baltimore MD, June

2008 Invited Speaker/Symposium Co-Chair, “Environmental Impact on Gene Expression,”Department of Defense Breast Cancer Research Program, Era of Hope Meeting, Baltimore MD, June

2008 Invited Speaker, “In Search of Modifiable Risk and Prognostic Factors for Breast Cancer,” Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Rockville, MD, February

2008 Invited Panel Member, “Grant Funding,” Graduate Student Academic & Professional Development, University of North Carolina, Chapel Hill, NC,

January 2007 Invited Speaker, “Contributing to our Understanding of Breast Cancer Risk and

Survival: the Long Island Breast Cancer Study Project,” Grand Rounds, Yale University School of Medicine, New Haven CT, December

2007 Invited Speaker, “University Cancer Research Fund Cancer Survivor Cohorts: Preliminary Plans,” Lineberger Comprehensive Cancer Center Annual

External Advisory Committee Meeting, University of North Carolina, Chapel Hill, NC, November

2007 Invited Speaker, “Contributing to our Understanding of Breast Cancer Risk and Survival: the Long Island Breast Cancer Study Project,” Department of

Medicine, Vanderbilt University, Nashville, TN, October 2007 Invited Speaker, “Developing Cancer Survivor Cohorts from Existing Epidemiologic

Studies of Cancer: the UNC Lineberger Experience,” Symposium on Cancer Survivorship, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, September

2007 Invited Speaker, “Lessons Learned while Conducting Epidemiologic Research in Breast and Esophageal Cancer,” Department of Epidemiology and Health

Policy, School of Medicine, University of Florida, Gainesville, FL, March 2007 Invited Speaker, “Lessons Learned in Conducting Epidemiologic Research:

Examples from Breast and Esophageal Cancer,” Program in Cancer Control, Comprehensive Cancer Center, Wake-Forest University, Winston-Salem, NC, January

2006 Invited Speaker, “The Epidemiology of Obesity and Cancer Risk and Prognosis,” North American Association for the Study of Obesity, Annual Meeting,

Boston, MA, October 2006 Invited Speaker, “Contributing to our Understanding of Cancer Development and

Prognosis,” Invited Speaker, Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, July

MD GAMMON

32

2006 Invited Speaker, "Researchers, Community Advocacy, and the Public: Insights from the Long Island Breast Cancer Study Project," Invited Speaker, Second North American Congress of Epidemiology, Seattle, WA, June

2006 Invited Speaker, “Lessons Learned and Future Directions: Examples from the Epidemiology of’ Cancers of the Breast and Esophagus,” Department of

Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, May

2005 Invited Speaker, "Epidemiology of Esophageal Cancer by Histologic Subtype," Gastrointestinal Specialized Program in Cancer Research (GI SPORE),

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, November

2005 Invited Speaker/Panel Member "Research Involving the Lay Public: the Long Island Experience," American College of Epidemiology, Annual Meeting, New Orleans, LA, September [Meeting Cancelled because of Hurricane Katrina]

2005 Invited Speaker, "Modifiable Risk Factors for Breast Cancer," ERA of Hope, Department of Defense, Philadelphia, PA, June 2005 Invited Speaker, "Obesity and Cancer," Lineberger Comprehensive Cancer Center Annual Retreat, University of North Carolina, Chapel Hill, March 2005 Invited Speaker, “Why Obesity May Cause Cancer and Reduce Survival Time,”

Nutrition, Energetics, and Cancer Training Grant, Annual Symposium, University of North Carolina, Chapel Hill, February

2004 Invited Speaker, "University of North Carolina Center for Transdisciplinary Research on Energetics," Annual External Advisors Meeting for the

Lineberger Comprehensive Cancer Center, December 2004 Invited Keynote Speaker, “Obesity May Cause Cancer and Reduce Survival Time,”

North American Association for the Study of Obesity, 2004 Annual Scientific Meeting, Las Vegas, NV, November

2004 Invited Speaker, “Polycyclic Aromatic Hydrocarbons and Breast Cancer,” Department of Epidemiology, School of Public Health, University of South Carolina, Columbia, SC, April

2002 Invited Speaker/Panel Member “Cigarette Smoking, Environmental Tobacco Smoke, and Breast Cancer,” Symposium on Women and Smoking, Annual

Investigators Meeting, California Tobacco-Related Disease Research Program, California Breast Cancer Research Program, and the American Cancer Society, San Jose, CA, December

2002 Invited Speaker “Long Island Breast Cancer Study Project,” Center for Environmental Susceptibility and Health, University of North Carolina at

Chapel Hill, NC, November 2002 Invited Speaker, “Breast Cancer and the Environment: Future Directions,”

Symposium on Breast Cancer and the Environment, University of California at Berkeley and Centers for Disease Control, Santa Cruz, CA, May

2001 Invited Speaker, “Epidemiology of Breast Cancer,” Pathophysiology of Environmentally Associated Disease, Division of Extramural Research and

Training Science Retreat National Institute of Environmental Health Sciences, Southern Pines, NC, November

2001 Invited Speaker, “Long Island Breast Cancer Study Project,” U.S. Senate Committee on the Environment and Public Works, Special Hearing on Cancer Clusters,

MD GAMMON

33

Chair: Senator Hillary Rodham Clinton, Adelphi University, Garden City, NY, June

2001 Invited Speaker/Symposium Chair “Breast Cancer: Potential Causes and Risk Assessment,” Breast Cancer Research Program Symposium, Oakland, CA,

March 1999 Invited Speaker, "Long Island Breast Cancer Study Project,” Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill,

NC, October 1999 Invited Speaker "Cigarette Smoking and Other Risk Factors in Relation to Cyclin D1

Expression in Esophageal and Gastric Cancer," Cancer Research Program, National Institutes of Environmental Health Sciences Center, Columbia University, New York, NY, May

1999 Invited Speaker, "Breast Cancer and the Environment: What is the Evidence for a Link?" Division of Research, Kaiser Permanente, Oakland, CA, April 1999 Invited Speaker, "Breast Cancer and the Environment: What is the Evidence for a

Link?" University of North Carolina, Department of Epidemiology, Chapel Hill, NC, March

1999 Invited Speaker, "Long Island Breast Cancer Study Project," External Advisory Committee, National Institute of Environmental Health Sciences Center, Environmental Health in Northern Manhattan, Columbia University, New York, NY, February

1999 Invited Speaker, "Environmental Risk Factors and p53 Expression in Breast Cancer," Department of Surgery, New York-Presbyterian Medical Center, New York, NY, February

1999 Invited Speaker, "Breast Cancer and Environmental Risk Factors: What is the Evidence for a Link?" Mt. Sinai School of Medicine, Derald Ruttenberg Cancer Center, New York, NY, January 1999 Invited Speaker, "Breast Cancer and the Environment: What is the Evidence for a Link?" Department of Epidemiology Seminar Series, School of Public Health, University of Minnesota, Minneapolis, MN, January

1998 Invited Speaker, "Long Island Breast Cancer Study Project," Breast Cancer Clusters Workshop sponsored by the U.S. Public Health Service's Office on Women's

Health, Boston, MA, December 1998 Invited Speaker, "Cigarette Smoking and Other Risk Factors in Relation to p53

Expression in Breast Cancer," Memorial Sloan-Kettering Cancer Center, Cancer and Public Health Seminar Series, Department of Epidemiology and Biostatistics/Department of Psychiatry, New York, NY, November

1998 Invited Speaker, "Environmental Risk Factors and p53 Expression in Breast Cancer," Breast Cancer Research Program, New York-Presbyterian Medical Center,

New York, NY, November 1998 Invited Speaker, "Risk Factors for Adenocarcinomas of the Esophagus and Gastric

Cardia," Fifth International Conference on Gastrointestinal Disease, Sponsored by George Washington University and University of Bordeaux II, Bordeaux, France, September

1998 Invited Speaker, “Long Island Breast Cancer Study Project,” Columbia-Presbyterian Health Sciences Advisory Council, New York, NY, April

1998 Invited Speaker, “Cyclin D1 in Esophageal and Gastric Cancer,” National Cancer

MD GAMMON

34

Institute, Division of Cancer Epidemiology and Genetics, Meeting of the NCI Collaborative Study of Esophageal and Gastric Adenocarcinomas, Bethesda, MD, March

1997 Invited Speaker, "Long Island Breast Cancer Study Project," Scientific Advisory Board to the Columbia School of Public Health, New York, NY, December

1997 Invited Speaker, "Long Island Breast Cancer Study Project," Epidemiology and Public Health, Yale University, New Haven, CT, December 1997 Invited Speaker, "The Epidemiology of Breast Cancer," National Action Plan on

Breast Cancer and Radiation, National Cancer Institute and the Susan B. Komen Foundation, Bethesda, MD, November

1997 Invited Speaker/Discussant "Physical Activity and Breast Cancer Risk," National Action Plan on Breast Cancer and Physical Activity, National Cancer Institute and the Susan B. Komen Foundation, Albuquerque, NM, November

1997 Invited Speaker, "Tobacco, Alcohol, and Socioeconomic Status and Esophageal and Gastric Adenocarcinomas," Memorial Sloan-Kettering Cancer Center, New York, NY, October

1997 Invited Speaker, "DDT, PCBs and Breast Cancer Risk: The Epidemiologic Evidence," Symposium on Pesticides, Diet and Breast Cancer, Cornell

University Institute for Comparative and Environmental Toxicology, Ithaca, NY, September

1997 Invited Speaker, "Long Island Breast Cancer Study Project," Columbia School of Public Health Alumni Association, New York, NY, June 1997 Invited Speaker, "Long Island Breast Cancer Study Project," Program on Breast Cancer and Environmental Risk Factors, Cornell University, Ithaca, NY, June 1997 Invited Speaker, "Long Island Breast Cancer Study Project," Columbia School of Public Health, Faculty Assembly, New York, NY February

1996 Invited Speaker, "Adenocarcinomas of the Esophagus and Gastric Cardia and Use of Tobacco and Alcohol," Herbert Irving Cancer Center Research Retreat, New York, NY, December

1996 Invited Speaker, "Abortion and Breast Cancer," Memorial Sloan-Kettering Cancer Center, New York, NY, December 1996 Invited Speaker, "Pilot Studies for the Long Island Breast Cancer Study Project," Program Meeting on Geographic Variation in Breast Cancer, National Institute of Environmental Health Sciences, Research Triangle Park, NC, September 1996 Invited Speaker, "Tobacco and Alcohol and Esophageal and Gastric Cardia

Adenocarcinomas," National Cancer Institute, Division of Cancer Epidemiology and Genetics, Meeting of the Collaborative Study of Esophageal and Gastric Adenocarcinoma, Boston, MA, June

1996 Invited Speaker, "The Long Island Breast Cancer Study Project," Bay Area Breast Cancer Study Group, University of California at San Francisco, CA, June 1996 Invited Speaker, "Breast Cancer and Genetics: The Indications and Implications," Columbia-Presbyterian Medical Center, New York, NY, June 1996 Invited Speaker, "Long Island Breast Cancer Study Project," National Cancer

Institute's Second Annual Meeting for the Long Island Breast Cancer Study Project, New York, NY, April

1996 Invited Speaker, "Physical Activity and Breast Cancer Risk," Helen Hayes Hospital

MD GAMMON

35

Conference on Critical Issues in Women's Health, Nyack, NY, April 1996 Invited Speaker, "Progress in Cancer Epidemiology," Columbia-Presbyterian Cancer Center, Scientific Advisory Committee Meeting, New York, NY, January

1995 Invited Speaker, "The Long Island Breast Cancer Study Project," Columbia University, Clinical Updates and Controversies in the Management of Breast

Cancer, New York, NY, December 1995 Invited Speaker, "The Long Island Breast Cancer Study Project," Joint Seminar,

Duke University/ University of North Carolina/National Institute of Environmental Health Sciences, Durham, NC, November

1995 Invited Speaker, "Lifestyle and Breast Cancer: Does Physical Activity Reduce Risk?" The North American Menopause Society, Sixth Annual Meeting, San

Francisco, CA, September 1995 Invited Speaker, "Treatment for Breast Cancer and Blood Levels of Chlorinated

Hydrocarbons,” Breast Cancer Research Programs, Columbia-Presbyterian Cancer Center, New York, NY, June

1995 Invited Speaker, "Long Island Breast Cancer Study Project," Columbia University College of Physicians and Surgeons, Department of Medicine, Hematology-

Oncology Rounds, New York, NY, January 1994 Invited Speaker, "Breast Cancer and the Environment," Columbia-Presbyterian Cancer Center, Research Retreat, New York, NY, December 1994 Invited Speaker, "Breast Cancer and the Environment on Long Island," Columbia-

Presbyterian Cancer Center, Scientific Advisory Committee Meeting, New York, NY, December

1994 Invited Speaker, "Risk Factors for Breast Cancer among Black Women," Columbia University School of Public Health, Faculty Assembly, New York, NY, April

1991 Invited Discussant, Workshop on Future Epidemiologic Studies of the Health Effects of Electromagnetic Fields (Invited Participant), Carmel, CA, February

1990 Invited Speaker, "Breast Cancer Risks and Controversies: Exogenous Estrogens and Breast Cancer," Department of Surgery and the Center for Continuing

Education, Comprehensive Breast Center, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, November

1990 Invited Speaker, "Infertility and Breast Cancer," Department of Environmental and Community Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, NJ, April

1988 Invited Speaker, "Infertility and Breast Cancer: A Population-Based, Case-Control Study," Columbia University School of Public Health, Division of

Epidemiology, New York, NY, August 1988 Invited Speaker, "Infertility and Breast Cancer: A Population-Based, Case-Control Study," Emory University School of Public Health, Department of Epidemiology and Biostatistics, Atlanta, GA, July 1988 Invited Speaker, "Infertility and Breast Cancer: A Population-Based, Case-Control Study," Illinois Cancer Council, Chicago, IL, July

Presentations Targeted to Lay Audiences: 2010 Invited Speaker/Panel Member, “Applying to Graduate & Professional Schools,” University of North Carolina, Chapel Hill, NC, April 2007 Invited Speaker/Panel Member, “Applying to Graduate & Professional Schools,”

MD GAMMON

36

University of North Carolina, Chapel Hill, NC, November 2007 Invited Speaker/Workshop Leader, “Breast Cancer Prevention Strategies,” California Breast Cancer Research Program, Los Angeles, CA, September 2007 Invited Speaker, “Modifiable Risk Factors for Breast Cancer,” California Breast Cancer Research Program, Los Angeles, CA, September 2006 Invited Speaker, "Contributing to our Understanding of the Epidemiology of Breast

Cancer Development and Prognosis," State of North Carolina Department of Public Health Scientific Speaker Series, Raleigh, NC, June

2006 Invited Speaker, "Cancer Causation," UNC-CH Judges Medical School, Chapel Hill, NC, March 2005 Panel Member, "Communicating Prevention Research on Women's Health," School of Journalism, University of North Carolina, Chapel Hill, March

2002 Invited Speaker, “Breast Cancer and the Environment: Where do we go from here?” Cancer Care, Westbury, NY, October

2002 Invited Speaker, “Long Island Breast Cancer Study Project: Where do we go from here?” Long Island Breast Cancer Network, Omni Center, Uniondale, NY, September 2002 Invited Speaker, “Long Island Breast Cancer Study Project: (I) PAH-DNA adducts, and (II) Organochlorine compounds in blood,” Long Island Breast Cancer

Network and National Institutes of Health investigators, media representatives, Omni Center, Uniondale, NY, August

2002 Invited Speaker, “Long Island Breast Cancer Study Project: Understanding the Peer- review Process,” Long Island Breast Cancer Network, Omni Center,

Uniondale, NY, May 2002 Invited Speaker, “Long Island Breast Cancer Study Project: Progress and Update,”

Women at Risk Lecture Series, South Nassau Communities Hospital, Long Island, NY, May

2002 Invited Speaker, "Update on the Long Island Breast Cancer Study Project: Communicating with the Media" Long Island Breast Cancer Network, Omni Center, Uniondale, NY, March 2002 Invited Speaker: "Progress on the Long Island Breast Cancer Study Project" Long Island Breast Cancer Network, Omni Center, Uniondale, NY, January

2001 Invited Speaker, "Update on the Long Island Breast Cancer Study Project: Organochlorine Compounds and Issues in Data Interpretation," Long Island Breast Cancer Network, Omni Center, Uniondale, NY, March 2000 Invited Speaker, “Understanding the Peer-Review Process for Scientific

Publications,” Long Island Breast Cancer Network, Omni Center, Uniondale, NY, January

1999 Invited Speaker, “Polycyclic Aromatic Hydrocarbons and the Risk of Breast Cancer: Scientific Rationale and Issues in Data Interpretation,” Long Island Breast

Cancer Network, American Cancer Society of Long Island, Hauppauge, NY, November

1999 Invited Speaker, "Physical Activity and Breast Cancer Risk," Update on Breast Health: Key Components for Risk Reduction on Long Island, Cornell

Cooperative Extension of Nassau County and the Maurer Foundation for Breast Health Education, Garden City, NY, April

1999 Invited Speaker, "Long Island Breast Cancer Study Project: Measuring Pesticide

MD GAMMON

37

Exposures in Epidemiology," Current Issues on Long Island Relating to Pesticides and Health, Cornell Cooperative Extension of Suffolk County, Ronkonkoma, NY, March

1998 Invited Speaker, "Update on the Long Island Breast Cancer Study Project: Comparing Results across Epidemiologic Studies," Long Island Breast Cancer Network, Omni Center, Uniondale, NY, November

1998 Invited Speaker, “Long Island Breast Cancer Study Project," The First Annual Breast Cancer Conference. The Maurer Foundation for Breast Health Education, Inc., Melville, NY, October

1998 Invited Speaker, "Long Island Breast Cancer Study Project," State University of New York at Old Westbury, Westbury, NY, October 1998 Invited Speaker, "Long Island Breast Cancer Study Project," News 12 Long Island, Woodbury, NY, October

1998 Invited Speaker, “Long Island Breast Cancer Study Project: Relevance to New Jersey,” After Breast Cancer Surgery, YM-YWHA of Bergen County,

Washington Township, NJ, October 1998 Invited Speaker, "Update on the Long Island Breast Cancer Study Project: Communicating Results based on Population-level Data" Long Island Breast Cancer Network, Omni Center, Uniondale, NY, September 1998 Invited Speaker, "The Long Island Breast Cancer Study Project: Interpretation of

Epidemiologic Data," Long Island Breast Cancer Network, Omni Center, Uniondale, NY, July

1998 Invited Speaker, “Physical Activity and Breast Cancer,” WOR Radio Station, New York, NY, February 1998 Invited Speaker, "Long Island Breast Cancer Study Project," Long Island Views, WABC News: Channel 7, New York, NY, January 1998 Invited Speaker, "Update on the Long Island Breast Cancer Study Project: Data Analysis Issues," Long Island Breast Cancer Network, Omni Center, Uniondale, NY, January

1997 Invited Speaker, "DDT, PCBs and Breast Cancer Risk: The Epidemiologic Evidence," Long Island Breast Cancer Network, Omni Center, Uniondale,

NY, November 1997 Invited Speaker, "Breast Cancer," Special Breast Cancer Town Meeting, News 12 Long Island, Woodbury, NY, October 1997 Invited Speaker, "Long Island Breast Cancer Study Project," National Cancer

Institute's Third Annual Meeting for the Long Island Breast Cancer Study Project, Hauppauge, NY, September

1997 Invited Speaker, "Long Island Breast Cancer Study Project," Congressional Television Show for Long Island, Washington D.C., August 1997 Invited Speaker, "Long Island Breast Cancer Study Project" Long Island Breast Cancer Network, Huntington, NY, August

1997 Invited Speaker, "Update on the Long Island Breast Cancer Study Project: Data Management and Quality Control," Long Island Breast Cancer Network, Omni Center, Uniondale, NY, July

1997 Invited Speaker, "Long Island Breast Cancer Study Project," Babylon Breast Cancer Coalition, W. Babylon, NY, May 1997 Invited Speaker, "Long Island Breast Cancer Study Project," Huntington Breast

MD GAMMON

38

Cancer Coalition Town Meeting, Huntington, NY, April 1997 Invited Speaker, "Progress on the Long Island Breast Cancer Study Project: Challenges of Assessing Ambient Environmental Exposures in an

Epidemiologic Study" American Cancer Society, Long Island Division, Hauppauge, NY, April

1997 Invited Speaker, "Long Island Breast Cancer Study Project," Plainview-Old Bethpage Breast Cancer Coalition and the Mid Island Y-JCC, Old Bethpage,

NY, February 1997 Invited Speaker, "Breast Carcinogenic Potential of Estrogenic Chemicals," Long Island Breast Cancer Network, New York, NY, January 1996 Invited Speaker, "Update on the Long Island Breast Cancer Study Project: Subject Recruitment," Long Island Breast Cancer Network, Omni Center, Uniondale,

NY, November 1996 Invited Speaker, "Long Island Breast Cancer Study Project," Huntington Breast Cancer Coalition, Huntington, NY, October

1996 Invited Speaker, "Long Island Breast Cancer Study Project," Eight Annual Breast Cancer Awareness Breakfast, Nassau County Department of Services to

Women, Uniondale, NY, October 1996 Invited Speaker, "Update on the Long Island Breast Cancer Study Project: Analyses

of the Environmental Water Samples," Long Island Breast Cancer Network, Suffolk Community College, Brentwood, NY, September

1996 Invited Speaker, "The Long Island Breast Cancer Study Project," Babylon Breast Cancer Coalition, W. Babylon, NY, September 1996 Invited Speaker, "Update on the Long Island Breast Cancer Study Project: Informed

Consent and Subject Confidentiality," Long Island Breast Cancer Network, Omni Center, Uniondale, NY, July

1996 Invited Speaker, "Update on the Long Island Breast Cancer Study: Minority Representation," Omni Center, Uniondale, NY, June 1996 Invited Speaker, "Long Island Breast Cancer Study Project," Adelphi University, Garden City, NY, May 1996 Invited Speaker, "Long Island Breast Cancer Study Project," Long Island Breast

Cancer Action Coalition, Nassau County Medical Center, East Meadow, NY, May

1996 Invited Speaker, "Public Relations and the Long Island Breast Cancer Study Project: Questionnaire Development" Long Island Breast Cancer Network,

Suffolk County Community College, Brentwood, NY, April 1995 Invited Speaker, "Long Island Breast Cancer Study Project," Town Meeting, Hauppauge, NY, March

1995 Invited Speaker, "Long Island Breast Cancer Study Project: Study Planning" Long Island Breast Cancer Network, West Hempstead, NY, January

PUBLICATIONS Peer-Reviewed Journal Articles (*indicates junior investigator): 1983 1. Douglass CW, Gillings D, Sollecito W, Gammon MD. National trends in the prevalence

and severity of the periodontal diseases. Journal of the American Dental Association 1983;107:403-12.

MD GAMMON

39

2. Douglass CW, Gillings D, Sollecito W, Gammon MD. The potential for increase in the periodontal diseases of the aged population. Journal of Periodontology 1983;54(12):721-30.

1984 3. Douglass CW, Gammon MD, Gillings D, Sollecito W, Rundle DG. Estimating the market

for periodontal services in the United States. Journal of the American Dental Association 1984;108:968-72.

4. Douglass CW, Gammon MD. Reassessing the epidemiology of lip cancer. Oral Surgery, Oral Medicine, and Oral Pathology 1984;57:631-42.

5. Douglass CW, Gammon MD. The epidemiology of dental caries and its impact on the operative dentistry curriculum. Journal of Dental Education 1984;48(10):547-55.

1985 6. Douglass CW, Gammon MD. The implications of oral disease trends for the treatment

needs of older adults. Gerodontics 1985;1(2):51-8. 7. Douglass CW, Gammon MD, Orr RB. Oral health status in the United States: prevalence of

inflammatory periodontal disease. Journal of Dental Education 1985;49(6):365-7. 8. Douglass CW, Gammon MD. Future need for dental treatment in Canada. Journal of the

Canadian Dental Association 1985;8:583-90. 1988 9. Douglass CW, Gammon MD, Atwood DA. Need and effective demand for prosthodontic

treatment. Journal of Prosthetic Dentistry 1988;59(1):94-104. 10. Douglass CW, Gammon MD, Atwood DA. Need and effective demand for prosthodontic

treatment. A report: Part one. Oral Health 1988 78:11-7, 21-3. 1990 11. Gammon MD, Thompson WD. Infertility and breast cancer: a population-based case-

control study. American Journal of Epidemiology 1990;132:708-16. 12. Kelsey JK, Gammon MD. Update. Epidemiology of breast cancer. Epidemiologic Reviews

1990;12:228-40. 1991 13. Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. American

Journal of Epidemiology. 1991;134:818-24. 14. Kelsey JK, Gammon MD. The epidemiology of breast cancer. CA-A Cancer Journal for

Clinicians 1991;41:146-65. 15. Schwartz SM, Weiss NS, Daling JR, Newcomb P, Liff J, Gammon MD, Thompson WD,

Watt JD, Armstrong BK, Weyer P, Isaacson P, Ek M. Incidence of histologic types of uterine sarcoma in relation to menstrual and reproductive history. International Journal of Cancer 1991;49:362-7.

1992 16. Kanetsky PA*, Mandelblatt J, Richart R, Gammon MD. Risk factors for cervical neoplasms

in a black, elderly population. Ethnicity and Disease 1992;2:337-42. 1993 17. Hoffman S*, Grisso JA, Kelsey JL, Gammon MD, O'Brien LA. Parity, lactation, and hip

fracture. Osteoporosis International 1993;3:171-6. 18. Gammon MD, John EM. Recent etiologic hypotheses concerning breast cancer.

Epidemiologic Reviews 1993;15:163-8. 19. Kelsey JK, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiologic

Reviews 1993;15:36-47. 1995

MD GAMMON

40

20. Brinton LA, Daling JR, Liff J, Schoenberg JB, Malone KE, Stanford JL, Coates RJ, Gammon MD, Hanson L, Hoover RN. Oral contraceptives and breast cancer risk among younger women. Journal of the National Cancer Institute 1995;87:827-35.

21. Brinton LA, Potischman NA, Swanson CA, Schoenberg JB, Coates RJ, Gammon MD, Malone KE, Stanford JL, Daling JR. Breastfeeding and breast cancer risk. Cancer Causes and Control 1995;6:199-208.

1996 22. Schwartz SM, Weiss NS, Daling JR, Gammon MD, Liff J, Watt JD, Isaacson P, Newcomb

P, Armstrong BK, Thompson WD. Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus. Cancer 1996;77:717-24.

23. Swanson CA, Coates RJ, Schoenberg JB, Malone KE, Gammon MD, Stanford JL, Shorr IJ, Potischman NA, Brinton LA. Body size and breast cancer risk among women under age 45 years. American Journal of Epidemiology 1996;143:698-706.

24. Gammon MD, Wolff MS, Neugut AI, Terry MB*, Britton JA*, Greenebaum E, Hibshoosh H, Levin B, Wang Q, Santella R. Treatment for breast cancer and blood levels of chlorinated hydrocarbons. Cancer Epidemiology, Biomarkers and Prevention 1996;5:467-71.

25. Weiss HA*, Brinton LA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB, Swanson CA. Epidemiology of in situ and invasive breast cancer in young women. British Journal of Cancer 1996;73:1298-1305.

26. Daling JR, Brinton LA, Voight LF, Weiss NS*, Coates RJ, Malone KE, Schoenberg JB, Gammon MD. Risk of breast cancer among white women following induced abortion. American Journal of Epidemiology 1996;144:373-80.

27. Gammon MD, Britton JA*, Teitelbaum ST*. Does physical exercise reduce the risk of breast cancer? A review of the epidemiologic literature. Menopause 1996;3:172-80.

28. Morrison EAB*, Gammon MD, Goldberg GL, Vermund SH, Burk RD. Pregnancy and cervical infection with human papillomaviruses. International Journal of Gynecology and Obstetrics 1996;54:125-30.

1997 29. Weiss HA*, Potischman N, Brinton LA, Brogan D, Coates RJ, Gammon MD, Malone KE,

Schoenberg JB. Prenatal and perinatal risk factors for breast cancer in young women. Epidemiology 1997;8:181-7.

30. Gammon MD, Wolff MS, Neugut AI, Terry MB*, Papadopoulos K, Levin B, Wang Q, Santella RM. Temporal variation in chlorinated hydrocarbons in healthy women. Cancer Epidemiology, Biomarkers and Prevention 1997;6:327-32.

31. Cook LS, Daling JR, Voight LF, Malone KE, deHart MP, Stanford JL, Weiss NS, Brinton LA, Gammon MD, Brogan D. Differences between women with and without breast augmentation: relevance to epidemiologic studies. Journal of the American Medical Association 1997;277:1612-7.

32. Brinton LA, Gammon MD, Malone KE, Schoenberg JB, Daling JR. Modification of oral contraceptive relationships by other breast cancer risk factors among younger women. Contraception 1997;55:197-203.

33. Swanson CA, Coates RJ, Malone KE, Gammon MD, Schoenberg JB, Brogan DJ, McAdams M, Potischman NA, Hoover RN, Brinton LA. Alcohol consumption and breast cancer risk among women under age 45. Epidemiology 1997;8:231-7.

34. Gammon MD, Schoenberg JB, Ahsan H*, Risch HA, Vaughan TL, Chow W-H, Rotterdam H, West AB, Dubrow R, Stanford JB, Mayne ST, Farrow DC, Niwa S, Blot WJ, Fraumeni

MD GAMMON

41

JF, Jr. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. Journal of the National Cancer Institute 1997;89:1277-84.

35. Potischman N, Swanson CA, Coates RJ, Weiss HA, Brogan DR, Stanford JL, Schoenberg JB, Gammon MD, Brinton LA. Dietary relationships with early onset (under age 45) breast cancer in a case-control study: influence of chemotherapy treatment. Cancer Causes and Control 1997;8:713-21.

36. Ahsan H*, Neugut AI, Gammon MD. Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. Cancer Epidemiology, Biomarkers and Prevention 1997;6:779-82.

1998 37. Brinton LA, Benichou J, Gammon MD, Brogan DJ, Coates R, Schoenberg JB. Ethnicity

and variation in breast cancer incidence. International Journal of Cancer 1997;73:349-55. 38. Gammon MD, John EM, Britton JA*. Recreational and occupational physical activity and

breast cancer. Journal of the National Cancer Institute 1998;90:100-17. 39. Chow W-H, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R,

Schoenberg JB, Mayne ST, Farrow DC, Ahsan H*, West AB, Rotterdam H, Niwa S, Fraumeni JF, Jr. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. Journal of the National Cancer Institute 1998;90:150-5.

40. Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow W-H, Dubrow R, Ahsan H*, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF, Jr, Blot WJ. Use of aspirin and other non-steroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiology, Biomarkers and Prevention 1998;7:97-102.

41. Gammon MD, Schoenberg JB, Britton JA*, Kelsey JL, Coates RJ, Brogan D, Potischman N, Swanson CA, Daling JR, Stanford JL, Brinton LA. Recreational physical activity and breast cancer risk among women under age 45 years. American Journal of Epidemiology 1998;147:273-80.

42. Potischman N, Weiss HA, Swanson CA, Coates RJ, Gammon MD, Malone KE, Brogan D, Stanford JL, Hoover RN, Brinton LA. Adolescent diet and risk of breast cancer among young women. Journal of the National Cancer Institute 1998;90:226-33.

43. Chow W-H, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, Fraumeni JF, Jr. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Research 1998;58:588-90.

44. Kanetsky PA*, Gammon MD, Mandelblatt J, Zhang Z-F, Ramsey E, Wright TC, Msyseoane S, Laxaro N, Felton HT, Sachdev RK, Richart RM, Curtin JP. Cigarette smoking and cervical dysplasia among non-Hispanic black women. Cancer Detection and Prevention 1998;22:109-19.

45. Kanetsky PA*, Gammon MD, Mandelblatt J, Zhang Z-F, Ramsey E, Dnistrian A, Norkus EP, Wright TC, Thomas L, Matseoane S, Lazaro N, Felton HT, Sachdev RK, Richart RM, Curtin JP. Dietary intake and blood levels of folate, vitamin E, retinoids, and carotenoids: associations with cervical dysplasia among non-Hispanic, black women. Nutrition and Cancer 1998;31:31-40.

46. Vaughan TL, Farrow DC, Hantsen PD, Chow W-H, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Rotterdam H, Dubrow R, Ahsan H*, West AB, Blot WJ, Fraumeni JF, Jr. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs and other medications that promote gastro-

MD GAMMON

42

esophageal reflux. Cancer Epidemiology, Biomarkers and Prevention 1998;7:749-56. 47. Gammon MD, Schoenberg JB, Britton JA*, Kelsey JL, Stanford JL, Malone KE, Coates

RJ, Brogan DJ, Potischman N, Swanson CA, Brinton LA. Electric blanket use and breast cancer risk among younger women. American Journal of Epidemiology 1998;148:556-65.

48. Weiss HA, Troisi RA, Rossing MA, Brogan D, Coates RJ, Gammon MD, Potischman NA, Swanson CA, Brinton LA. Fertility problems and breast cancer risk in young women: a case-control study. Cancer Causes and Control 1998;9:331-9.

49. Troisi R, Weiss HA, Hoover RN, Potischman NA, Swanson CA, Brogan D, Coates RJ, Gammon MD, Malone KE, Daling JR, Brinton LA. Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 1998;9:641-7.

50. Gammon MD, Schoenberg JB, Teitelbaum SL*, Brinton LA, Potischman N, Swanson CA, Brogan DJ, Coates RJ, Malone KE, Stanford JL. Cigarette smoking and breast cancer risk among young women (United States). Cancer Causes and Control 1998;9:583-90.

1999 51. Potischman N, Swanson CA, Coates RJ, Gammon MD, Brogan DR, Curtin J, Brinton LA.

The intake of food groups and associated micronutrients in relation to risk of early stage breast cancer. International Journal of Cancer 1999;82:315-21.

52. Gammon MD, Hibshoosh H, Terry MB*, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD. Cigarette smoking and other risk factors in relation to p53 protein expression in breast cancer among young women. Cancer Epidemiology, Biomarkers and Prevention 1999;8:255-63.

53. Hall HI, Coates RJ, Uhler R, Brinton LA, Gammon MD, Brogan DR, Potischman N, Swanson CA. Stage of breast cancer in relation to body mass index and bra cup size. International Journal of Cancer 1999;82:23-7.

54. Gammon MD, Hibshoosh H, Terry MB*, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women. Cancer Epidemiology, Biomarkers and Prevention 1999;8:413-9.

55. Nastiuck KL, Mansuhkani M, Terry MB*, Kularatne P, Rubin MA, Maleamed J, Gammon MD, Ittmann MM, Krolewski JJ. Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men. Prostate 1999;4:172-7.

56. Coates RJ, Uhler RJ, Hall HI, Potischman N, Brinton LA, Ballard-Barbash R, Gammon MD, Brogan DR, Daling JR, Malone KE, Schoenberg JB, Swanson CA. Risk of breast cancer in young women in relation to body size and weight gain in adolescence and early adulthood. British Journal of Cancer 1999;81:167-74.

57. Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB. Breast cancer in young women and history of selected medical conditions. International Journal of Epidemiology 1999;28:816-23.

58. Arber N, Gammon MD, Hibshoosh H, Britton JA*, Zhang Y, Schoenberg JB, Rotterdam H, Holt PR, Weinstein IB. Increased expression of cyclin D1 in esophageal and gastric cancers. Human Pathology 1999;30:1087-92.

2000 59. Arber N, Shapira I, Ratan J, Stern B, Hibshoosh H, Moshkowitz M, Gammon M, Fabian I,

Halpern Z. Activation of c-K-ras mutations in human gastrointestinal tumors. Gastroenterology 2000;118(6):1045-50.

60. Farrow DC, Vaughan TL, Sweeney C, Gammon MD, Chow W-H, Risch HA, Stanford JL, Hansten PD, Mayne ST, Schoenberg JB, Rotterdam H, Ahsan H*, West AB, Dubrow R,

MD GAMMON

43

Fraumeni Jr JF, Blot WJ. Gastroesophageal reflux disease, use of H2 antagonists, and risk of esophageal and gastric cancer. Cancer Causes and Control 2000;11:231-8.

61. Brinton LA, Gammon MD, Coates RJ, Hoover RN. Tubal ligation and risk of breast cancer. British Journal of Cancer 2000;82:1600-4.

62. Santella RM, Gammon MD, Young TL, Zhang YJ, Hayes SC, Terry MB*, Schoenberg JB, Brinton LA, Bose S, Teitelbaum SL*, Hibshoosh H. Immunohistochemical analyses of polycylic aromatic hydrocarbon-DNA adducts in breast tumor tissue. Cancer Letters 2000;154:143-9.

63. Westhoff C, Britton JA*, Gammon MD, Wright T, Kelsey JL. Oral contraceptives and benign ovarian tumors. American Journal of Epidemiology 2000;152:242-6.

64. Britton JA*, Westhoff C, Howe G, Gammon MD. Diet and benign ovarian tumors. Cancer Causes and Control 2000;11:389-401.

65. Butler LM*, Potischman NA, Newman B, Millikan RC, Brogan D, Gammon MD, Swanson CA, Brinton LA. Menstrual risk factors and early-onset breast cancer. Cancer Causes and Control 2000;11:451-8.

66. Madigan P, Troisi R, Potischman N, Brogan D, Gammon MD, Malone KE, Brinton LA. Characteristics of respondents and non-respondents in a case-control study of breast cancer in younger women. International Journal of Epidemiology 2000;29:793-8.

67. Britton JA*, Westhoff C, Howe G, Gammon MD. Lactose and benign ovarian tumors in a case-control study. British Journal of Cancer 2000;11:1552-5.

68. Britton JA*, Gammon MD, Kelsey JL, Brogan DR, Coates RJ, Schoenberg JB, Potischman N, Swanson CA, Stanford JL, Brinton LA. Characteristics associated with recent recreational exercise among women 20 to 45 years of age. Women & Health 2000;31:81-96.

2001 69. Coates RJ, Uhler RJ, Brogan DR, Gammon MD, Malone KE, Swanson CA, Flag ER,

Brinton LA. Patterns and determinants of the breast cancer detection methods in younger women in the United States. Cancer Causes and Control 2001;12(5):431-42.

70. Dhillon PK, Farrow DC, Vaughan TL, Chow W-H, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H, Dubrow R, West AB, Rotterdam H, Blot WJ, Fraumeni Jr JF. Association between family history of cancer and risk of esophageal and gastric cancer in the United States. International Journal of Cancer 2001;93(1):148-52.

71. Mayne ST, Risch HA, Dubrow R, Chow W-H, Gammon MD, Vaughan TL, Farrow DC, Schoenberg JB, Stanford JL, Ahsan H, West AB, Rotterdam H, Blot WJ, Fraumeni Jr JF. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiology, Biomarkers and Prevention 2001;10:1055-62.

2002 72. Engel LS*, Vaughan TL, Gammon MD, Chow W-H, Risch HA, Dubrow R, Mayne ST,

Rotterdam H, Schoenberg JB, Stanford JL, West AB, Blot WJ, Fraumeni Jr JF. Occupation and risk of esophageal and gastric cancers. American Journal of Industrial Medicine 2002;42:11-22.

73. Gammon MD, Neugut AI, Santella RM, Teitelbaum SL*, Britton JA*, Terry MB*, Eng SM*, Wolff MS, Stellman SD, Kabat GC, Levin B, Bradlow HL, Hatch M, Beyea J, Camann D, Trent M, Senie R, Garbowski G, Maffeo C, Montalvan P, Berkowitz G, Kemeny M, Citron C, Schnabel F, Schuss A, Hajdu S, Vinceguerra V, Collman GW, Obrams GI. The Long Island Breast Cancer Study Project: Description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Research and Treatment 2002;74:235-54.

MD GAMMON

44

74. Gammon MD, Santella RM, Neugut AI, Eng SM*, Teitelbaum SL*, Paykin A, Levin B, Terry MB*, Young TL, Wang LW, Wang Q, Britton JA, Wolff MS, Stellman SD, Hatch M, Kabat GC, Senie R, Garbowski G, Maffeo C, Berkowitz G, Kemeny M, Citron M, Schuss A, Hajdu S, Vinceguerra V. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon (PAH)-DNA adducts. Cancer Epidemiology, Biomarkers and Prevention 2002;11:677-85.

75. Gammon MD, Wolff MS, Neugut AI, Eng SM*, Teitelbaum SL*, Britton JA*, Terry MB*, Levin B, Stellman SD, Kabat GC, Hatch M, Senie R, Berkowitz G, Bradlow HL, Garbowski G, Maffeo C, Montalvan P, Kemeny M, Citron M Schnabel F, Schuss A, Hajdu S, Vinceguerra V, Santella RM. Environmental toxins and breast cancer on Long Island. II. Organochlorine compounds. Cancer Epidemiology, Biomarkers and Prevention 2002;11: 686-97.

76. Terry MB*, Gaudet MM*, Gammon MD. Epidemiology of gastric cancer. Seminars in Gastric Oncology 2002;12:111-27.

77. Furberg AH*, Millikan RC, Geradts J, Gammon MD, Dressler LG, Ambrosone CB, Newman B. Environmental factors in relation to the risk of breast cancer characterized by p53 protein expression. Cancer Epidemiology, Biomarkers and Prevention 2002;11:829-35.

78. Britton JA*, Gammon MD, Schoenberg JB, Stanford JL, Kelsey JL, Brogan DR, Coates RJ, Potischman N, Swanson CA, Brinton LA. Risk of breast cancer subclassified by joint steroid receptor status in relation to established and putative hormone-related characteristics among women 20 to 54 years. American Journal of Epidemiology 2002;156:507-16.

79. Terry MB*, Gammon MD, Schoenberg JB, Brinton LA, Hibshoosh H. Oral contraceptive use and Cyclin D1 overexpression in breast cancer among young women. Cancer Epidemiology, Biomarkers, and Prevention 2002;11(10):1100-3.

80. Potischman N, Coates RJ, Swanson CA, Carroll RJ, Daling JR, Brogan DR, Gammon MD, Midthune D, Curtin J, Brinton LA. Increased risk of early stage breast cancer related to consumption of sweet foods among women less than age 45. Cancer Causes Control 2002;13:937-46.

2003 81. Althuis M*, Brogan D, Coates R, Daling J, Gammon MD, Malone K, Schoenberg JB,

Brinton LA. Hormonal content and potency of oral contraceptives and breast cancer risk. British Journal of Cancer 2003;88:50-7.

82. Butler LM*, Sinha R, Millikan RC, Martin CF, Newman B, Gammon MD, Ammerman, AS, Sandler RS. Heterocyclic amines and other characteristics of meat intake, and association with colon cancer in a population-based study. American Journal of Epidemiology 2003;157:434-45.

83. Faraglia B, Chen SY, Gammon MD, Zhang YJ, Teitelbaum SL*, Neugut AI, Ahsan H, Garbowski GC, Hibshoosh H, Lin D, Kadlubar FF, Santella RM. Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: The influence of tobacco smoke. Carcinogenesis 2003;24:719-25.

84. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert JJ, Blot WJ, Fraumeni Jr. JF, Chow W-H. Increased risk of non-cardia gastric cancer associated with pro-inflammatory cytokine gene polymorphisms. Gastroenterology 2003;24:1193-201.

85. Althuis M*, Brogan D, Coates R, Daling JR, Gammon MD, Malone K, Schoenberg JB, Brinton LA. Breast cancer among very young premenopausal women (United States). Cancer Causes and Control 2003;14:151-60.

MD GAMMON

45

86. Schoenfeld ER, O’Leary ES*, Henderson K, Grimson R, Kabat GD, Ahnn S, Kuane WT, Gammon MD, Leske MC for the EBCLIS group. Electromagnetic fields and breast cancer on Long Island: A case-control study. American Journal of Epidemiology 2003;158:47-58.

87. O’Leary ES*, Schoenfeld ER, Henderson K, Grimson R, Kabat GC, Kuane WT, Gammon MD, Leske MC for the EBCLIS Group. Wire coding in the EMF and Breast cancer on Long Island Study – Relationship to magnetic fields. Journal of Exposure Analysis and Environmental Epidemiology 2003;13:283-93.

88. Kabat GC, O’Leary ES*, Schoenfeld ER, Green JM, Grimson R, Henderson K, Kuane WT, Gammon MD, Britton JA*, Teitelbaum SL*, Neugut AI, Leske MC for the EBCLIS group. Electric blanket use and breast cancer on Long Island. Epidemiology 2003;14;514-20.

89. Engel LS*, Chow W-H, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail M, Fraumeni Jr JF. Population attributable risks of esophageal and gastric cancers. Journal of the National Cancer Institute 2003;95:1404-13.

90. Teitelbaum ST*, Britton JA*, Gammon MD, Schoenberg JB, Brogan DR, Coates RJ, Daling JR, Malone K, Swanson CA, Brinton LA. Occupation and breast cancer in women under 45 years of age. Cancer Causes and Control 2003;14:627-37.

91. Furberg AH*, Millikan RC, Geradts J, Gammon MD, Dressler LG, Ambrosone CB, Newman B. Reproductive factors in relation to the risk of breast cancer characterized by p53 protein expression. Cancer Causes and Control 2003;14:609-18.

92. Hoyo C*, Reid MLV, Parrish T, Smith L, Gammon M. Barriers and strategies for sustained participation of African American men in cohort studies. Ethnicity and Disease 2003;13:470-6.

2004 93. Gammon MD, Eng SM*, Teitelbaum SL*, Kabat GC, Britton JA*, Terry MB*, Neugut AI,

Santella RM. Environmental tobacco smoke and breast cancer incidence. Environmental Research (electronic publication:doi:10.1016/j.envres.2003.08.009) 2004;96:176-85.

94. Gammon MD, Terry MB*, Arber N, Chow W-H, Risch HA, Vaughan TL, Schoenberg JB, Mayne ST, Stanford JL, Dubrow R, Rotterdam H, West AB, Fraumeni Jr JF, Weinstein IB, Hibshoosh H. NSAID use associated with a decrease in the incidence of esophageal and gastric cardia adenocarcinomas that overexpress cyclin D1: a population-based study. Cancer Epidemiology, Biomarkers and Prevention 2004;13:34-9.

95. Terry MB*, Gammon MD, Zhang FF, Rawfik H, Teitelbaum SL, Britton JA, Subbaramaiah K, Dannenberg AJ, Neugut AI. The effect of frequency, duration, and hormone receptor status on aspirin and breast cancer. Journal of the American Medical Association 2004;291:2433-40.

96. Abraído-Lanza AF*, Chao MT, Gammon MD. Breast and cervical cancer screening among Latinas and non-Latina whites. American Journal of Public Health 2004;94:1393-8.

97. Gaudet MM*, Britton JA*, Kabat GC, Steck-Scott S*, Eng SM*, Teitelbaum SL*, Terry MB*, Neugut AI, Gammon MD. Intake of vegetables, fruits, and antioxidant vitamins and breast cancer characterized by hormone receptor status. Cancer Epidemiology, Biomarkers, and Prevention 2004;13:1485-94.

98. Ahn J*, Gammon MD, Santella RM, Gaudet MM*, Britton JA, Teitelbaum SL*, Terry MB*, Neugut AI, Josephy PD, Ambrosone CB. Myeloperoxidase (MPO) genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Research 2004;64:7634-9.

99. Terry MB*, Gammon MD, Zhang FF, Eng SM*, Paykin AB, Wang Q, Hayes S, Teitelbaum SL*, Neugut AI, Santella RM. Polymorphism in the DNA repair gene XPD,

MD GAMMON

46

polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 2004;13:2053-8.

100. Gammon MD, Sagiv SK*, Eng SM*, Shantakumar S*, Gaudet MM*, Teitelbaum SL*, Britton JA, Terry MB*, Wang LW, Wang Q, Stellman SD, Beyea J, Hatch M, Kabat GC, Wolff MS, Levin B, Neugut AI, Santella RM. Polycyclic aromatic hydrocarbons (PAH)-DNA adducts and breast cancer: a pooled analysis. Archives of Environmental Health 2004;59(12):640-9.

2005 101. Gooden MK*, Carter-Edwards L, Hoyo C*, Akbar J, Cleveland R*, Oates V, Jackson E,

Furberg AH*, Gammon MD. Perceptions of participation in an observational epidemiologic study of cancer among African Americans. Ethnicity and Disease 2005;15:68-75.

102. Trivers KF*, De Roos AJ, Gammon MD, Vaughan AL, Risch HA, Olshan AF, Schoenberg JB, Mayne ST, Stanford JL, Dubrow R, Abrahamson P, Rotterdam H, West AB, Fraumeni JF, Chow W-H. Demographic and lifestyle predictors of survival in patients with esophageal and gastric cancers. Clinical Gastroenterology and Hepatology 2005;3:225-30.

103. Shen J*, Gammon MD, Terry MB, Wang LW, Wang Q, Zhang FF, Teitelbaum SL*, Eng SM, Sagiv SK*, Gaudet MM*, Neugut AI, Santella RM. Polymorphisms in XRCC1, PAH-DNA adducts, cigarette smoking, dietary antioxidants and breast cancer risk. Cancer Epidemiology, Biomarkers, and Prevention 2005;14(2):336-42.

104. Chen J*, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, Teitelbaum SL*, Britton JA, Terry MB, Neugut AI, Santella RM. One-carbon metabolism, MTHFR polymorphisms and breast cancer risk. Cancer Research 2005;65(4):1606-14.

105. Robinson W*, Stevens J, Gammon MD, John EM. Obesity before age 13 and risk of advanced prostate cancer. American Journal of Epidemiology 2005;161(12):1107-14.

106. Shantakumar S*, Gammon MD, Eng SM*, Sagiv SK*, Gaudet MM*, Teitelbaum SL*, Britton JA, Terry MB, Paykin A, Young TL, Wang LW, Wang Q, Stellman SD, Beyea J, Hatch M, Camann D, Prokopczyk B, Kabat G, Levin B, Neugut AI, Santella RM. Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females. Journal of Exposure Assessment and Environmental Epidemiology 2005;15(6):482-90.

107. Eng SM*, Gammon MD, Terry MB, Kushi LH, Teitelbaum SL*, Britton JA, Neugut AI. Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. American Journal of Epidemiology 2005;162:229-37.

108. Ahn J*, Gammon MD, Santella RM, Gaudet MM*, Britton JA, Teitelbaum SL*, Terry MB, Nowell S, Davis W, Garza C, Neugut AI, Ambrosone CB. Associations between breast cancer risk and endogenous antioxidant catalase (CAT), fruit and vegetable consumption, and supplement use. American Journal of Epidemiology 2005;162(10):943-52.

109. Shen J*, Terry MB, Gammon MD, Gaudet MM*, Teitelbaum SL*, Eng SM*, Sagiv SK*, Neugut AI, Santella RM. MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. Carcinogenesis 2005;26(12):2131-7.

110. Wolff MS, Britton JA, Teitelbaum SL*, Eng SM*, Deych E, Ireland K, Liu Z, Neugut AI, Santella RM, Gammon MD. Improving organochlorine biomarker models for cancer research. Cancer Epidemiology, Biomarkers and Prevention 2005;14(9):2224-36.

111. Gaudet MM*, Gammon MD, Santella RM, Britton JA, Teitelbaum SL*, Eng SM*, Terry MB, Bensen JT, Schroeder J, Olshan AF, Neugut AI, Ambrosone CB. MnSOD Val-9Ala

MD GAMMON

47

genotype, pro- and anti-oxidant environmental modifiers, and breast cancer among women on Long Island, New York. Cancer Causes and Control 2005;16:1225-34.

112. Santella RM, Gammon M, Terry M, Senie R, Shen J, Kennedy D, Agrawal M, Faraglia B, Zhang FF. DNA adducts, DNA repair genotype/phenotype and cancer risk. Mutation Research 2005; 592:29-35.

113. Ahn J*, Gammon MD, Santella RM, Gaudet MM*, Britton JA, Teitelbaum SL*, Terry MB, Neugut AI, Ambrosone CB. No association between GPX1 Pro198 Leu polymorphism and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 2005;14:2459-61.

2006 114 Terry MB, Gammon MD, Zhang FF, Kabat GC, Britton JA, Teitelbaum SL*, Neugut AI.

Lifetime alcohol intake and breast cancer risk. Annals of Epidemiology 2006;16(3):230-240. 115. Kabat GC, O'Leary ES, Gammon MD, Sepkovic WS, Teitelbaum SL*, Britton JA, Terry

MB, Neugut AI, Santella RM, Bradlow HL. Estrogen metabolism and breast cancer on Long Island. Epidemiology 2006;17:81-91.

116. Mayne S, Risch HA, Dubrow R, Chow W-H, Gammon MD, Vaughan TL, Borchardt L, Schoenberg JB, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni, Jr, JF. Carbonated soft drink consumption and risk of esophageal adenocarcinoma. Journal of the National Cancer Institute 2006;98:72-5.

117. Cleveland RJ*, Gammon MD, Edminston SN, Teitelbaum SL*, Britton JA, Terry MB, Eng SM, Neugut AI, Santella RM, Conway K. Interactions between IGF1 genotype and known risk factors for breast cancer in the Long Island Breast Cancer Study Project. Carcinogenesis 2006;27(4):758-765.

118. Terry MB, Gammon MD, Zhang FF, Wang Q, Britton JA, Teitelbaum SL*, Neugut AI, Santella RM. ADH3 genotype, alcohol intake, and breast cancer risk. Carcinogenesis 2006;27(4):840-847.

119. Fink BN*, Gaudet MM*, Britton JA, Abrahamson PE*, Teitelbaum SL, Jacobson J*, Bell P, Thomas JA, Kabat GC, Neugut AI, Gammon MD. Fruits, vegetables, and micronutrient intake in relation to breast cancer survival. Breast Cancer Research and Treatment 2006;98(2):199-208.

120. Shen J*, Terry MB, Gammon MD, Gaudet MM*, Teitelbaum SL*, Eng SM, Sagiv SK*, Neugut AI, Santella RM. IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk. Breast Cancer Research and Treatment 2006;99(1):1-7.

121. Rossner Jr. P*, Gammon MD, Terry MB, Agrawal M, Zhang FF, Teitelbaum SL*, Eng SM, Gaudet MM*, Neugut AI, Santella RM. Urinary 15--F2t-isoprostane, but not 8-oxodeoxyguanosine levels, are associated with breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 2006;15(4):639-44.

122. Rossner Jr. P*, Terry MB, Gammon MD, Zhang FF, Teitelbaum SL, Eng SM, Sagiv SK*, Gaudet MM*, Neugut AI, Santella RM. OGG1 polymorphisms and breast cancer risk. Cancer Epidemiology Biomarkers and Prevention 2006;15(4):811-5.

123. Gaudet MM*, Bensen AT, Olshan AF, Schroeder J, Terry MB, Eng SM, Teitelbaum SL*, Britton JA, Lehman TA, Neugut AI, Ambrosone CB, Santella RM, Gammon MD. Catechol-O-Methyltransferase haplotypes and breast cancer among women on Long Island, New York. Breast Cancer Research and Treatment 2006;99(2):235-40.

124. Ahn J*, Gammon MD, Santella RM, Gaudet MM*, Britton JA, Teitelbaum SL*, Terry MB, Neugut AI, Eng SM, Zhang Y, Garza C, Ambrosone CB. Effects of Glutathione S-transferase A1 (GSTA1) genotype and potential modifiers on breast cancer risk.

MD GAMMON

48

Carcinogenesis 2006;27(9):1876-82. 125. O'Leary EE*, Schoenfeld ER, Stevens RG, Kabat JC, Henderson K, Grimson R, Gammon

MD, Leske MC. Shift-work, light-at-night, and breast cancer on Long Island. American Journal of Epidemiology 2006;164(4):358-66.

126. Beyea J, Hatch M, Stellman SD, Santella RM, Teitelbaum ST*, Propokczyk B, Camann D, Gammon MD. Validation and calibration of a model used to reconstruct historical exposure to polycyclic aromatic hydrocarbons for use in epidemiologic studies. Environmental Health Perspectives 2006;114(7):1053-8.

127. Fink BN*, Steck SE*, Wolff MS, Kabat GC, Gammon MD. Construction of a flavonoid database for assessing intake in a population-based sample of women on Long Island, New York. Nutrition and Cancer 2006;56(1):57-66.

128. Abrahamson PE*, Gammon MD, Lund MJ, Flagg EW, Porter PL, Stevens J, Swanson CA, Brinton LA, Eley JW, Coates RJ. General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiology, Biomarkers and Prevention 2006;15(10):1871-7.

129. Abrahamson PE*, Gammon MD, Lund MJ, Britton JA, Marshall SW, Flagg EW, Porter PL, Brinton LA, Eley JW, Coates RJ. Recreational physical activity and survival among young women with breast cancer. Cancer 2006;107(8):1777-85.

130. Shen J*, Gammon MD, Terry MB, Teitelbaum SL*, Neugut AI, Santella RM. Genetic polymorphisms in the cyclooxygenase-2 gene, use of NSAIDs, and breast cancer risk. Breast Cancer Research 2006;(6):R71.

2007 131. Shantakumar S*, Terry MB, Teitelbaum SL*, Britton JA, Millikan RC, Moorman PG,

Neugut AI, Gammon MD. Reproductive factors and breast cancer risk among older women. Breast Cancer Research and Treatment 2007;102(3):365-74.

132. Trivers KF*, Gammon MD, Abrahamson PE*, Lund MJ, Flagg EW, Kaufman JS, Moorman PG, Cai J, Olshan AF, Porter PL, Brinton LA, Eley JW, Coates RJ. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Research and Treatment 2007;103(1):93-102.

133. Fink BN*, Steck SE*, Wolff MS, Britton JA, Teitelbaum SL*, Millikan RC, Schroeder JC, Neugut AI, Gammon MD. Dietary flavonoid intake and breast cancer risk among women on Long Island. American Journal of Epidemiology 2007;165(5):514-23.

134. Teitelbaum SL*, Gammon MD, Britton JA, Neugut AI, Levin B, Stellman SD. Reported residential pesticide use and breast cancer risk on Long Island, NY. American Journal of Epidemiology 2007;165(6):643-51.

135. Terry MB, Perrin M, Salafia CM, Zhang FF, Neugut AI, Teitelbaum SL*, Britton JA, Gammon MD. Preeclampsia, pregnancy-related hypertension and breast cancer risk. American Journal of Epidemiology 2007;165(9):1007-14..

136. Shantakumar S*, Terry MB, Paykin A, Teitelbaum SL*, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. American Journal of Epidemiology 2007;165(10):1187-98.

137. Sagiv SK*, Gaudet MM*, Eng SM, Abrahamson PE*, Shantakumar S*, Teitelbaum SL*, Britton JA, Bell P, Thomas J, Neugut AI, Santella RM, Gammon MD. Active and passive cigarette smoke and breast cancer survival. Annals of Epidemiology 2007;17(5):385-393.

138. Hold GL, Rabkin CS, Chow W-H, Smith MG, Gammon MD, Risch HA, Vaughan TL, McColl KEL, Lissowska J, Schoenberg JB, Blot WJ, Mowat NAG, Fraumeni Jr. JF, El-

MD GAMMON

49

Omar EM. A functional polymorphism of Toll-like receptor 4 gene is associated with increased risk of gastric cancer and its precursors. Gastroenterology 2007;132(3):905-12.

139. Steck SE*, Gaudet MM*, Eng SM, Britton JA, Teitelbaum SL*, Neugut AI, Santella RM, Gammon MD. Cooked meat and breast cancer risk – lifetime versus recent dietary intake. Epidemiology 2007;18(3):373-82.

140. Gooden KM*, Schroeder JC, North KE, Gammon MD, Hartmann KM, Taylor J, Baird DD. Val153Met polymorphism of Catechol-O-Methyltransferase and prevalence of uterine leiomyomata. Reproductive Science 2007;14(2):117-20.

141. Steck SE*, Gammon MD, Hebert JR, Wall DE, Zeisel SH. GSTM1, GSTT1, GSTP1 and GSTA1 polymorphisms are not associated with urinary isothiocyanate metabolites following broccoli consumption in humans. Journal of Nutrition 2007;137(4):904-909.

142. Xu X*, Gammon MD, Zhang H, Wetmur JG, Rao M, Teitelbaum SL*, Britton JA, Neugut AI, Santella RM, Chen J. Polymorphisms of one-carbon metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis 2007;28(7):1504-9.

143. Xu X*, Gammon MD, Wetmur JD, Rao M, Gaudet MM*, Teitelbaum SL*, Britton JA, Neugut AI, Santella RM, Chen J. A functional 19bp deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer among multivitamin users. American Journal of Clinical Nutrition 2007;85(4):1098-102.

144. Cohen SS*, Signorello LB, Gammon MD, Blot WJ. Obesity and use of mammography among black and white women. Cancer Causes and Control 2007;18(7):765-73.

145. Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch HA, Stanford JL, Chow W-H. GST, NAT1, CYP1A1 polymorphisms and risk of esophageal or gastric adenocarcinomas. Cancer Detection and Prevention 2007;31(3):233-6.

146. Steck SE*, Gaudet MM*, Britton JA, Teitelbaum SL*, Terry, MB, Neugut AI, Santella RM, Gammon MD. Interactions among GSTM1, GSTT1 and GSTP1 polymorphisms, cruciferous vegetable intake, and breast cancer risk. Carcinogenesis 2007;28(9):1954-9.

147. Terry MB*, Gammon MD, Zhang FF, Vaughan TL, Chow W-H, Risch HA, Schoenberg JB, Mayne ST, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni, Jr. JF, Santella RM. Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas. Cancer Causes and Control 2007;18(9):1039-46.

148 Trivers KF*, Gammon MD, Abrahamson PE*, Lund MJ, Flagg EW, Moorman PG, Kaufman JS, Cai J, Porter PL, Brinton LA, Eley WJ, Coates RJ. Oral contraceptives and breast cancer survival in women aged 20-54 years. Cancer Epidemiology, Biomarkers and Prevention 2007;16(9):1822-7.

149. Cleveland RJ*, Eng SM, Abrahamson PE*, Britton JA, Teitelbaum SL*, Neugut AI, Gammon MD. Weight gain prior to breast cancer diagnosis and survival. Cancer Epidemiology, Biomarkers and Prevention 2007;16(9):1803-11.

150. Crew KD*, Gammon MD, Terry MB, Zhang FF, Zablotska LB, Agrawal M, Shen J, Long CM, Eng SM, Sagiv SK*, Tietelbaum SL*, Neugut AI, Santella RM. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 2007;16(10):2033-41.

151. Rossner P Jr.*, Terry MB, Gammon MD, Agrawal M, Zhang FF, Ferris JS, Teitelbaum SL, Eng SM, Gaudet MM*, Neugut AI, Regina M. Santella. Protein carbonyl levels and breast cancer risk. Journal of Cellular & Molecular Medicine 2007;11(5):1138-48.

152. Crew KD*, Gammon MD, Terry MB, Zhang FF, Agrawal M, Eng SM, Sagiv S*, Tietelbaum SL*, Neugut AI, Santella RM. Genetic polymorphisms in apoptosis-associated genes FAS and FASL and breast cancer risk. Carcinogenesis 2007;28(12):2548-51.

MD GAMMON

50

153. Fink BN*, Steck SE*, Wolff MS, Britton JA, Kabat GC, Gaudet MM*, Abrahamson PE*, Bell P, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD. Dietary flavonoid intake and breast cancer survival on Long Island. Cancer Epidemiology, Biomarkers and Prevention 2007;16(11):2285-92.

2008 154. Talbott KE*, Gammon MD, Kibriya MG, Chen Y, Teitelbaum SL, Long CM, Gurvich I,

Santella RM, Ahsan H. A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk. Breast Cancer Research Treatment 2008;111(3):481-7.

155. Shen J*, Gammon MD, Terry MB, Teitelbaum SL, Neugut AI, Santella RM. Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk. European Journal of Cancer 2008;44(5):710-7.

156. Butler LM*, Millikan RC, Sinha R, Keku TO, Winkel S, Harlan B, Eaton A, Gammon MD, Sandler RS. N-acetyltransferase 1 and 2, heterocyclic amines and colon cancer in a population-based study. Mutation Research 2008;638(1-2):162-74.

157. Nyante SJ*, Gammon MD, Coates RJ, Malone KE, Daling JR, Brinton LA. The association between oral contraceptive use and lobular and ductal breast cancer in young women. International Journal of Cancer 2008;122(4):936-41.

158. Gaudet MM*, Gammon MD, Bensen J, Sagiv SK*, Shantakumar S*, Teitelbaum SL, Britton JA, Eng SM, Terry MB, Memeo L, Hibshoosh H, Neugut AI, Santella RM. Genetic variation of TP53, PAH-related exposures, and breast cancer risk among women on Long Island, New York. Breast Cancer Research and Treatment 2008;108(1):93-9.

159. Xu X*, Gammon MD, Zeisel SH, Lee Y, Wetmur JG, Bradshaw PT*, Teitelbaum SL, Neugut AI, Santella RM, Chen J. Choline metabolism and risk of breast cancer in a population-based study. FASEB Journal 2008;22(6):2045-52.

160. Chen Y*, Gammon MD, Teitelbaum SL, Britton JA, Terry MB, Shantakumar S*, Eng SM, Wang Q, Gurvich I, Neugut AI, Santella RM, Ahsan H. Estrogen-biosynthesis gene CYP17 and interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: Results from the Long Island Breast Cancer Study Project. Carcinogenesis 2008;29:766-71.

161. Navarro Silvera SA*, Mayne ST, Risch H, Gammon MD, Vaughan T, Chow W-H, Dubrow R, Schoenberg J, Stanford JL, West AB, Rotterdam H, Blot WJ, Fraumeni, Jr. J. Food group intake and risk of subtypes of esophageal and gastric cancer. International Journal of Cancer 2008;123(4):852-60.

162. Golembesky AK*, Gammon MD, North KE, Bensen JT, Schroeder JC, Teitelbaum SL, Neugut AI, Santella RM. Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer incidence: a LIBCSP ancillary study. Carcinogenesis 2008 29(10):1944-9.

163. Xu X*, Gammon MD, Wetmur JG, Bradshaw PT*, Teitelbaum SL, Neugut AI, Santella RM, Chen J. B-vitamin intake, one-carbon metabolism and survival among a population-based cohort of women with breast cancer. Cancer Epidemiology, Biomarkers and Prevention 2008;17(8):2109-16.

164. Beyea J, Stellman SD, Hatch M, Gammon MD. Airborne emissions from 1961 to 2004 of Benzo[a]pyrene from US vehicles per km of travel based on tunnel studies. Environmental Science & Technology 2008;42(19):7315-7320.

165. Vo TT*, Gladen BC, Cooper GS, Baird DB, Daniels JL, Gammon MD, Richardson DB. Dichlorodiphenyldichloroethane and polychlorinated biphenyls: their intra-individual

MD GAMMON

51

changes, correlations and predictors. Cancer Epidemiology Biomarkers and Prevention 2008;17(10):2729-36.

2009 166. Rossner Jr. P*, Gammon MD, Zhang Y, Terry MB, Hibshoosh H, Memeo L, Mansukhani

M, Long C-M, Garbowski G, Agrawal M, Kalra TS, Gaudet MM*, Teitelbaum SL, Neugut AI, Santella RM. Mutations in p53, p53 protein overexpression and breast cancer survival. Journal of Cellular & Molecular Medicine 2009;13(9b):3847-3857.

167. Xu X*, Gammon MD, Zhang Y, Bestor TH, Zeisel SH, Wetmur JG, Wallenstein S, Bradshaw PT*, Garbowski G, Teitelbaum SL, Neugut AI, Santella SM, Chen J. BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Research and Treatment 2009;115(2):397-404.

168. Figueroa JD*, Terry MB, Gammon MD, Vaughan TL, Risch HA, Zhang F-F, Kleiner DE, Bennett WP, Dubrow R, Mayne ST, Fraumeni Jr JF, Chow W-H. Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression. Cancer Causes and Control 2009;20(3):361-8.

169. Shen J*, Gammon MD, Terry MB, Wang Q, Bradshaw P, Teitelbaum SL, Neugut AI, Santella RM. Telomere length, oxidative damage, antioxidants and breast cancer risk. International Journal of Cancer 2009;124(7):1637-43.

170. Sagiv SK*, Gammon MD, Eng SM, Teitelbaum SL, Neugut AI, Santella RM. PAH-DNA adducts and breast cancer survival. Environmental Research 2009;109(3):287-91.

171. Hold GL, Rabkin CS, Gammon MD, Berry SH, Smith MG, Lissowska J, Risch HA, Chow W-H, Ashley N, Mowat G, Vaughan TL, El-Omar EM. CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations. European Journal of Cancer Prevention 2009;18(2):117-9.

172. McCarty KM*, Santella RM, Steck SE*, Cleveland RJ*, Ahn J*, Ambrosone CB, North K, Sagiv SK*, Eng SM, Teitelbaum SL, Neugut AI, Gammon MD. PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environmental Health Perspectives 2009;117:552-558.

173. Crew KD*, Gammon MD, Steck SE*, Hershman DL, Cremers S, Dworakowski E, Shane E, Terry MB, Desai M, Teitelbaum SL, Neugut AI, Santella RM. Association between plasma 25-Hydroxyvitamin D and breast cancer risk. Cancer Prevention Research (Phila Pa) 2009;2(6):598-604.

174. Greenlee H*, Gammon MD, Abrahamson PE*, Gaudet MM*, Terry MB, Hershman DL, Desai M, Teitelbaum SL, Neugut AI, Jacobson JS. Prevalence and predictors of antioxidant supplement use during breast cancer treatment: The Long Island Breast Cancer Study Project. Cancer 2009;115(14):3271-82.

175. Bradshaw PT*, Sagiv SK*, Kabat GC, Satia JA, Britton JA, Teitelbaum SL, Neugut AI, Gammon MD. Consumption of sweet foods and breast cancer risk: a case-control study of women on Long Island, New York. Cancer Causes and Control 2009;20(8):1509-15.

176. Hoyo C*, Schildkraut JM, Murphy SK, Chow W-H, Vaughan TL, Risch H, Marks JR, Jirtle RL, Calingeart B, Mayne S, Fraumeni Jr. J, Gammon MD. IGF2R polymorphisms and risk of esophageal and gastric adenocarcinoma. International Journal of Cancer 2009;125(11):2673-8.

177. Xu X*, Gammon MD, Zeisel SH, Bradshaw PT*, Wetmur JG, Teitelbaum SL, Neugut AI, Santella RM, Chen J. High intakes of choline and betaine reduce breast cancer mortality in a population-based study. FASEB J 2009;23(11):4022-8.

MD GAMMON

52

2010 178. Xu X*, Gammon MD, Zhang Y, Cho YH, Wetmur JG, Bradshaw PT*, Garbowski G,

Hibshoosh H, Teitelbaum SL, Neugut AI, Santella RM, Chen J. Gene promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Research and Treatment 2010;121(3):685-92.

179. Cleveland RJ*, Gammon MD, Long C-M, Gaudet MM*, Eng SM, Teitelbaum SL, Neugut AI, Santella RM. Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival. Breast Cancer Research and Treatment 2010;120(3):745-52.

180. Shen J*, Gammon MD, Wu H-C, Terry MB, Wang Q, Bradshaw PT*, Teitelbaum SL, Neugut AI, Santella RM. Multiple genetic variants in telomere pathway genes and breast cancer risk. Cancer Epidemiology Biomarkers and Prevention 2010;19(1):219-28.

181. Mordukhovich I*, Rossner Jr P*, Terry MB, Santella R, Zhang Y-J, Hibshoosh H, Memeo L, Mansukhani M, Long C-M, Garbowski G, Agrawa M, Gaudet MM*, Steck SE*, Sagiv SK*, Eng SM, Teitelbaum SL, Neugut AI, Conway-Dorsey K, Gammon MD. Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumors. Environmental Health Perspectives 2010;118(4):511-8.

182. Cook MB*, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Wu AH, Ward MH, Giffen C, Casson AG, Abnet CC, Murray LJ, Corley DA, Nyrén O, Vaughan TL, Chow W-H. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: A pooled analysis from the international BEACON consortium. Journal of the National Cancer Institute 2010; 102(17):1344-53.

183. Bradshaw PT*, Ibrahim J, Gammon MD. Bayesian proportional hazards regression model with non-ignorably missing time-varying covariates. Statistics and Medicine 2010; 29(29):3017-29.

2011 184. Lochhead P+, Ng MT,+ (+Co-first-authors) Hold GL, Rabkin CS, Vaughan TL, Gammon

MD, Risch HA, Lissowska J, Mukhopadhya I, Chow W-H, El-Omar EM. Effect of genetic polymorphisms in 8q24 and 9p24 on risk of upper gastrointestinal cancer. European Journal of Cancer Prevention 2011;20(1):54-57.

185. Cohen SS*, Gammon MD, Signorello LB, North KE, Lange EM, Fowke JH, Hargreaves MK, Cai Q, Zheng W, Blot WJ, Matthews ED. Serum adiponectin in relation to body mass index and other predictors in black and white women. Annals of Epidemiology 2011;21(2):86-94.

186. Lochhead P, Frank B, Hold GL, Rabkin CS, Ng M, Vaughan TL, Risch HA, Gammon MD, Lissowska J, Weck MN, Raum E, Illig T, Klopp N, Dawson A, McColl KE, Brenner H, Chow W-H, El-Omar EM. Genetic variation in the PSCA gene and upper gastrointestinal cancer risk in Caucasians. Gastroenterology 2011;140(2):435-41.

187. Cohen SS*, Gammon MD, North KE, Millikan RC, Lange EM, Williams SM, Zheng W, Cai Q, Long J, Smith JR, Signorello LB, Blot WJ, Matthews CE. ADIPOQ, ADIPOR1, and ADIPOR2 gene polymorphisms in relation to serum adiponectin levels and body mass index in black and white women. Obesity 2011;19(10):2053-62.

188. Cai Q, Wen W, Li G, Chen K, Zhang L, Zheng H, Shen H, Hu Z, Wang F, Shen C-Y, Wu P-E, Shieh Y-L, Gammon MD, Santella RM, Blot WJ, Signorello LB, Egan KM, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Garcia-Closas M, Haiman CA, Henderson BE, Le Marchand L, Khoo US, Chan KYK, Chan SY, Iwasaki M, Kasuga Y, Tsugane S,

MD GAMMON

53

Long J, Li C, Shi J, Deming SL, Xiang Y-B, GaoY-T, Lu W, Shu X-O, Zheng W. Consortium study of breast cancer susceptibility locus at 6q25.1 among over 30,000 women. Cancer Research 2011;71(4):1344-55.

189. Freedman ND, Murray LJ, Kamangar F, Abnet CC, Cook MB*, Nyrén O, Ye W, Wu A, Bernstein L, Brown LM, Ward MH, Pandeya N, Green A, Casson AG, Giffen C, Risch HA, Gammon MD, Chow W-H, Vaughan TL, Corley DA, Whiteman DC. Alcohol intake and risk of esophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. GUT 2011;60(8):1029-37.

190. Navarro Silvera SA*, Mayne ST, Risch HA, Gammon MD, Vaughan T, Chow W-H, Dubin JA, Dubrow R, Schoenberg J, Stanford JL, West AB, Rotterdam H, Blot WJ. Principal components analysis of dietary and lifestyle patterns on the risk of subtypes of esophageal and gastric cancer. Annals of Epidemiology 2011;21(7):543-50.

191. Nyante SJ*, Gammon MD, Kaufman J, Bensen J, Lin D, Barnholtz-Sloan JS, Hu Y, He QC, Millikan RC. Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes. Breast Cancer Research and Treatment 2011;129(2):593-606.

192. Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, Gammon MD, Thompson WD, Bernstein JL. Risk factors by molecular subtypes of breast cancer across a population-based sample of women 56 years of age or younger. Breast Cancer Research and Treatment 2011;130(2):587-97.

193. Desai M, Esserman DA, Gammon MD, Terry MB. Multiple imputation to improve estimation performance in molecular epidemiologic studies assessing interaction. (Collection of Biostatistics Research Archive.) Epidemiologic Perspectives and Innovations 2011;8(1):5.

194. Xu X*, Gammon MD, Hernandez-Vargas H, Herceg Z, Wetmur JG, Teitelbaum SL, Bradshaw PT*, Neugut AI, Santella RM, Chen J. The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study. Epigenetics 2011;6(11):1276-83.

2012 195. Liao LM, Vaughan TL, Corley DA, Cook MB, Casson AG, Kamangar F, Abnet CC, Risch

HA, Giffen C, Freedman ND, Chow W-H, Sadeghi S, Pandeya N, Whiteman DC, Murray LJ, Bernstein L, Gammon MD, Wu AH. NSAID use and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the BEACON consortium. Gastroenterology 2012;142(3):442-452.e5.

196. Cho YH*+, Shen J*+ (+Co-first authors), Gammon MD, Zhang Y-J, Wang Q, Gonzalez K, Xu X*, Bradshaw PT*, Teitelbaum SL, Garbowski G, Hibshoosh H, Neugut AI, Chen J, Santella RM. Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Research and Treatment 2012;131(1):197-205.

197. Cleveland RJ*, Eng SM, Stevens J, Bradshaw PT*, Teitelbaum SL, Neugut AI, Gammon MD. Influence of prediagnostic recreational physical activity on survival from breast cancer. European Journal of Cancer Prevention 2012;21(1):46-54.

198. Bradshaw PT*, Ibrahim JG, Stevens J, Cleveland R, Abrahamson PE, Satia JA, Teitelbaum SL, Neugut AI, Gammon MD. Post-diagnosis change in bodyweight and survival after breast cancer diagnosis. Epidemiology 2012; 23(2):320-327.

199. Xu X*, Gammon MD, Hernandez-Vargas H, Herceg Z, Wetmur JG, Teitelbaum SL, Bradshaw PT, Neugut AI, Santella RM, Chen J. DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB

MD GAMMON

54

2012;26(6):2657-66. 200. Lubin JH, Cook MB, Pandeya N, Vaughan TL, Abnet CC, Giffen C, Webb PM, Murray LJ,

Casson AG, Risch HA, Ye W, Kamangar K, Bernstein L, SharpL, Nyrén O, Gammon MD, Corley DA, Wu AH, Brown LM, Chow W-H, Ward MH, Freedman ND, Whiteman DC. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the BEACON Consortium. Cancer Epidemiology 2012;36(3):306-16.

201. Shen J*, Gammon MD, Terry MB, Bradshaw PT*, Wang Q, Teitelbaum SL, Neugut AI, Santella RM. Genetic polymorphisms in telomere pathway genes and breast cancer survival. Breast Cancer Research Treatment 2012;134(1):393-400.

202. Cleveland RJ*, North KE, Stevens J, Teitelbaum SL, Neugut AI, Gammon MD. The association of diabetes with breast cancer incidence and survival. Cancer Causes Control 2012;23(7):1193-203.

203. McCullough LE*, Eng SM, Bradshaw PT*, Cleveland R*, Teitelbaum SL, Neugut AI, Gammon MD. Fat or fit: The joint effects of physical activity, weight gain, and body size on breast cancer risk. Cancer 2012;118(19):4860-8.

204. Palmer AJ, Lochhead P, Hold GL, Rabkin CS, Chow WH, Lissowska J, Vaughan TL, Berry S, Gammon M, Risch H, El-Omar EM. Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations. Eur J Cancer Prev 2012;21(6):541-544.

205. Su Z, Gay LJ, Strange A, Palles C, Band G, Whiteman DC, Lescai F, Langford C, Nanji M, Edkins S, van der Winkel A, Levine D, Sasieni P, Bellenguez C, Howarth K, Freeman C, Trudgill N, Tucker AT, Pirinen M, Peppelenbosch MP, van der Laan LJ, Kuipers EJ, Drenth JP, Peters WH, Reynolds JV, Kelleher DP, McManus R, Grabsch H, Prenen H, Bisschops R, Krishnadath K, Siersema PD, van Baal JW, Middleton M, Petty R, Gillies R, Burch N, Bhandari P, Paterson S, Edwards C, Penman I, Vaidya K, Ang Y, Murray I, Patel P, Ye W, Mullins P, Wu AH, Bird NC, Dallal H, Shaheen NJ, Murray LJ, Koss K, Bernstein L, Romero Y, Hardie LJ, Zhang R, Winter H, Corley DA, Panter S, Risch HA, Reid BJ, Sargeant I, Gammon MD, Smart H, Dhar A, McMurtry H, Ali H, Liu G, Casson AG, Chow WH, Rutter M, Tawil A, Morris D, Nwokolo C, Isaacs P, Rodgers C, Ragunath K, MacDonald C, Haigh C, Monk D, Davies G, Wajed S, Johnston D, Gibbons M, Cullen S, Church N, Langley R, Griffin M, Alderson D, Deloukas P, Hunt SE, Gray E, Dronov S, Potter SC, Tashakkori-Ghanbaria A, Anderson M, Brooks C, Blackwell JM, Bramon E, Brown MA, Casas JP, Corvin A, Duncanson A, Markus HS, Mathew CG, Palmer CN, Plomin R, Rautanen A, Sawcer SJ, Trembath RC, Viswanathan AC, Wood N, Trynka G, Wijmenga C, Cazier JB, Atherfold P, Nicholson AM, Gellatly NL, Glancy D, Cooper SC, Cunningham D, Lind T, Hapeshi J, Ferry D, Rathbone B, Brown J, Love S, Attwood S, MacGregor S, Watson P, Sanders S, Ek W, Harrison RF, Moayyedi P, de Caestecker J, Barr H, Stupka E, Vaughan TL, Peltonen L, Spencer CC, Tomlinson I, Donnelly P, Jankowski JA; Esophageal Adenocarcinoma Genetics Consortium; Wellcome Trust Case Control Consortium 2. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nature Genetics 2012;44(10):1131-6.

206. McCullough LE*, Santella RM, Cleveland RJ, Bradshaw PT*, Millikan RC, North KE, Olshan AF, Eng SM, Ambrosone CB, Ahn J, Steck SE, Teitelbaum SL, Neugut AI, Gammon MD. Polymorphisms in oxidative stress genes, physical activity and breast cancer risk. Cancer Causes and Control 2012;23(12):1949-58.

207. Hoyo C+, Cook MB+*, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, Brown

MD GAMMON

55

LM, Risch HA, Ye W, Sharp L, Wu AH, Ward MH, Casson AG, Murray LJ, Corley DA, Nyrén O, Vaughan TL, Chow W-H, Gammon MD. (+Joint first authors; contributed equally in the preparation of this manuscript.) Body mass index and oesophageal and oesophagogastric junction adenocarcinomas in men and women: a pooled analysis from the international BEACON consortium. International Journal of Epidemiology 2012;41(6):1706-1718.

2013 208. He K, Xun P*, Brasky TM, Gammon MD, Stevens J, White E. Intake of long-chain omega-

3 fatty acids and fish in relation to incidence of pancreatic cancer. American Journal of Epidemiology 2013;177(2):152-60.

209. Han X*, Li J, Brasky TM, Xun P, Stevens J, White E, Gammon MD, He K. Antioxidant intake and pancreatic cancer risk: the VITamins And Lifestyle (VITAL) Study. Cancer 2013;119(7):1314-20.

210. Nye MD*, Hoyo C, Huang Z, Vidal AC, Wang F, Overcash F, Smith JS, Vasquez B, Hernandez B, Swai B, Oneko O, Mlay P, Obure J, Gammon MD, Bartlett JA, Murphy SK. Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer. PLOSOne 2013;8(2):e56325.

211. White A J*, Teitelbaum SL, Wolff MS, Britton JA, Stellman SD, Neugut AI, Gammon MD. Exposure to fogger trucks and breast cancer incidence in the Long Island Breast Cancer Study Project: a case-control study. Environmental Health 2013 Mar 15;12:24.

212. Bradshaw PT*+, Khankari N*+, Teitelbaum SL, Xu X*, Fink BN, Steck S, Gaudet MM, Kabat GC, Wolff MS, Neugut AI, Santella RM, Chen J, Gammon MD. (+Joint first authors; contributed equally in the preparation of this manuscript.) Nutrient pathways and breast cancer risk: the Long Island Breast Cancer Study Project. Nutrition and Cancer 2013: 65(3): 345-354.

213. Beyea J, Stellman SD, Teitelbaum SL, Mordukhovich I*, Gammon MD. Imputation method for lifetime exposure assessment in air pollution epidemiologic studies. Environmental Health 2013;12:62.2013.

214. Link A*, Gammon MD, Jacobson JS, Abrahamson P, Bradshaw P, Terry MB, Teitelbaum S, Neugut AI, Greenlee H. Use of self-care and practitioner-based forms of complementary and alternative medicine among women with breast cancer . Evidence-Based Complementary and Alternative Medicine 2013;2013:301549.

215. Levine D, Ek WE, Zhang R, Liu X, Onstad L, Sather C, Lao-Sirieix P, Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Murray LJ, Reid BJ, Chow W-H, Risch HA, Nyrén O, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Chanock S, Harrington P, Caldas I, Debiram-Beecham I, Caldas C, Hayward NK, Pharoah P, Fitzgerald R, MacGregor S, Whiteman DC, Vaughan TL. A Genome-Wide Association Study Identifies New Susceptibility Loci for Esophageal Adenocarcinoma and Barrett’s Esophagus. Nature Genetics 2013;45(12):1487-93.

216. Ek W, Levine D, D'Amato M, Pedersen N, Magnusson P, Bresso F, Onstad L, Schmidt P, Törnblom H, Nordenstedt H, Romero Y, Chow W-H, Murray L, Gammon M, Liu G, Bernstein L, Casson A, Risch H, Shaheen N, Bird N, Reid B, Corley D, Hardie L, Ye W, Wu A, Zucchelli M, Spector T, Hysi P, Vaughan T, Whiteman D, MacGregor S. Barrett's esophagus and esophageal adenocarcinoma show a substantial genetic component, with large genetic overlap between the diseases. Journal of the National Cancer Institute 2013;105(22):1711-8.

2014

MD GAMMON

56

217. Khankari NK*, Bradshaw PT*, McCullough LE*, Teitelbaum SL, Steck SE, Fink BN, Xu X, Ahn J, Ambrosone CB, Crew KD, Terry MB, Neugut AI, Chen J, Santella RM, Gammon MD. Genetic variation in multiple biologic pathways, flavonoid intake and breast cancer. Cancer Causes Control 2014;25(2):215-26.

218. McCullough LE*, Santella RM, Cleveland RJ, Millikan RC (deceased), Olshan AF, North KE, Bradshaw PT, Eng SM, Terry MB, Shen J, Crew KD, Rossner P, Teitelbaum SL, Neugut AI, Gammon MD. Polymorphisms in DNA repair genes, recreational physical activity and breast cancer risk. International Journal of Cancer 2014;134(3):654-63.

219. Navarro Silvera SA*, Mayne ST, Gammon MD, Vaughan TL, Chow W-H, Dubin JA, Dubrow R, Stanford JL, West AB, Rotterdam H, Blot, WJ, Risch HA. Diet and lifestyle factors and risk of subtypes of esophageal and gastric cancer: classification tree analysis. Annals of Epidemiology 2014;24(1):50-7.

220. Smith GS*, Schoenbach V, Richardson D, Gammon MD. Particulate air pollution and susceptibility to the development of pulmonary tuberculosis disease in North Carolina: an ecological study. International Journal of Environmental Health 2014;24(2):103-12.

221. Ahsan H, Halpern J, Kibriya MG, Pierce B, Tong L, Gamazon E, McGuire V Shi J, Jasmine F, Roy S, Brutus R, Argos M, Chang-Claude J, Andrulis I, Hopper JL, John E, Malone K, Ursin G, Gammon MD, Thomas DC, Seminara DS , Casey G, Knight JA, Southey MC, Giles GG, Santella RM, Lee E, Conti D, Duggan D, Gallinger S, Haile R, Jenkins M, Lindor L, Newcomb P, Michailidou K , Apicella C, Park DJ , Peto J, Fletcher O , dos Santos Silva I , Lathrop M, Hunter DJ, Chanock SJ , Meindl A , Schmutzler RK, Müller-Myhsok B, Lichtner P, Nickels S , Hein R , Flesch-Janys D, Dahmen N, Nevanlinna H, Aittomäki K , Blomqvist C, Hall P, Czene K , Irwanto K, Liu J, Rahman N, Turnbull C , FBCS , Dunning AM , Pharoah P, Waisfisz Q, Meijers-Heijboer H, Uitterlinden AG, Rivadeneira F, Nicolae D, Easton DF, Cox NJ, Whittemore AS . A genome-wide association study of early-onset breast cancer identifies pfkm as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. Cancer Epidemiology Biomarkers and Prevention 2014;23(4):658-69.

222. Thrift AP*, Risch HA, Onstad L, Shaheen NJ, Casson AG, Bernstein L, Corley DA, Levine DM, Chow WH, Reid BJ, Romero Y, Hardie LJ, Liu G, Wu AH, Bird NC, Gammon MD, Ye W, Whiteman DC, Vaughan TL. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. Clin Gastroenterol Hepatol. 2014;12(10):1667-1676.

223. Bradshaw PT*, Ibrahim JG, Cleveland RJ, Stevens J, Satia JA, Teitelbaum SL, Neugut AI, Gammon MD. Post-diagnosis physical activity and survival after breast cancer diagnosis: the Long Island Breast Cancer Study Project. Breast Cancer Research and Treatment 2014;145(3):735-42.

224. Cook MB, Corley DA, Murray LJ, Liao LM, Kamangar F, Ye W, Gammon MD, Risch RA, Casson AG, Freedman ND, Chow W-H, Wu AH, Bernstein L, Nyrén O, Pandeya N, Whiteman DC, Vaughan TL. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON). PlosOne 2014 Jul 30;9(7):e103508.

225. Buas MF*, Levine DM, Makar KW, Utsugi H, Onstad L, Li S, Galipeau PC, Shaheen NJ, Hardie LJ, Romero Y, Bernstein L, Gammon MD, Casson AG, Bird NC, Risch HA, Ye W, Liu G, Corley DA, Blount PL, Fitzgerald RC, Whiteman DC, Wu AH, Reid BJ, Vaughan TL. Integrative post genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis. 2014 Dec;35(12):2740-7.

MD GAMMON

57

226. Thrift AP*, Shaheen NJ, Gammon MD, Bernstein L, Reid BJ, Onstad L, Risch HA, Liu G, Bird NC, Wu AH, Corley DA, Romero Y, Chow WH, Casson AG, Levine D, Zhang R, Ek WE, MacGregor S, Ye W, Hardie LJ, Vaughan TL, Whiteman DC. Obesity and risk of esophageal adenocarcinoma and Barrett’s esophagus: a Mendelian randomization study. Journal of the National Cancer Institute 2014;106(11): dju252 doi:10.1093/jnci/dju252.

227. White AJ*, Teitelbaum SL, Stellman SD, Beyea J, Steck SE, Mordukhovich I*, McCarty KM, Ahn J, Rossner, Jr. P, Santella RM, Gammon MD. Indoor air pollution exposure from use of indoor stoves and fireplaces in association with breast cancer. Environmental Health 2014 Dec 12;13(1):108.

2015 228. Nyante SJ*, Gammon MD, Kaufman JS, Bensen JT, Lin DY, Barnholtz-Sloan JS, Hu Y,

He Q, Luo J, Millikan RC. Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects. Cancer Causes and Control 2015 Jan;26(1):121-31.

229. Palles C, Chegwidden L, Li X, Findlay JM, Farnham G, Giner FC, Peppelenbosch MP, Kovac M, Adams CL, Prenen H, Briggs S, Harrison R, Sanders S, MacDonald D, Haigh C, Tucker A, Love S, Nanji M, deCaestecker J, Ferry D, Rathbone B, Hapeshi J, Barr H, Zietek B, Maroo N, Gay L, Underwood T, Boulter L, McMurtry H, Monk D, Patel P, Ragunath K, Al Dulaimi D, Murray I, Koss K, Veitch A, Trudgill N, Nwokolo C, Rembacken B, Atherfold P, Green E, Ang Y, Kuipers EJ, Chow W, Paterson S, Kadri S, Beales I, Grimley C, Mullins P, Beckett C, Farrant M, Dixon A, Kelly S, Johnson M, Wajed S, Dhar A, Sawyer E, Roylance R, Onstad L, Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Reid BJ, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Fitzgerald R, Whiteman DC, Risch HA, Levine DM, Vaughan TL, Verhaar AP, van den Brande J, Toxopeus EL, Spaander MC, Wijnhoven BP, van der Laan LJ, Krishnadath K, Wijmenga C, Trynka G, McManus R, Reynolds JV, O'Sullivan J, MacMathuna P, McGarrigle SA, Kelleher D, Vermeire S, Cleynen I, Bisschops R, Tomlinson I, Jankowski J. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus. Gastroenterology. 2015 Feb;148(2):367-78.

230. Reimers LL*, Crew KD, Bradshaw PT, Santella RM, Steck SE, Sirosh I, Terry MB, Hershman DL Shane E, Cremers S, Dworakowski E, Teitelbaum SL, Neugut AI, Gammon MD. Vitamin D-Related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes and Control 2015 Feb;26(2):187-203.

231. Smith GS*, Van den Eeden S, Baxter R, Van Rie A, Herring A, Richardson DB, Emch M, Gammon MD. Cigarette smoking and pulmonary tuberculosis in northern California. Journal of Epidemiology and Community Health 2015 Jun;69(6):568-73.

232. Petrick JL*, Steck SE, Bradshaw PT, Trivers KF, Abrahamson PE, Engel LS, He K, Chow W-H, Mayne ST, Risch HA, Vaughan TL, Gammon MD. Dietary intake of flavonoids and esophageal and gastric cancer: incidence and survival in the United States of America (USA). British Journal of Cancer 2015 Mar 31;112 Suppl:1291-300.

233. McCullough LE, Eng SM, Bradshaw PT, Cleveland RJ, Steck SE, Terry MB, Shen J, Crew KD, Rossner Jr. P, Ahn J, Ambrosone CB, Teitelbaum SL, Neugut AI, Santella RM, Gammon MD. Genetic polymorphisms in DNA repair and oxidative stress pathways may modify the association between body size and postmenopausal breast cancer. Annals of Epidemiology 2015 Apr;25(4):263-9.

234. Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush MJ, Maranian MJ, Bolla MK, Wang Q, Shah M, Perkins BJ, Czene K, Eriksson M, Darabi H, Brand JS, Bojesen SE,

MD GAMMON

58

Nordestgaard BG, Flyger H, Nielsen SF, Rahman N, Turnbull C; BOCS, Fletcher O, Peto J, Gibson L, Dos-Santos-Silva I, Chang-Claude J, Flesch-Janys D, Rudolph A, Eilber U, Behrens S, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Khan S, Aaltonen K, Ahsan H, Kibriya MG, Whittemore AS, John EM, Malone KE, Gammon MD, Santella RM, Ursin G, Makalic E, Schmidt DF, Casey G, Hunter DJ, Gapstur SM, Gaudet MM, Diver WR, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Berg CD, Chanock SJ, Figueroa J, Hoover RN, Lambrechts D, Neven P, Wildiers H, van Limbergen E, Schmidt MK, Broeks A, Verhoef S, Cornelissen S, Couch FJ, Olson JE, Hallberg E, Vachon C, Waisfisz Q, Meijers-Heijboer H, Adank MA, van der Luijt RB, Li J, Liu J, Humphreys K, Kang D, Choi JY, Park SK, Yoo KY, Matsuo K, Ito H, Iwata H, Tajima K, Guénel P, Truong T, Mulot C, Sanchez M, Burwinkel B, Marme F, Surowy H, Sohn C, Wu AH, Tseng CC, Van Den Berg D, Stram DO, González-Neira A, Benitez J, Zamora MP, Perez JI, Shu XO, Lu W, Gao YT, Cai H, Cox A, Cross SS, Reed MW, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N; kConFab Investigators; AOCS Group, Lindblom A, Margolin S, Teo SH, Yip CH, Taib NA, Tan GH, Hooning MJ, Hollestelle A, Martens JW, Collée JM, Blot W, Signorello LB, Cai Q, Hopper JL, Southey MC, Tsimiklis H, Apicella C, Shen CY, Hsiung CN, Wu PE, Hou MF, Kristensen VN, Nord S, Alnaes GI; NBCS, Giles GG, Milne RL, McLean C, Canzian F, Trichopoulos D, Peeters P, Lund E, Sund M, Khaw KT, Gunter MJ, Palli D, Mortensen LM, Dossus L, Huerta JM, Meindl A, Schmutzler RK, Sutter C, Yang R, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H, Chia KS, Chan CW, Fasching PA, Hein A, Beckmann MW, Haeberle L, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Ashworth A, Orr N, Schoemaker MJ, Swerdlow AJ, Brinton L, Garcia-Closas M, Zheng W, Halverson SL, Shrubsole M, Long J, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H, Hamann U, Brüning T; GENICA Network, Radice P, Peterlongo P, Manoukian S, Bernard L, Bogdanova NV, Dörk T, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Tollenaar RA, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubinski J, Jaworska K, Huzarski T, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Kabisch M, Torres D, Neuhausen SL, Anton-Culver H, Luccarini C, Baynes C, Ahmed S, Healey CS, Tessier DC, Vincent D, Bacot F, Pita G, Alonso MR, Álvarez N, Herrero D, Simard J, Pharoah PP, Kraft P, Dunning AM, Chenevix-Trench G, Hall P, Easton DF. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature Genetics 2015 Apr;47(4):373-80.

235. Khankari NK*, Bradshaw PT, Steck SE, He K, Olshan AF, Shen J, Ahn J, Chen Y, Ahsan H, Terry MB, Teitelbaum SL, Neugut AI, Santella RM, Gammon MD. Dietary intake of fish, polyunsaturated fatty acids, and survival after breast cancer: a population-based, follow-up study on Long Island, NY. Cancer 2015 Jul 1;121(13):2244-52.

236. McCullough LE*, Chen J, White AJ, Xu X, Cho YH, Bradshaw PT, Eng SM, Teitelbaum SL, Terry MB, Garbowski G, Neugut AI, Hibshoosh H, Santella RM, Gammon MD. Global DNA methylation, measured by the luminometric methylation assay (LUMA), associates with postmenopausal breast cancer in non-obese and physically active women. Journal of Cancer 2015 May 1;6(6):548-54.

237. McCullough LE*, Eng SM, Bradshaw PT, Cleveland RJ, Steck SE, Terry MB, Shen J, Crew KD, Rossner Jr. P, Ahn J, Ambrosone CB, Teitelbaum SL, Neugut AI, Santella RM, Gammon MD. Gene-specific promoter methylation status in hormone-receptor-positive breast cancer associates with postmenopausal body size and recreational physical activity.

MD GAMMON

59

International Journal of Cancer and Clinical Research 2015;2(1). pii: 013. 238. Buas MF, Onstad L, Levine DM, Risch HA, Chow W-H, Liu G, Fitzgerald RC, Bernstein L,

Ye W, Bird NC, Romero Y, Casson AG, Corley DA, Shaheen NJ, Wu AH, Gammon MD, Reid BJ, Hardie LJ, Peters U, Whiteman DC, Vaughan TL. MiRNA-related SNPs and risk of esophageal adenocarcinoma and Barrett's esophagus: Post genome-wide association analysis in the BEACON consortium. PLOS ONE 2015 Jun 3;10(6):e0128617.

239. Zhang C, Doherty JA, Burgess S, Hung RJ, Lindström S, Kraft P, Gong J, Amos C, Sellers TA, Monteiro AN, Chenevix-Trench G, Bickeböller H, Risch A, Brennan P, McKay J, Houlston R, Landi MT, Timofeeva M, Wang Y, Heinrich J, Kote-Jarai Z, Eeles RA, Muir K, Wiklund F, Grönberg H, Berndt SI, Chanock SJ, Schumacher F, Haiman CA, Henderson BE, Amin Al Olama A, Andrulis IL, Hopper JL, Chang-Claude J, John EM, Malone KE, Gammon MD, Ursin G, Whittemore AS, Hunter DJ, Gruber SB, Knight JA, Hou L, Le Marchand L, Newcomb PA, Hudson TJ, Chan AT, Li L, Woods MO, Ahsan H, Pierce BL; GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL. Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Human Molecular Genetics 2015 Sep 15;24(18):5356-66.

240. Petrick JL*, Steck SE, Bradshaw PT, Chow W-H, Engel LS, He K, Risch HA, Vaughan TL, Gammon MD. Dietary flavonoid intake and Barrett’s esophagus in western Washington state. Annals of Epidemiology 2015 Oct;25(10):730-735.

241. Cho YH*, McCullough LE*, Gammon MD, Wua H-C, Zhang Y-J, Wang Q, Xu X, Teitelbaum SL, Neugut AI, Chen J, Santella RM. Promoter hypermethylation in white blood cell DNA and breast cancer risk. Journal of Cancer 2015;6(9):819-24.

242. Strizich G*, Gammon MD, Jacobson1 JS, Wall M, Abrahamson P, Bradshaw PT, Terry MB, Teitelbaum S, Neugut AI, Greenlee H. Latent classes of complementary medicine use among women with breast cancer. BMC Complementary and Alternative Medicine 2015 Nov 19;15(1):411.

243. Lee E, Stram DO, Ek VE, Onstad LE, MacGregor S, Gharahkhani P, Ye W, Lagergren J, Bird NC, Romero Y, Shaheen NJ, Murray LJ, Hardie LJ, Gammon MD, Chow W-H, Risch HA, Corley DA, Levine DM, Whiteman DC, Bernstein L, Vaughan TL, Wu AH. Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk. Cancer Epidemiology Biomarkers and Prevention 2015 Nov;24(11):1801-3.

244. Khankari NK*, Bradshaw PT, Steck SE, He K, Olshan AF, Shen J, Ahn J, Chen Y, Ahsan H, Terry MB, Teitelbaum SL, Neugut AI, Santella RM, Gammon MD. Polyunsaturated fatty acid interactions and breast cancer incidence: a population-based case-control study on Long Island, New York. Annals of Epidemiology 2015 Dec;25(12):929-35.

245. White AJ*, Chen J, McCullough LE*, Xu X, Cho Y-H, Teitelbaum SL, Neugut AI, Terry MB, Hibshoosh H, Santella RM, Gammon MD. Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study. Cancer Causes and Control 2015 Dec;26(12):1791-802.

246. Taylor NJ*, Bensen JT, Poole C, Troester MA, Gammon MD, Luo J, Millikan RC, Olshan AF. Genetic variation in cell cycle regulatory gene AURKA and association with intrinsic breast cancer subtype. Molecular Carcinogenesis. 2015 Dec;54(12):1668-77.

247. Zhang B, Shu X-O, Delahanty RJ, Michailidou K, Bolla MK, Wang Q, Dennis J, Wen W, Zeng C, Long J, Li C, Dunning AM, Chang-Claude J, Shah M, Perkins B, Czene K, Darabi H, Eriksson M, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Neven P, Wildiers H, Floris G, Schmidt MK, Rookus MA, van den Hurk K, de Kort WLAM, Couch FJ, Olson E, Hallberg E, Vachon C, Rudolph A, Seibold P, Flesch-Janys D, Peto J,

MD GAMMON

60

dos-Santos-Silva I, Fletcher O, Johnson N, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Li J, Humphreys K, Brand J, Guénel P, Truong T, Cordina-Duverger E, Menegaux F, Burwinkel B, Marme F, Yang R, Surowy H, Benitez J, Zamora MP, Perez JIA, Menéndez P, Cox A, Cross SS, Reed MWR, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Chenevix-Trench G, kConFab Investigators, Australian Ovarian Study Group, Haiman CA, Henderson BE, Schumacher F, Marchand LL, Lindblom A, Margolin S, Hooning MJ, Martens JWM, Tilanus-Linthorst MMA, Collée JM, Hopper JL, Southey MC, Tsimiklis H, Apicella C, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Giles GG, Milne RL, McLean C, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow AJ, Ashworth A, Orr N, Jones M, Figueroa J, Garcia-Closas M, Brinton L, Lissowska J, Dumont M, Labrèche F, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H, Brüning T, Ko Y-D, The GENICA Network, Peterlongo P, Manoukian S, Bonanni B, Radice P, Bogdanova N, Antonenkova N, Dörk T, Mannermaa A, Kataja V, Kosma V-M, Hartikainen JM, Devilee P, Tollenaar RAEM, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubiński J, Jaworska-Bieniek K, Durda K, Hamann U, Torres D, Meindl A, Schmutzler RK, Neuhausen SL, Anton-Culver H, Kristensen VN, Grenaker Alnæs GI, the DRIVE Project, Pierce BL, Kraft P, Peters U, Lindstrom S, Seminara D, Burgess S, Ahsan H, Whittemore AS, John EM, Gammon MD, Malone KE, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Alonso MR, Álvarez N, Herrero D, Pharoah PDP, Simard J, Hall P, Hunter DJ, Easton DF, Zheng W. Height and risk of breast cancer in women: evidence from prospective studies and Mendelian randomization. J Natl Cancer Inst. 2015;107(11).

2016 248. Bradshaw PT*, Stevens J, Khankari N*, Teitelbaum SL, Neugut AI, Gammon MD.

Cardiovascular disease mortality among breast cancer survivors. Epidemiology 2016 Jan;27(1):6-13.

249. Dhahos J*, Abnet CC, Anderson LA, Bernstein L, Brown LM, Chow WH, Freedman ND, Gammon MD, Kamangar F, Liao L, Murray LJ, Nyrén O, Risch HA, Vaughan TL, Ward MH, Xiao Q, Ye W, Whiteman DC, Wu AH, Cook MB. Age-specific risk factor profiles of adenocarcinomas of the esophagus: a pooled analysis from the international BEACON consortium. International Journal of Cancer 2016 Jan 1;138(1):55-64.

250. Mordukhovich I*, Beyea J, Herring AH, Hatch M, Stellman SD, Teitelbaum SL, Richardson DB, Millikan RC, Engel L, Shantakumar S, Steck SE, Neugut AI, Rossner Jr. P, Santella RM, Gammon MD. Vehicular traffic-related polycyclic aromatic hydrocarbon exposure and breast cancer incidence: The Long Island Breast Cancer Study Project. Environmental Health Perspectives 2016 Jan;124(1):30-8.

251. White AJ*, Chen J, Teitelbaum SL, McCullough LE*, Xu X, Cho YH, Conway K, Beyea J, Stellman SD, Steck SE, Mordukhovich I, Eng SM, Terry MB, Engel LS, Hatch M, Neugut AI, Hibshoosh H, Santella RM, Gammon MD. Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer. Environmental Research 2016 Feb;145:93-100.

252. Parada Jr H*, Wolff MS, Engel LS, White AJ*, Eng SM, Cleveland R, Khankari N*, Teitelbaum SL, Neugut AI, Gammon MD. Organochlorine insecticides DDT and chlordane in relation to survival following breast cancer. International Journal of Cancer 2016 Feb 1;138(3):565-75.

253. McCullough LE*, Chen J, Cho YH, Khankari NK, Bradshaw PT, White AJ, Garbowski G,

MD GAMMON

61

Teitelbaum SL, Terry MB, Neugut AI, Hibshoosh H, Santella RM, Gammon MD. DNA methylation modifies the association between obesity and survival after breast cancer diagnosis. Breast Cancer Research and Treatment 2016 Feb;156(1):183-94.

254. Ek WE, Lagergren K, Cook M, Wu AH, Abnet CC, Levine D, Chow W-H, Bernstein L, Risch HA, Shaheen NJ, Bird NC, Reid BJ, Corley DA, Hardie LJ, Fitzgerald RC, Gammon MD, Romero Y, Liu G, Ye W, Vaughan TL, MacGregor S, Whiteman DC, Westberg L, Lagergren J. Polymorphisms in genes in the androgen pathway and risk of Barrett’s esophagus and esophageal adenocarcinoma. International Journal of Cancer 2016 Mar 1;138(5):1146-52.

255. Parada Jr. H*, Wolff MS, Engel LS, Eng SM, Khankari NK*, Neugut AI, Teitelbaum SL, Gammon MD. Polychlorinated biphenyls and their association with survival following breast cancer. European Journal of Cancer 2016 Mar;56:21-30.

256. Kim J, Mersereauc JE, Khankari N, Bradshaw PT, McCullough LE, Cleveland R, Shantakumar S, Teitelbuam SL, Neugut AI, Senie RT, Gammon MD. Polycystic ovarian syndrome (PCOS), related symptoms/sequelae, and breast cancer risk in a population-based case-control study. Cancer Causes Control 2016 Mar;27(3):403-14.

257. White AJ*, Bradshaw PT, Herring AH, Teitelbaum SL, Beyea J, Stellman SD, Steck SE, Mordukhovich I, Eng SM, Engel LS, Conway K, Hatch M, Neugut AI, Santella RM, Gammon MD. Exposure to multiple sources of polycyclic aromatic hydrocarbons and breast cancer incidence. Environment International 2016 Apr-May;89-90:185-92.

258. Smith GS*, Van Den Eeden SK, Shan J, Baxter R, Herring A, Richardson DB, VanRie A, Garcia C, Emch M, Gammon MD. Air pollution and pulmonary tuberculosis: a nested case-control study among members of a northern California health plan. Environmental Health Perspectives 2016 Feb 9. [Epub ahead of print]

259. Beard JD*, Engel LS, Richardson DB, Gammon MD, Baird C, Umbach DM, Allen KD, Stanwyck CL, Keller J, Sandler DP, Schmidt S, Kamel R. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology. Environment International 2016 May;91:104-15.

260. Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H, Aittomäki K, Ambrosone C, Andrulis IL, Anton-Culver H, Arndt V, Arun BK, Arver B, Barile M, Barkardottir RB, Barrowdale D, Beckmann L, Beckmann MW, Benitez J, Blank SV, Blomqvist C, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldes T, Caligo MA, Canzian F, Carpenter J, Chang-Claude J, Chanock SJ, Chung WK, Claes KB, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Damiola F, Darabi H, de la Hoya M, Devilee P, Diez O, Ding YC, Dolcetti R, Domchek SM, Dorfling CM, Dos-Santos-Silva I, Dumont M, Dunning AM, Eccles DM, Ehrencrona H, Ekici AB, Eliassen H, Ellis S, Fasching PA, Figueroa J, Flesch-Janys D, Försti A, Fostira F, Foulkes WD, Friebel T, Friedman E, Frost D, Gabrielson M, Gammon MD, Ganz PA, Gapstur SM, Garber J, Gaudet MM, Gayther SA, Gerdes AM, Ghoussaini M, Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Gronwald J, Guénel P, Gunter M, Haeberle L, Haiman CA, Hamann U, Hansen TV, Hart S, Healey S, Heikkinen T, Henderson BE, Herzog J, Hogervorst FB, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Humphreys K, Hunter DJ, Huzarski T, Imyanitov EN, Isaacs C, Jakubowska A, James P, Janavicius R, Jensen UB, John EM, Jones M, Kabisch M, Kar S, Karlan BY, Khan S, Khaw KT, Kibriya MG, Knight JA, Ko YD, Konstantopoulou I, Kosma VM, Kristensen V, Kwong A, Laitman Y, Lambrechts D, Lazaro C, Lee E, Le Marchand L, Lester J, Lindblom A,

MD GAMMON

62

Lindor N, Lindstrom S, Liu J, Long J, Lubinski J, Mai PL, Makalic E, Malone KE, Mannermaa A, Manoukian S, Margolin S, Marme F, Martens JW, McGuffog L, Meindl A, Miller A, Milne RL, Miron P, Montagna M, Mazoyer S, Mulligan AM, Muranen TA, Nathanson KL, Neuhausen SL, Nevanlinna H, Nordestgaard BG, Nussbaum RL, Offit K, Olah E, Olopade OI, Olson JE, Osorio A, Park SK, Peeters PH, Peissel B, Peterlongo P, Peto J, Phelan CM, Pilarski R, Poppe B, Pylkäs K, Radice P, Rahman N, Rantala J, Rappaport C, Rennert G, Richardson A, Robson M, Romieu I, Rudolph A, Rutgers EJ, Sanchez MJ, Santella RM, Sawyer EJ, Schmidt DF, Schmidt MK, Schmutzler RK, Schumacher F, Scott R, Senter L, Sharma P, Simard J, Singer CF, Sinilnikova OM, Soucy P, Southey M, Steinemann D, Stenmark-Askmalm M, Stoppa-Lyonnet D, Swerdlow A, Szabo CI, Tamimi R, Tapper W, Teixeira MR, Teo SH, Terry MB, Thomassen M, Thompson D, Tihomirova L, Toland AE, Tollenaar RA, Tomlinson I, Truong T, Tsimiklis H, Teulé A, Tumino R, Tung N, Turnbull C, Ursin G, van Deurzen CH, van Rensburg EJ, Varon-Mateeva R, Wang Z, Wang-Gohrke S, Weiderpass E, Weitzel JN, Whittemore A, Wildiers H, Winqvist R, Yang XR, Yannoukakos D, Yao S, Zamora MP, Zheng W, Hall P, Kraft P, Vachon C, Slager S, Chenevix-Trench G, Pharoah PD, Monteiro AA, García-Closas M, Easton DF, Antoniou AC. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nature Communications. 2016 Apr 27;7:11375

261. Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, Shu XO, Schmidt MK, Milne RL, García-Closas M, Chang-Claude J, Lindstrom S, Bojesen SE, Ahsan H, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Beckmann MW, Beeghly-Fadiel A, Benitez J, Blomqvist C, Bogdanova NV, Børresen-Dale AL, Brand J, Brauch H, Brenner H, Burwinkel B, Cai Q, Casey G, Chenevix-Trench G, Couch FJ, Cox A, Cross SS, Czene K, Dörk T, Dumont M, Fasching PA, Figueroa J, Flesch-Janys D, Fletcher O, Flyger H, Fostira F, Gammon M, Giles GG, Guénel P, Haiman CA, Hamann U, Harrington P, Hartman M, Hooning MJ, Hopper JL, Jakubowska A, Jasmine F, John EM, Johnson N, Kabisch M, Khan S, Kibriya M, Knight JA, Kosma VM, Kriege M, Kristensen V, Le Marchand L, Lee E, Li J, Lindblom A, Lophatananon A, Luben R, Lubinski J, Malone KE, Mannermaa A, Manoukian S, Margolin S, Marme F, McLean C, Meijers-Heijboer H, Meindl A, Miao H, Muir K, Neuhausen SL, Nevanlinna H, Neven P, Olson JE, Perkins B, Peterlongo P, Phillips KA, Pylkäs K, Rudolph A, Santella R, Sawyer EJ, Schmutzler RK, Schoemaker M, Shah M, Shrubsole M, Southey MC, Swerdlow AJ, Toland AE, Tomlinson I, Torres D, Truong T, Ursin G, Van Der Luijt RB, Verhoef S, Wang-Gohrke S, Whittemore AS, Winqvist R, Pilar Zamora M, Zhao H, Dunning AM, Simard J, Hall P, Kraft P, Pharoah P, Hunter D, Easton DF, Zheng W. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes Control. 2016 May;27(5):679-93.

262. Mordukhovich I*, Beyea J, Herring AH, Hatch M, Stellman SD, Teitelbaum SL, Richardson DB, Millikan RC, Engel LS, Shantakumar S, Steck SE, Neugut AI, Rossner Jr. P, Santella RM, Gammon MD. Polymorphisms in DNA repair genes, traffic-related polycyclic aromatic hydrocarbon exposure, and breast cancer incidence. International Journal of Cancer 2016 Jul 15;139(2):310-21.

Peer-Reviewed Journal Articles (Accepted) (*indicates junior investigator): Peer-Reviewed Journal Articles (Under Revision) (*indicates junior investigator): 263. Guo Y, Warren Andersen S, Shu X-O, Michailidou K, Bolla K, Wang Q, Garcia-Closas M,

et al. Body Mass Index genetic scores and breast cancer risk: Mendelian randomization analyses of data from 145,000 women of European descent. PLOS Medicine (under

MD GAMMON

63

revision) 264. Gharahkhani P, Fitzgerald RC, Vaughan TL, et al. Large scale meta-analysis identifies

several new risk loci for esophageal adenocarcinoma, including the first locus independent of Barrett’s esophagus. Lancet Oncology (under revision)

Peer-Reviewed Journal Articles (Submitted) (*indicates junior investigator): 265. Beyea J, Stellman S, Hatch M, White AJ*, Mordukhovich I*, Gammon MD. Sediment

profiles can extend PAH emission rates from US vehicle tailpipes back to the 1930s for use in environmental epidemiology. (submitted)

266. Beard JD, Engel LS, Richardson DB, Gammon MD, Baird C, Umbach DM, Allen KD, Stanwyck CL, Keller J, Sandler DP, Schmidt S, Kamel F. Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis survival. (submitted)

267. Buas MF, He Q, Johnson LG, Onstad L, Levine DM, Thrift AP, Lagergren J, Fitzgerald R, Ye W, Calda C, Bird NC, Shaheen NJ, Bernstein L, Gammon MD, Wu AH, Hardie LJ, Pharoah P, Liu G, Iyer P, Reid BJ, Corley DA, Risch HA, Murray LJ, Chow W-H, Whiteman DC, Vaughan TL, Madeleine MM. Germline variation in inflammation-related pathways and risk of Barrett’s esophagus and esophageal adenocarcinoma. (submitted)

268. Khankari NK*, Bradshaw PT, Steck SE, He K, Olshan AF, Ahn J, Terry MB, Crew KD, Teitelbaum SL, Neugut AI, Santella RM, Gammon MD. Interaction between polyunsaturated fatty acids and genetic variants with breast cancer incidence. (submitted)

269. McClain KM*, McCullough LE, Bradshaw PT, Shantakumar S, Terry MB, Neugut AI, Gammon MD. Age-specific indicators of a healthy lifestyle and risk for postmenopausal breast cancer. (submitted)

270. Niehoff N*, White AJ*, McCullough LE, Steck SE, Beyea J, Mordukhovich I, Shen J, Neugut AI, Conway-Dorsey K, Santella RM, Gammon MD. Polycyclic aromatic hydrocarbons and postmenopausal breast cancer: an evaluation of effect measure modification by body mass index and weight change. (submitted)

Peer-Reviewed Journal Articles -- Collaborative Authorship: 271. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and

hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiologic studies. Lancet 1996;347:1713-27.

272. Collaborative Group on Hormonal Factors in Breast Cancer. Breast Cancer and hormonal contraceptives: further results. Contraception 1996;3(Suppl):1S-106S.

273. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047-59.

274. Marrett L, Theis B, Ashbury FD, and an Expert Panel. Workshop report: Physical activity and cancer prevention. Chronic Diseases in Canada 2000;21:143-49.

275. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;27:1389-99.

276. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breast feeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002;360:187-95.

MD GAMMON

64

277. Collaborative Group on Hormonal Factors in Breast Cancer. Alcohol, tobacco and breast cancer -- collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. British Journal of Cancer 2002;87:1234-45.

278. Beral V, Bull D, Doll R, Peto R, Reeves G; Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83,000 women with breast cancer from 16 countries. Lancet 2004;363(9414):1007-16.

279. Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncology 2012:13(11); 1141-1151.

280. Lu Y, Ek WE, Whiteman D, Vaughan TL, Spurdle AB, Easton DF, Pharoah PD, Thompson DJ, Dunning AM, Hayward NK, Chenevix-Trench G; Q-MEGA and AMFS Investigators; ANECS-SEARCH; UKOPS-SEARCH; BEACON Consortium, Macgregor S. Most common 'sporadic' cancers have a significant germline genetic component. Hum Mol Genet. 2014;23(22):6112-8.

281. Gharahkhani P, Tung J, Hinds D, Mishra A; Barrett's and Esophageal Adenocarcinoma Consortium (BEACON), Vaughan TL, Whiteman DC, MacGregor S; BEACON study investigators; on behalf of the Barrett's and Esophageal Adenocarcinoma Consortium BEACON investigators (Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Murray LJ, Reid BJ, Chow WH, Risch HA, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Whiteman DC, Vaughan TL). Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett's esophagus. Hum Mol Genet. 2015 Dec 23. pii: ddv512. [Epub ahead of print]

Invited, Peer-Reviewed Editorial/Review (*indicates junior investigator): 282. Gammon MD, Bertin JE, Terry MB*. Abortion and the risk of breast cancer: is there a

believable association? Journal of the American Medical Association 1996;275:321-2. 283. Gooden KM*, Carter-Edwards L, Hoyo C*, Akbar J, Cleveland RJ*, Oates V, Jackson E,

Furberg H, Gammon MD. For the patient. Recruitment strategies for cancer research studies. Ethnicity & Disease 2005 Winter;15(1):151.

284. Gammon MD, Fink BN*, Steck SE*, Wolff MS. Soy intake and breast cancer: elucidation of an unanswered question. British Medical Journal 2008;98(1):2-3.

285. Gammon MD, Santella RM. PAH, genetic susceptibility, and breast cancer risk: an update from the Long Island Breast Cancer Study Project. European Journal of Cancer 2008;44(5):636-40.

286. Petrick JL*, Li N*, McClain KM*, Steck SE, Gammon MD. Dietary risk reduction factors for the Barrett’s esophagus-esophageal adenocarcinoma continuum: a review of the recent literature. Current Nutrition Reports 2015;4(1):47-65.

287. McCullough LE, McClain KM*, Gammon MD. The promise of leisure-time physical activity to reduce risk of cancer development. JAMA Internal Medicine 2016 May 16. doi: 10.1001/jamainternmed.2016.1521. [Epub ahead of print]

Letters (* indicates junior investigator): 288. Gammon MD, Thompson WD. RE: Polycystic ovaries and breast cancer. The authors

reply. American Journal of Epidemiology 1992;136:373. 289. Kelsey JK, Gammon MD, John E. RE: Reproductive factors and breast cancer. The authors

reply. American Journal of Epidemiology 1994;140:659-61. 290. Gammon MD, Terry MB*, Bertin JE. RE: Abortion and the risk of breast cancer: a case-

MD GAMMON

65

control study in Greece. International Journal of Cancer 1995;63:671. 291. Wolff MS, Camann D, Gammon MD, Stellman SD. Proposed PCB congener groupings for

epidemiologic studies. Environmental Health Perspectives 1997;105:13-4. 292. Terry MB*, Gammon MD, Ng-Mak D, Thompson WD. Bias from misclassification of p53

status. American Journal of Epidemiology 1998;147:511-2. 293. Gammon MD, Terry MB*, Teitelbaum SL*, Britton JA*, Levin B. Organochlorine

residues and breast cancer. New England Journal of Medicine 1998;338:989. 294. Gammon MD, Santella RM. RE: Environmental toxins and breast cancer on Long Island.

I. Polycyclic aromatic hydrocarbons (PAH)-DNA adducts. The authors respond. Cancer Epidemiology, Biomarkers, and Prevention 2003;12:75-6.

295. Kabat GC, O'Leary ES*, Schoenfeld ER, Leske MC, Gammon MD. RE: Electric blanket use and breast cancer. Epidemiology 2004;15:377-8.

296. Terry MB*, Gammon M, Neugut AI. Association of aspirin use and hormone receptor status with breast cancer risk—Reply. Journal of the American Medical Association 2004; 92: 427.

297. Mayne ST, Risch H, Dubrow R, Chow WH, Gammon MD, Vaughan T, et al. RE: Carbonated soft drink consumption and risk of esophageal adenocarcinoma. Journal of the National Cancer Institute 2006;98:72-75.

298. Terry MB*, Flom J, Gammon M. RE: Selection and recall bias in a case-control study of lifetime alcohol intake and breast cancer risk. Annals of Epidemiology 2006;16(12):920-1.

Book Chapters (* indicates mentored junior investigator): 1. Douglass CW, Gammon MD, Horgan WJ. Epidemiology of oral cancer. In: Shklar G (ed.)

Oral Cancer. Philadelphia, WB Saunders Company, 1984. 2. Gammon MD. Selected statistical measures in epidemiology (Chapter 16). In: Weintraub J,

Douglass CW, Gillings D. BIOSTATS: Data Analysis for Dental Health Professionals. Chapel Hill, NC, CAVCO, Inc., 1984, 1985.

3. Gammon MD, Gillings D. Nonparametric statistics: paired and unpaired significance tests (Chapter 17). In: Weintraub J, Douglass CW, Gillings D. BIOSTATS: Data Analysis for Dental Health Professionals. Chapel Hill, NC, CAVCO, Inc., 1984, 1985.

4. Weintraub J, Douglass CW, Gillings D, Gammon MD. Hypothesis testing, level of significance, and power (Chapter 11). In: Weintraub J, Douglass W, Gillings D. BIOSTATS: Data Analysis for Dental Health Professionals. Chapel Hill, NC, CAVCO Inc., 1984, 1985.

5. Weintraub J, Douglass CW, Gillings D, Gammon MD. Hypothesis testing, level of significance, and power (Chapter 11). In: Weintraub J, Douglass W, Gillings D. BIOSTATS: Primer for Health Professionals. Chapel Hill, NC, CAVCO Inc., 1985.

6. Gammon MD. Selected statistical measures in epidemiology. In: Weintraub J, Gillings D and Douglass CW. BIOSTATS: Primer for Health Professionals. Chapel Hill, NC, CAVCO, Inc., 1985.

7. Gammon MD, Gillings D. Nonparametric statistics: paired and unpaired significance tests (Chapter 17). In: Weintraub J, Douglass CW, Gillings D. BIOSTATS: Primer for Dental Health Professionals. Chapel Hill, NC, CAVCO, Inc., 1985.

8. Abrahamson PI*, Gammon MD. Physical activity and cancer survival. In: McTeirnan A (ed.). Cancer Prevention and Management Through Exercise and Weight Control, New York, CRC Press, 2006.

9. Hoyo C*, Gammon MD. Obesity/overweight and risk of esophageal adenocarcinoma. In: McTeirnan A (ed.). Cancer Prevention and Management Through Exercise and Weight

MD GAMMON

66

Control, New York, CRC Press, 2006. Abstracts (* indicates mentored junior investigator): 1. Douglass CW, Gillings D, Sollecito W, Gammon MD. The potential for increase in the

periodontal diseases of the aged population. American Association of Dental Education, Dallas TX, 1983.

2. Douglass CW, Gammon MD. The epidemiology of dental caries and its impact on the operative dentistry curriculum. American Association of Dental Education, 1984. (Selected for an oral presentation)

3. Douglass CW, Gammon MD, Orr RB. Oral health status in the United States: prevalence of inflammatory periodontal disease. American Association of Dental Education, Las Vegas, NV, March 1985. (Selected for an oral presentation)

4. Gammon MD, Thompson WD. Polycystic ovaries and the risk of breast cancer. Society for Epidemiologic Research, Snowbird, Utah, June 1990. (Selected for an oral presentation)

5. Schwartz SM, Weiss NS, Daling JR, Newcomb PA, Liff JM, Gammon MD, Thompson WD, Watt JD, Armstrong BK, Weyer P, Isaacson P. Reproductive and hormonal risk factors for histologic types of uterine sarcoma. Society for Epidemiologic Research, Buffalo, NY, June 1991.

6. Schoenberg JB, Gammon MD, Lewis H, Wilcox H, Kohler B. Changing patterns of esophageal and gastric adenocarcinoma in New Jersey. New Jersey Commission for Cancer Research, Lawrenceville, NJ, November 1992.

7. Gammon MD, Schwartz AV, Thompson WD. Age-specific risk factors for breast cancer among young black women. American Society for Preventive Oncology, Washington, DC, March 1994. (Selected for an oral presentation)

8. Swanson CA, Coates RJ, Schoenberg JB, Malone KE, Gammon MD, Stanford JL, Shorr IJ, Potischman NA, Brinton LA. Body size and breast cancer risk among women under age 45. New Jersey Commission for Cancer Research, Lawrenceville, NJ, June 1995.

9. Arber N, Gammon MD, Hibshoosh H, Lightdale C, Britton JA*, Zhang Y, Neugut A, Heitjan D, Yap E, Rotterdam H, Hold P, Weinstein I. Increased expression of cyclin D1 is in an early event in esophageal and gastric tumors. American Association of Cancer Research, April 1996.

10. Arber N, Hibshoosh H, Moss SF, Lightdale C., Zhang Y, Heitjan D, Yap E, Gammon MD, Neugut AI, Weinstein IB, Holt PR. Increased expression of cyclin D1 is common and early event in gastro-intestinal cancers. American Gastroenterological Association, May 1996.

11. Swanson CA, Coates RJ, Malone KE, Gammon MD, Schoenberg JB, Brogan DR, Potischman NA, Brinton LA. Alcohol consumption and breast cancer risk among women under age 45. Society for Epidemiologic Research, Boston, MA, June 1996.

12. Moss SF, Arber N, Hibshoosh H, Wang S, Gammon MD, Bernstein IB, Holt PR. Cyclin D1 expression in gastric carcinogenesis. IX International Workshop on Gastroduodenal Pathology and Heliocobacter pylori, June 1996.

13. Potischman N, Weiss HA, Coates RJ, Stanford JB, Schoenberg JB, Gammon MD, Brinton LA. Adolescent diet and risk of early onset breast cancer. American Society of Nutritional Sciences at Experimental Biology, 1997.

14. Ahsan H*, Neugut AI, Gammon MD. Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. American Society for Preventive Oncology, New Orleans, LA, March 1997.

15. Kanetsky PA*, Gammon MD, Mandelblatt J, Zhang Z-F, Ramsey E, Wright TC, Msyseoane S, Laxaro N, Felton HT, Sachdev RK, Richart RM, Curtin JP. Smoking and

MD GAMMON

67

cervical dysplasia among black women. American Society for Preventive Oncology, New Orleans, LA, March 1997. (Honorable mention for best poster)

16. Kanetsky PA*, Gammon MD, Mandelblatt J, Zhang Z-F, Ramsey E, Dnistrian A, Norkus E, Wright TC, Thomas L, Msyseoane S, Laxaro N, Felton HT, Sachdev RK, Richart RM. Micronutrients and cervical dysplasia among black women. American Society for Preventive Oncology, New Orleans, LA, March 1997.

17. Chow W-H, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Fraumeni Jr JR. H. pylori and CagA status in relation to risk of adenocarcinomas of esophagus and stomach. International H. Pylori Meeting, Lisbon, Portugal, September 1997.

18. Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow W-H, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni Jr JF, Blot WJ. Use of aspirin and other non-steroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. American College of Epidemiology, Boston, MA, September 1997.

19. Gammon MD, Hibshoosh H, Terry MB*, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD. Oral contraceptive use and HER-2/neu-positive breast cancer among young women. Department of Defense Breast Cancer Research Program, ERA of Hope Meeting, Washington, DC, November 1997. (Selected for an oral presentation)

20. Britton JA*, Gammon MD, Schoenberg JB, Kelsey JL, Coates RJ, Brogan D, Potischman N, Swanson CA, Daling JR, Stanford JL, Brinton LA. Recreational physical activity and breast cancer risk among young women. National Action Plan on Breast Cancer, Workshop on Physical Activity and Breast Cancer. Albuquerque, NM, November 1997.

21. Gammon MD, Hibshoosh H, Terry MB*, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD. p53 protein overexpression in relation to epidemiologic risk factors for breast cancer in young women. American Society for Preventive Oncology, Washington, DC, March 1998. (Honorable mention for best poster)

22. Vaughan T, Farrow D, Chow W-H, Gammon MD, Risch H, Hansten P, Schoenberg S, Mayne S Fraumeni Jr JF. Risk of esophageal and gastric adenocarcinoma and use of calcium antagonists and other medications that promote gastroesophageal reflux. American Society for Preventive Oncology, Washington, DC, March 1998. (Honorable mention for best poster)

23. Chow W-H, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Fraumeni Jr JF. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. American Society for Preventive Oncology, Washington, DC, March 1998.

24. Gammon MD, Schoenberg JB, Teitelbaum SL*, Brinton LA*, Potischman N, Swanson CA, Brogan DJ, Malone KE, Stanford JL. Cigarette smoking and breast cancer risk among young women. Society for Epidemiologic Research, Chicago, IL, June 1998.

25. Camann D, Stellman S, Gammon MD, Teitelbaum SL, Levin B, Wolff M, Neugut AI, Yau AY. Distributions of pesticides, PAH, and PCB congeners in Long Island carpet dust. International Society for Exposure Assessment, Boston, MA, August 1998.

26. Farrow CD, Vaughan TL, Stanford JL, Risch HA, Gammon MD, Chow W-H, Sweeney C, Hansten PD, Mayne ST, Schoenberg JB, Rotterdam H, Ahsan H, West AB, Dubrow R, Fraumeni Jr JF, Blot WJ. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. American College of Epidemiology, San Francisco, CA, September 1998.

27. Hall HI, Coates RJ, Uhler R, Brinton LA, Gammon MD, Potischman N, Brogan D, Malone

MD GAMMON

68

KE, Swanson CA. Stage of breast cancer in relation to body mass and breast size.13th National Conference on Chronic Disease Prevention and Control, Atlanta, GA, December 1998.

28. Hibshoosh H, Gammon MD, Rotterdam H, West AB, Terry MB*, Vaughan TL, Risch HA, Chow W-H, Fraumeni Jr JF, Arber N, Weinstein IB. Cyclin D1 overexpression in esophageal and gastric carcinomas correlation to histopathology. U.S. and Canadian Academy of Pathology, San Francisco, CA, March 1999.

29. Mayne S, Risch H, Dubrow R, Chow W-H, Gammon M, Vaughan T, Farrow D, Schoenberg J, Stanford J, Ahsan H, Fraumeni Jr. JF. Nutrient intake and risk of adenocarcinomas of the esophagus and gastric cardia. American Society of Nutritional Sciences, Washington, DC, April 1999.

30. Britton JA*, Westhoff CL, Howe G, Gammon MD. The relation between lactose and benign ovarian tumors. Society for Epidemiologic Research, Baltimore, MD, June 1999.

31. Coates RJ, Uhler RJ, Brogan DR, Gammon MD, Malone K, Swanson CA, Flagg ER, Brinton LA. Patterns and determinants of breast cancer detection methods among women aged 20-44 (United States). American Society of Preventive Oncology, Bethesda, MD, March 2000.

32. Xie H, Keiner D, Chow W-H, Risch HA, Gammon MD, Vaughan TL, Mayne ST, Rotterdam H, Farrow DC, Frumeni Jr JF. p53 protein overexpression in esophageal and gastric carcinomas. American Association of Cancer Research, San Francisco, CA, April 2000.

33. Gammon MD, Hibshoosh H, Terry MB, Neugut AI, Wolff MS, Santella RM. p53, environmental risk factors and breast cancer. DOD Breast Cancer Research Program ERA of Hope Meeting, Atlanta, GA, June 2000.

34. Camann DE, Colt JS, Teitelbaum SL, Rudel RA, Hart RM, Gammon MD. Pesticide and PAH distributions in house dust from seven areas of USA. SETAC, Nashville, TN, November 2000.

35. El-Omar EM, Chow W-H, Gammon MD, Vaughan TL, Risch HA, Frumeni JF, Jr. Pro-inflammatory genotypes of IL-1beta, TNF-alpha and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas. Digestestive Diseases Week sponsored by American Gastroenterological Association, Society for Surgery of the Alimentary Tract, American Society for Gastrointestinal Endoscopy and the American Association for Study of Liver Diseases, Atlanta, GA, May 2001.

36. Stellman SD, Beyea J, Hatch M, Prokopczyk B, Gammon MD. Validation of airborne PAH exposure opportunity estimates for a large-scale epidemiologic study using soil samples collected at subjects' homes. International Exposure Assessment Association, Charleston, SC, November 2001.

37. Camann DE, Teitelbaum SL*, Stellman SD, Gammon MD. Distributions and quality of pesticide, PAH, and PCB measurements in Long Island carpet dust. International Exposure Assessment Association, Charleston, SC, November 2001.

38. Terry MB*, Gammon MD, Schoenberg JB, Brinton LA, Hibshoosh H. Oral contraceptive use and Cyclin D1 overexpression in breast cancer among young women. American Society of Preventive Medicine, Washington, DC, March 2002.

39. Britton JA*, Gammon MD, Schoenberg JB, Stanford JL, Kelsey JL, Brogan DR, Coates RJ, Potischman N, Swanson CA, Brinton LA. Risk of breast cancer subclassified by joint steroid receptor status in relation to established and putative hormone-related characteristics among women 20 to 54 years. American Association for Cancer Research, San Francisco,

MD GAMMON

69

CA, April 2002. 40. Teitelbaum ST*, Britton JA*, Gammon MD, Schoenberg JB, Brogan Dr, Coates RJ,

Daling JR, Malone K, Swanson CA, Brinton LA. Occupation and breast cancer in women under 45 years of age. American Association for Cancer Research, San Francisco, CA, April 2002.

41. Althuis M, Brogan D, Coates R, Daling J, Gammon MD, Malone K, Schoenberg JB, Brinton LA. Breast cancer among very young premenopausal women. Society for Epidemiologic Research, Palm Desert, CA, June 2002.

42. Beyea J, Hatch M, Stellman SD, Santella RM, Teitelbaum ST, Prokopczyk B, Camann D, Gammon MD. Historical reconstruction of exposure to polycyclic aromatic hydrocarbons and model validation: examples from the Long Island Breast Cancer Study Project. International Association for Environmental Exposures and Exposure Assessment, Vancouver, BC, August 2002.

43. Chen J*, Gammon MD, Kabat GC, Terry MB*, Neugut AI, Santella RM. Intake and metabolism of B vitamins and risk of breast cancer in the Long Island Breast Cancer Study Project. DOD Breast Cancer Research Program, ERA of Hope Meeting, Orlando FL, September 2002.

44. Cleveland RJ*, Gammon MD, Baric R. Insulin-like growth factor I polymorphisms and breast cancer. DOD Breast Cancer Research Program, ERA of Hope Meeting, Orlando FL, September 2002.

45. Niguidula NJ, Santella RM, Gammon MD, Terry MB*, Schoenberg JB, Hibshoosh H. 4-aminobiphenyl-DNA adduct damage breast tissue and the relationship to polymorphisms of metabolizing genes. DOD Breast Cancer Research Program, ERA of Hope Meeting, Orlando, FL, September 2002.

46. Bernstein J, Thompson WD, Press M, Lapinski R, Bleiweiss I, Schildkraut J, Gammon MD, Haile R. HER-2/neu and p53 overexpression among women with breast cancer. Society for Epidemiologic Research, Atlanta, GA, June 2003.

47. Chen J*, Gammon MD, Chan W, Palomeque C, Kabat GC, Terry MB, Britton JA, Teitelbaum SL*, Neugut AI, Santella RM. Folate metabolism modifies the risk of breast cancer in the Long Island Breast Cancer Study Project. American Association of Cancer Research, Washington, DC, July 2003.

48. Trivers K*, DeRoos A, Gammon MD, Vaughan T, Risch HR, Fraumeni Jr JF, Chow W-H. Demographic and lifestyle predictors of survival in patients with esophageal or gastric tumors. American Association of Cancer Research, Washington, DC, July 2003.

49. Britton JA*, Wolff MS, Teitelbaum SL*, Eng SM*, Neugut AI, Santella RM, Gammon MD. Predictors of organochlorine residues in serum used as biomarkers in a study of breast cancer. American Association of Cancer Research, Washington, DC, July 2003.

50. Furberg AH*, Millikan RC, Geradts J, Gammon MD, Dressler LG, Ambrosone CB, Newman B. Reproductive factors in relation to the risk of breast cancer characterized by p53 protein expression. American Association of Cancer Research, Washington, DC, July 2003.

51. Terry MB*, Gammon MD, Zhang FF, Wang Q, Neugut AI, Teitelbaum SL*, Britton JA, Santella RM. Alcohol intake, ADH3 genotype and breast cancer risk. American Association of Cancer Research, Washington, DC, July 2003.

52. Zimmerman R*, Ahsan H, Gammon M, Greenberg D. Comparing familial aggregation study designs: The Long Island Breast Cancer Study Project. American Society of Human Genetics, 2003.

53. Ahn J*, Gammon MD, Santella RM, Gaudet MM*, Britton JA, Teitelbaum SL*, Neugut

MD GAMMON

70

AI, Terry MB, Ambrosone CB. Myeloperoxidase (MPO) genotype, dietary antioxidants, and breast cancer risk. SNPs, Haplotypes, and Cancer: Applications in Molecular Epidemiology, Key Biscayne, FL, September 2003.

54. Terry MB*, Gammon MD, Zhang FF, Wang Q, Eng SM, Neugut AI, Teitelbaum SL*, Britton JA, Santella RM. XPD polymorphisms, cigarette smoking, and breast cancer incidence. SNPs, Haplotypes, and Cancer: Applications in Molecular Epidemiology, Key Biscayne, FL, September 2003.

55. Abrahamson PE*, Gammon MD, Lund MJ, Britton JA, Eley W, Porter P, Brinton LA, Coates RJ. Physical activity and breast cancer survival among young women. American Society for Preventive Oncology, Bethesda, MD, March 2004.

56. Ahn J*, Gammon MD, Santella RM, Gaudet MM*, Britton JA, Teitelbaum SL*, Neugut AI, Terry MB*, Conway K, Ambrosone CB. Catalase (CAT) genotype, dietary antioxidants, and breast cancer risk. American Association of Cancer Research, Orlando, FL, March 2004.

57. Rossner P*, Gammon MD, Shen J*, Terry MB*, Teitelbaum SL*, Neugut AI, Santella RM.. OGG1 Ser326Cys polymorphism and breast cancer risk. American Association of Cancer Research, Orlando, FL, March 2004.

58. Shen J*, Terry MB*, Gammon MD, Zhang FF, Wang Q, Teitelbaum SL*, Neugut AI, Santella RM. Genetic Polymorphisms in the DNA repair gene XRCC1 and Breast Cancer Risk – Results from Long Island Breast Cancer Study Project (LIBCSP). American Association of Cancer Research, Orlando, FL, March 2004.

59. Abrahamson PE*, Gammon MD, Lund MJ, Britton JA, Eley W, Flagg EW, Porter P, Brinton LA, Coates RJ. Obesity and breast cancer survival among young women. Society for Epidemiology Research, Salt Lake City, UT, June 2004.

60. Ahn J*, Gammon MD, Santella RM, Gaudet MM*, Britton JA, Teitelbaum SL, Neugut AI, Terry MB*, Conway K, Eng SM*, Ambrosone CB. Glutathione S-transferase A1 (GSTA1) genotype, cigarette smoking, and breast cancer risk. NCI-sponsored Pathobiology of Cancer Workshop, Keystone, CO, July 2004.

61. Eng SM*, Gammon MD, Terry MB*, Kushi LH, Teitelbaum SL*, Britton JA, Neugut AI. Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. 12th SPORE Investigators Workshop, National Cancer Institute, Baltimore, MD, July 2004.

62. Navarro Silvera SA, Mayne ST, Risch H, Gammon MD, Vaughan T, Chow W-H, Dubin JA, Dubrow R, Schoenberg J, Stanford JL, West AB, Rotterdam H, Blot W, Fraumeni JF. Dietary/lifestyle patterns and risk of subtypes of esophageal and gastric cancer: factor analysis. American Institute of Cancer Research, July 2004.

63. Shantakumar S*, Gammon MD, Eng SM*, Sagiv SK*, Gaudet MM*, Teitelbaum SL*, Britton JA, Wang LW, Wang Q, Stellman SD, Beyea J, Hatch M, Camann D, Neugut AI, Santella RM. Environmental exposures and other characteristics associated with detectable PAH-DNA adducts among a population-based sample of healthy women. International Society for Environmental Epidemiology, New York, NY, August 2004.

64. Teitelbaum SL*, Gammon MD, Britton JA, Neugut AI, Stellman SD, Wolff M. Characteristics and patterns of residential pesticide use on Long Island, NY. International Society for Environmental Epidemiology, New York, NY, August 2004.

65. Gaudet MM*, Gammon MD, Abrahamson PE*, Potischman N, Lund MJ, Porter PL, Brinton LA, Flagg EW, Eley JW, Coates RJ. Protein intake and breast cancer survival among young women. American Association for Cancer Research, Frontiers in Cancer

MD GAMMON

71

Prevention Research, October 2004. 66. Rossner P*, Terry MB*, Gammon MD, Agrawal M, Zhang FF, Teitelbaum SL*, Eng SM,

Gaudet MM*, Neugut AI, Santella RM. The association of urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels with breast cancer risk. American Association for Cancer Research, March 2005.

67. Rossner P*, Terry MB*, Gammon MD, Zhang FF, Teitelbaum SL*, Eng SM*, Sagiv SK*, Gaudet MM*, Neugut AI, Santella RM. The effect of three polymorphisms in OGG1 gene on breast cancer risk. American Association for Cancer Research, March 2005.

68. Shen J*, Terry MB*, Gammon MD, Zhang FF, Teitelbaum SL*, Eng SM*, Sagiv SK*, Gaudet MM*, Neugut AI, Santella RM. IGHMBP2 Thr671Ala polymorphism and breast cancer risk –– DNA repair mechanistic insights from a molecular epidemiological study. American Association for Cancer Research, March 2005.

69. Gaudet MM*, Bensen JT, Olshan AF, Schroeder J, Terry MB*, Eng SM*, Teitelbaum SL*, Britton JA, Eng SM*, Lehman TA, Neugut AI, Ambrosone CB, Santella RM, Gammon MD. Interactions of lifestyle factors, Catechol-O-Methyltransferase, and the risk of breast cancer. Annual Lineberger Comprehensive Cancer Center Retreat, University of North Carolina, Chapel Hill, NC, March, 2005.

70. Abrahamson PE*, Gammon MD, Lund MJ, Britton JA, Eley W, Porter P, Brinton LA, Coates RJ. Physical activity and breast cancer survival among young women. Annual Lineberger Comprehensive Cancer Center Retreat, University of North Carolina, Chapel Hill, NC, March 2005.

71. Abrahamson PE*, Gammon MD, Lund MJ, Britton JA*, Eley W, Flagg EW, Porter P, Brinton LA, Coates RJ. Obesity and breast cancer survival among young women. Annual Lineberger Comprehensive Cancer Center Retreat, University of North Carolina, Chapel Hill, NC, March 2005. (Award for Best Poster, Population-Sciences)

72. Shantakumar S*, Gammon MD, Eng SM*, Sagiv SK*, Gaudet MM*, Teitelbaum SL*, Britton JA, Wang LW, Wang Q, Stellman SD, Beyea J, Hatch M, Camann D, Neugut AI, Santella RM. Environmental exposures and other characteristics associated with detectable PAH-DNA adducts among a population-based sample of healthy women. Annual Lineberger Comprehensive Cancer Center Retreat, University of North Carolina, Chapel Hill, NC, March 2005.

73. Xu X*, Gammon MD, Rao M, Wetmur JG, Teitelbaum SL*, Britton JA, Gaudet MM*, Terry MB*, Neugut AI, Santella RM, Chen J*. A 19bp deletion polymorphism of a folate-metabolizing gene, Dihydrofolate Reductase (DHFR), and risk of breast cancer. Department of Defense, ERA of Hope, Philadelphia, PA, June 2005.

74. Teitelbaum SL*, Wolff MS, Neugut AI, Santella RM, Gammon MD. Gene-environment interactions and breast cancer on Long Island, NY. Department of Defense, ERA of Hope, Philadelphia, PA, June 2005.

75. Gaudet MM*, Gammon MD, Ambrosone CB, Britton JA, Teitelbaum SL*, Eng SM*, Terry MB, Bensen JT, Schroeder J, Olshan AF, Neugut AI, Santella RM. Interactions of lifestyle factors and MNSOD and breast cancer. Department of Defense, ERA of Hope, Philadelphia, PA, June 2005.

76. Conway K, Parrish E, Edminston S, Tolbert D, Novotny D, Melton J, Wold L, Gammon MD, Sellers T, Hartmann L. Presence of the estrogen receptor alpha A908G (K303R) mutation in benign and invasive breast tissues from a case-control study of benign breast disease and subsequent breast cancer. Department of Defense, ERA of Hope, Philadelphia, PA, June 2005.

MD GAMMON

72

77. Chen J*, Gammon MD, Wetmur JG, Zhang Y-J, Santella RM. One-carbon metabolism and breast cancer survival. Department of Defense, ERA of Hope, Philadelphia, PA, June 2005.

78. Steck SE*, Gaudet MM*, Eng SM*, Britton JA, Teitelbaum SL*, Neugut AI, Santella RM, Gammon MD. Lifetime versus recent dietary intake of polycyclic aromatic hydrocarbon and heterocyclic amine sources and breast cancer risk. American Institute of Cancer Research, July 2005.

79. Trivers KF*, Gammon MD, Abrahamson PE*, Lund MJ, Kaufman JS, Moorman PG, Olshan AF, Cai J, Porter PL, Brinton LA, Eley JW. Reproductive factors and breast cancer survival in women less than 55 years of age. American Association of Cancer Research, International Conference on Frontiers in Cancer Prevention Research, Baltimore, MD, November 2005.

80. Jacobson JS*, Gould SA, Greenlee H*, Terry MB, Abrahamson P*, Gaudet MM*, Grann VR, Neugut AI, Gammon MD. Antioxidant use during treatment for breast cancer. Society for Integrative Medicine, November 2005.

81. Trivers KF*, Gammon MD, Abrahamson PE*, Lund MJ, Kaufman JS, Moorman PG, Cai J, Porter PL, Brinton LA, Eley JW, Coates RJ. Oral contraceptives and breast cancer survival in younger women. American Association of Cancer Research New Developments in the Epidemiology of Cancer Prognosis, Charleston, SC, January 2006.

82. Terry MB*, Gammon MD, Zhang FF, Schoenberg JB, Brinton LA, Hibshoosh H. Cyclin E overexpression and breast cancer among young women. American Society of Preventive Oncology, Annual Meeting, Washington DC, February 2006.

83. Xu X*, Gammon MD, Wetmur JG, Voho A, Rao M, Teitelbaum SL*, Gaudet MM*, Neugut AI, Santella RM, Chen J. Functionality of the DHFR 19bp deletion polymorphism and its association with breast cancer risk among multivitamin users. American Association of Cancer Research, Annual Meeting, Washington DC, April 2006.

84. Shantakumar S*, Terry MB*, Paykin A, Teitelbaum SL*, Britton JA, Moorman PG, Kritchevsky SB, Neugut AI, Gammon MD. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk. American Association of Cancer Research, Annual Meeting, Washington DC, April 2006.

85. Fink BN*, Steck SE*, Wolff MS, Britton JA, Teitelbaum SL*, Millikan RC, Schroeder JC, Neugut AI, Gammon MD. Dietary flavonoid intake and breast cancer risk among women in the Long Island Breast Cancer Study Project. American Association of Cancer Research, Annual Meeting, Washington DC, April 2006. (AACR Scholar-in-Training Award for being ranked in the top 10% of all submitted abstracts; selected for an oral presentation.)

86. Rossner Jr. P*, Gammon MD, Terry MB*, Agrawal M, Ferris JS, Zhang FF, Teitelbaum SL*, Eng SM, Gaudet MM*, Neugut AI, Santella RM. Plasma protein carbonyl levels and breast cancer risk. American Association of Cancer Research, Annual Meeting, Washington DC, April 2006.

87. Steck SE*, Gaudet MM, Eng SM*, Britton JA, Teitelbaum SL*, Neugut AI, Santella RM, Gammon MD. Lifetime versus recent dietary intake of polycyclic aromatic hydrocarbon and heterocyclic amine sources and breast cancer risk. Center for Environmental Health and Susceptibility Research Day, Chapel Hill, NC, April 2006.

88. Sagiv SK*, Gaudet MM*, Eng SM, Abrahamson PE*, Shantakumar S*, Teitelbaum SL*, Britton JA, Bell P, Thomas J, Neugut AI, Santella RM, Gammon MD. Active and passive cigarette smoke and breast cancer survival. Science Day, Center for Environmental Health and Susceptibility, University of North Carolina, Chapel Hill, NC, April 2006.

MD GAMMON

73

89. Trivers KF*, Gammon MD, Abrahamson PE*, Lund MJ, Kaufman JS, Moorman PG, Cai J, Porter PL, Brinton LA, Eley JW, Coates RJ. Oral contraceptives and breast cancer survival in younger women. Annual Lineberger Comprehensive Cancer Center Retreat, University of North Carolina, Chapel Hill, May 2006. (Award for Best Poster, Population-Sciences)

90. Shantakumar S*, Terry MB, Teitelbaum SL*, Britton JA, Neugut AI, Gammon MD. Reproductive risk factors for breast cancer among older women. Second American Congress of Epidemiology, Seattle, WA, June 2006.

91. Fink BN*, Steck SE*, Wolff MS, Britton JA, Kabat GC, Gaudet MM*, Abrahamson PE*, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD. Dietary flavonoid intake and breast cancer survival among women on Long Island. Second American Congress of Epidemiology, Seattle, WA, June 2006. (Selected for an oral presentation)

92. Cleveland RJ*, Eng SM, Abrahamson PE*, Gaudet MM*, Britton JA, Teitelbaum SL*, Neugut AI, Gammon MD. Weight change prior to diagnosis and breast cancer survival. Second American Congress of Epidemiology, Seattle, WA, June 2006. (Selected for an oral presentation)

93. Xu X*, Gammon MD, Zhang H, Wetmur JG, Rao M, Teitelbaum SL*, Britton JA, Neugut AI, Santella RM, Chen J. Polymorphisms of one-carbon metabolizing genes and risk of breast cancer in a population-based study. American Association of Cancer Research., Los Angeles, CA, April 2007.

94. Steck SE*, Santella RM, Terry MB, Crew K*, Shen J*, Gaudet MM*, Eng SM, Britton JA, Teitelbaum SL*, Neugut AI, Gammon MD. Joint effects of cooked meat intake and DNA repair gene polymorphisms and breast cancer risk. Molecular Epidemiology Subgroup, American Association of Cancer Research, Albuquerque NM, May 2007.

95. Bradshaw PT*, Satia JA, Kabat GC, Britton JA, Teitelbaum SL*, Neugut AI, Gammon MD. Consumption of sweets and breast cancer risk among women on Long Island, NY. Society for Epidemiologic Research, Boston, MA, June 2007. (Selected for an oral presentation)

96. Hoyo C*, Schildkraut J, Murphy SK, Chow W-H, Vaughn TL, Risch H, Marks J, Calingeart B, Mayne S, Fraumeni Jr. J, Gammon MD. IGF2R polymorphisms and esophageal and gastric cardia adenocarcinomas. 9th World Congress on Gastrointestinal Cancer. Barcelona, Spain, June 2007. (Selected for an oral presentation)

97. Greenlee H*, Gammon MD, Abrahamson PE*, Gaudet MM*, Terry MB, Hershman DL, Desai M, Teitelbaum SL*, Neugut AI, Jacobson JS. Use of supplemental antioxidants after breast cancer diagnosis and during breast cancer treatment among women with breast cancer in the Long Island Breast Cancer Study Project. Society of Integrative Oncology Conference, San Francisco, CA, November 2007.

98. Greenlee H*, Gammon MD, Gaudet MM*, Terry MB, Hershman DL, Desai M, Rossner Jr. P*, Teitelbaum S*, Santella R, Neugut AI, Jacobson JS. Supplemental antioxidant intake and plasma protein carbonyl concentrations in the Long Island Breast Cancer Study Project, American Association for Cancer Research Frontiers in Cancer Prevention, Philadelphia, PA, December 2007.

99. Xu X*, Gammon MD, Zhang Y, Bestor TH, Zeisel SH, Wetmur JG, Teitelbaum SL, Neugut AI, Santella RM, Chen J. BRCA1 Promoter methylation is associated with increased mortality among a population-based sample of women with breast cancer. American Association of Cancer Research Annual Meeting, San Diego CA, April 2008

100. Xu X*, Gammon MD, Zeisel SH, Lee YL, Wetmur JG, Teitelbaum SL, Bradshaw PT*,

MD GAMMON

74

Neugut AI, Santella RM, Chen J. Choline metabolism and risk of breast cancer. American Association of Cancer Research Annual Meeting, San Diego CA, April 2008

101. Shen J*, Gammon MD, Terry MB, Wang Q, Teitelbaum SL, Neugut AI, Santella RM. Telomere length, oxidative damage, antioxidants and breast cancer risk. American Association of Cancer Research Annual Meeting, San Diego CA, April 2008

102. Xu X*, Gammon MD, Wetmur JG, Bradshaw PT*, Teitelbaum SL, Neugut AI, Santella RM, Chen J. One-carbon metabolism and survival among a population-based cohort of women with breast cancer. Era of Hope 2008 Meeting, Department of Defense, Baltimore MD, June 2008. (Selected for an oral presentation)

103. Chen J, Gammon MD, Xu X*, Zhang Y, Bestor TH, Zeisel SH, Wetmur JG, Wallenstein S, Bradshaw PT*, Garbowski G, Teitelbaum SL, Neugut AI, Santella SM. BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Era of Hope 2008 Meeting, Department of Defense, Baltimore MD, June 2008. (Selected for an oral presentation)

104. Cleveland RJ*, Eng SM, Stevens J, Teitelbaum SL, Neugut AI, Gammon MD. Prediagnostic recreational physical activity and survival from breast cancer. American Institute of Cancer Research Annual Meeting, Washington DC, November 2008.

105. Bradshaw P*, Shantakumar S*, Cleveland R*, Eng S, Terry M, Teitelbaum S*, Neugut A, Gammon M. Physical activity, body size, and breast cancer risk among older, postmenopausal women on Long Island, NY. American Society for Preventive Oncology Annual Meeting, Tampa FL, March 2009.

106. Xu X*, Gammon MD, Zhang Y, Cho YH, Wetmur JG, Teitelbaum SL, Neugut AI, Santella RM, Chen J. Gene promoter methylation and breast cancer survival in a population-based study. American Association of Cancer Research Annual Meeting, Denver CO, April 2009.

107. Shen J*, Gammon MD, Wu H-C, Terry MB, Wang Q, Bradshaw P, Teitelbaum SL, Neugut AI, Santella RM. Genetic variants in telomere pathway genes and breast cancer risk. American Association of Cancer Research Annual Meeting, Denver CO, April 2009.

108. Bradshaw PT*, Ibrahim J, Abrahamson P*, Stevens J, Millikan R, Satia J, Teitelbaum SL, Neugut AI, Gammon MD. Change in body size and survival among women diagnosed with breast cancer on Long Island, NY. Society for Epidemiologic Research, Anaheim CA, June 2009. (Selected for an oral presentation in a spotlight session)

109. Sucheston L, Choi J-Y, Laden F, Millikan Robert, Zirpoli G, Grasela M, Gammon M, Teitelbaum S, Wolff M, Zhang T, Moysich K. Pooled analyses of polychlorinated biphenyls (PCBs) exposure and CYP1A1 genetic polymorphisms on breast cancer risk. International Society Environmental Epidemiology, Dublin Ireland, August 2009.

110. Cohen SS*, Gammon MD, Millikan RC, North KE, Lange EM, Signorello LB, Blot WJ, Matthews CE. Serum adiponectin in relation to body mass index and other behavioral and environmental predictors in white and African-American women. North American Association for the Study of Obesity, Washington DC, October 2009.

111. Xu X*, Gammon MD, Zhang Y, Cho YH, Wetmur JG, Bradshaw PT*, Teitelbaum SL, Neugut AI, Santella RM, Chen J. The role of one-carbon metabolism in global and promoter methylation of breast cancer in a population-based study. American Association for Cancer Research Annual Meeting, Washington DC, April 2010.

112. Shen J*, Gammon MD, Terry MB, Wang Q, Bradshaw PT*, Teitelbaum SL, Neugut AI, Santella RM. Genetic polymorphisms in telomere pathway genes may potentially impact breast cancer survival. American Association for Cancer Research Annual Meeting, Washington DC, April 2010.

MD GAMMON

75

113. Nyante SJ*, Gammon MD, Kaufman JS, Bensen JT, Lin DY, Barnholtz-Sloan JS, Luo J, Millikan RC. Association between adiponectin, leptin, and leptin receptor polymorphisms and breast cancer subtypes. Society for Epidemiologic Research Annual Meeting, Seattle WA, June 2010.

114. Bradshaw P*, Ibrahim J, Cleveland R*, Teitelbaum S, Neugut A, Gammon M. Post-diagnosis physical activity and survival after breast cancer diagnosis: the Long Island Breast Cancer Study. American Institute of Cancer Research Annual Meeting, Washington DC, October 2010.

115. Xu X*, Gammon MD, Wetmur JG, Teitelbaum SL, Bradshaw PT, Neugut AI, Santella RM, Chen J. Global DNA methylation by LUMA predicts breast cancer risk in a population-based study. American Association for Cancer Research Annual Meeting, Orlando FL, April 2011. [Recognized as Highly Rated – Top 2% of all Abstracts.]

116. Bradshaw PT*, Cleveland RJ, Stevens J, Rosamond W, Abrahamson PE, Teitelbaum SL, Neugut AI, Gammon MD. Post-diagnosis weight gain in breast cancer survivors: when should we intervene? San Antonio Breast Cancer Symposium, San Antonio TX, December 2011.

117. Link A*, Gammon MD, Jacobson JS, Abrahamson P, Bradshaw P, Terry MB, Teitelbaum S, Neugut A, Greenlee H. Self-care and complementary and alternative medicine use during treatment among women with breast cancer in the Long Island Breast Cancer Study Project. Society for Integrative Oncology, Cleveland OH, November 2011.

118. Bradshaw PT*+, Khankari N*+, Teitelbaum SL, Chen J, Gammon MD, for the LIBCSP. Nutrient pathways and breast cancer risk: An application of hierarchical modeling. American Institute of Cancer Research Annual Meeting, Washington DC, November 2011.

119. McCullough L*, Gammon M, Cleveland R, Bradshaw P*, Millikan R, North K, Olshan A, Eng S, Ambrosone C, Ahn J, Steck S, Teitelbaum S, Neugut A, Santella R. Polymorphisms in oxidative stress genes, physical activity and breast cancer risk. American Association of Cancer Research, Chicago IL, March-April 2012. (Selected for a Minority Student in Training Award).

120. Navarro Silvera SA, Mayne ST, Risch H, Gammon MD, Vaughan T, Chow W-H, Dubin JA, Dubrow R, Stanford JL, West AB, Rotterdam H, Blot WJ. Diet and lifestyle factors and risk of subtypes of esophageal and gastric cancer: classification tree analysis. Cancer Caucus, American Public Health Association, San Francisco CA, October 2012.

121. Bradshaw P*, Ibrahim J, Stevens J, Cleveland B, Abrahamson P, Teitelbaum S, Neugut A, Gammon M. Post-diagnosis body mass index and survival after breast cancer diagnosis: the Long Island Breast Cancer Study. The Obesity Society, Atlanta GA, November 2012

122. Khankari N*, Bradshaw P*, McCullough L*, Teitelbaum S, Steck S, Fink B, Xu X, Ahn J, Ambrosone C, Crew K, Neugut A, Santella R, Chen J, Gammon M. Flavonoid-gene interactions and breast cancer. American Institute of Cancer Research, Washington DC, November 2012 (meeting cancelled due to Hurricane Sandy); the UNC Center for Environmental Health and Susceptibility, Annual External Advisory Committee Meeting, Chapel Hill NC November 2012; and the American Society of Preventive Oncology, Memphis TN, March 2013 (Selected for UNC Student Travel Award).

123. Samai PS*, Bradshaw PT*, Teitelbaum SL, Neugut AI, Gammon MD. Examining the shape of the obesity-breast cancer incidence curve. American Institute of Cancer Research, Washington DC, November 2012 (meeting cancelled due to Hurricane Sandy).

124. White AJ*, Teitelbaum SL, Wolff MS, Stellman SD, Neugut AI, Gammon MD. Exposure

MD GAMMON

76

to fogger trucks and breast cancer incidence in the Long Island Breast Cancer Study Project (LIBCSP). Breast Cancer and Environment Research Program (BCERP) Extended Environmental Exposures Annual Meeting, San Francisco CA, November 2012; and the UNC Center for Environmental Health and Susceptibility, Annual External Advisory Committee Meeting, Chapel Hill NC, November 2012

125. McCullough LE*, Santella RM, Cleveland RJ, Millikan RC, Olshan AF, North KE, Bradshaw PT, Eng SM, Terry MB, Shen J, Crew KD, Rossner P, Teitelbaum SL, Neugut AI, Gammon MD. Polymorphisms in DNA repair genes, recreational physical activity and breast cancer risk. American Association of Cancer Research (AACR)-Japanese Cancer Association Joint Conference: Breakthroughs in Basic and Translational Cancer Research, February 2013 Maui, HI.

126. Reimers L*, Crew KD, Santella RM, Steck SE, Terry MB, Hershman DL, Shane E, Cremers S, Dworakowski E, Teitelbaum SL, Neugut AI, Gammon MD. Association between polymorphisms in the vitamin D receptor pathway, plasma 25-hydroxyvitamin D levels, and breast cancer risk. American Society of Preventive Oncology, Memphis TN, March 2013.

127. Mordukhovich I*, Beyea J, Herring A, Hatch M, Stellman S, Teitelbaum SL, Richardson D, Millikan RC, Neugut AI, Santella RM, Gammon MD. Vehicular traffic exposure to polycyclic aromatic hydrocarbons and breast cancer risk. Environmental Health Annual Meeting, Boston MA, March 2013 (withdrawn).

128. Kim J*, Gammon MD, Mersereau JE. BRCA mutation carriers: a new target population for fertility preservation consultation and treatment. Annual Meeting for the American Congress of Obstetrics and Gynecology. New Orleans LA, May 2013.

129. Petrick JL*, Steck SE, Bradshaw PT*, Engel LS, He K, Vaughan TL, Gammon MD. Dietary flavonoid intake and risk of Barrett’s esophagus. Society for Epidemiologic Research Annual Meeting, Boston MA, June 2013.

130. Smith GS*, VandenEeden S, Baxter R, VanRie A, Herring A, Richardson DB, Emch M, Gammon MD. Cigarette smoking and pulmonary tuberculosis in northern California. Union World Conference on Lung Health, Paris France, November 2013.

131. Smith GS*, Van Den Eeden SK, Shan J, Baxter R, Herring A, Richardson DB, VanRie A, Garcia C, Emch M, Gammon MD. Air pollution and pulmonary tuberculosis among a population-based sample of northern California residents. Union World Conference on Lung Health, Paris France, November 2013 (Selected for Oral Presentation).

132. Petrick JL*, Steck SE, Bradshaw PT*, Chow WH, Engel LS, He K, Risch HA, Vaughan TL, MD Gammon. Dietary flavonoid intake and risk of esophageal and gastric cancers. American Institute of Cancer Research, Washington DC, November 2013.

133. McCullough L*, Eng S, Bradshaw P, Cleveland R, Steck S, Terry M, Shen J, Crew K, Rossner P, Ahn J, Ambrosone C, Teitelbaum S, Neugut A, Santella R, Gammon M. Polymorphisms in DNA repair and oxidative stress may modify the body size-breast cancer association. American Society of Preventive Oncology, Bethesda MD March 2014. (Best Poster Award for Trainees)

134. Khankari N*, Bradshaw P, Steck S, Olshan A, He K, Teitelbaum S, Neugut A, Santella R, Gammon M. Polyunsaturated fatty acids, genetic susceptibility, and breast cancer incidence. Society for Epidemiologic Research, Seattle WA June 2014.

135. White AJ*, Teitelbaum SL, Stellman SD, Beyea J, Steck SE, Mordukhovich I, McCarty KM, Ahn J, Neugut AI, Rossner Jr P, Santella RM, Gammon MD. Indoor Air Pollution Exposure from Use of Indoor Stoves and Fireplaces in Association with Breast Cancer. Society for Epidemiologic Research, Seattle WA June 2014. (Selected for Oral

MD GAMMON

77

Presentation) 136. Bradshaw PT*, Khankari N*, Steck SE, Teitelbaum SL, Neugut AI, Gammon MD.

Consumption of sweets and survival among women with breast cancer. American Institute of Cancer Research, Washington DC, October 2014.

137. Parada Jr., H.*, Wolff MS, Engel LS, White AJ*, Eng SM, Cleveland R, Khankari N*, Teitelbaum SL, Neugut AI, Gammon MD. Organochlorine insecticides DDT and chlordane in relation to survival following breast cancer. Society for Epidemiologic Research, Denver CO, June 2015. (Selected for Oral Presentation)

138. McClain KM*, Bradshaw PT*, Gammon MD, Olshan AF. Fish intake and the risk of head and neck cancer. Society for Epidemiologic Research, Denver CO, June 2015.

139. White AJ*, Chen J, McCullough LE*, Xu X, Cho Y-H, Teitelbaum SL, Neugut AI, Terry MB, Hibshoosh H, Santella RM, Gammon MD. Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study. Society for Epidemiologic Research, Denver CO, June 2015.

140. Parada, Jr. H*, Wolff MS, Engel LS, Eng SM, Khankari NK*, Teitelbaum SL, Neugut AI, Gammon MD. Polychlorinated biphenyls and their association with survival following breast cancer. Society for Epidemiologic Research, Denver CO, June 2015. (Selected for Late Breaker Oral Presentation)

141. Parada, Jr. H*, Wolff MS, Engel LS, Eng SM, Khankari NK*, Teitelbaum SL, Neugut AI, Gammon MD. Polychlorinated biphenyls and their association with survival following breast cancer. Lineberger Comprehensive Cancer Center Annual Scientific Retreat, September 2015. (Best Student Poster Award in Population Sciences)

142. White AJ*, Bradshaw PT, Herring AH, Teitelbaum SL, Beyea J, Stellman SD, Steck SE, Mordukhovich I, Eng SM, Engel LS, Conway K, Hatch M, Neugut AI, Santella RM, Gammon MD. Exposure to multiple sources of polycyclic aromatic hydrocarbons and breast cancer incidence. San Antonio Breast Cancer Symposium, December 2015.

143. White AJ*, Chen J, Teitelbaum SL, McCullough LE*, Xu X, Cho YH, Conway K, Beyea J, Stellman SD, Steck SE, Mordukhovich I, Eng SM, Terry MB, Engel LS, Hatch M, Neugut AI, Hibshoosh H, Santella RM, Gammon MD. Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer. San Antonio Breast Cancer Symposium, December 2015.

144. McCullough LE*, Chen J, Cho YH, Khankari NK, Bradshaw PT, White AJ, Garbowski G, Teitelbaum SL, Terry MB, Neugut AI, Hibshoosh H, Santella RM, Gammon MD. DNA methylation modifies the association between obesity and survival after breast cancer diagnosis. American Association of Cancer Research Annual Meeting, New Orleans LA, April 2016.

145. McClain KM*, McCullough LE, Bradshaw PT, Shantakumar S, Cleveland R, Eng SM, Terry MB, Neugut AI, Teitelbaum SL, Gammon MD. Age-specific indicators of a healthy lifestyle and risk for postmenopausal breast cancer: associations with alcohol intake, obesity, physical activity, and aspirin use. Society for Epidemiologic Research, Joint Epidemiology Congress, Miami FL, June 2016.

146. Parada Jr. H*, Steck SE, Cleveland RJ, Teitelbaum SL, Neugut AI, Santella RM, Gammon MD. Genetic polymorphisms of phase I metabolizing enzyme genes, grilled and smoked meat intake, and breast cancer incidence. Society for Epidemiologic Research, Joint Epidemiology Congress, Miami FL, June 2016.

MD GAMMON

78